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Abstract 
Introduction 
High plantar pressures have been shown to be a key risk factor for foot ulceration 
in people with diabetes. Consequently, patients are often prescribed insoles designed to 
reduce pressure. New technologies, such as plantar pressure measurement devices and 
3D foot scanners, have the potential to improve insole design. However, it is not clear to 
what extent such technologies are currently being used by clinicians, nor which other 
factors influence clinical decision making in the prescription of insoles. Furthermore, 
there has been minimal previous research designed to understand how best to use 
technology to improve insole design for patients with diabetes.  
Methods 
This thesis comprises four separate studies: a first qualitative study aimed at 
understanding the factors influencing practitioner decision making and the current role of 
technology. Three other quantitative studies were then performed to help understand the 
potential role of technology in designing insoles for medium-risk patients with diabetes 
and neuropathy. For each of these three studies, individually customised insoles were 
manufactured for every patient using CAD/CAM technology and data on both plantar 
pressure and foot shape. The first study investigated the reproducibility of plantar 
pressure collection in patients with diabetes and neuropathy while wearing the customised 
insoles, while the second investigated the effect of systematically varying two insole 
design features, metatarsal bar position and cushion material, on plantar pressures. In the 
final study, associations were investigated between changes in plantar pressure with 
different customised insole designs and specific structural and biomechanical foot 
characteristics of each participant. 
Results  
The findings of the qualitative study suggest that current clinical practice is based 
on training but that it develops in time based on practitioner’s clinical experience. 
Technology is not normally used because the data is considered too complex to use and 
interpret. However, practitioners agreed that they would use technology that is more user-
friendly and focused on improving patient outcomes.  
 xv 
 
The first quantitative study showed a relatively high level of pressure variability (up to 
55 KPa under metatarsal heads) which we suggest is a characteristic of patients with 
diabetes and neuropathy. The second quantitative study showed that customised insoles 
which incorporate both a metatarsal bar and cushioning materials in front of the bar are 
effective in reducing peak pressures (PP). However, the optimum design was that which 
incorporated a combination of poron (cushioning material) with a metatarsal bar, located 
distal or on the point of PP. In the final quantitative study, specific individual 
characteristics which predicted PP changes were identified, such as tissue stiffness and 
joint range of movement (ROM). Based on these findings, some tentative 
recommendations for insole prescription were suggested. For example, to reduce PP 
under the 1st metatarsal when high tissue stiffness is present use a metatarsal bar just 
behind the PP combined with poron if there is a low range of movement of the 1st 
metatarsophalangeal joint. But if there is a high range of movement of the 1st 
metatarsophalangeal joint, a distal metatarsal bar with Poron should be used. 
Conclusion 
Taken together, the results of this work show that practitioners are willing to 
embrace more technology within their clinical practice and that it could be used to 
improve the efficacy of insoles designed to reduce plantar pressures for people with 
diabetes. 
 
 1 
 
1 Introduction 
1.1 Diabetes  
Diabetes mellitus (DM) is a condition characterised by high blood glucose levels, 
which is associated with the risk of developing severe co-morbidities and complications, 
including heart disease, stroke, blindness, kidney disease, nerve damage, and foot 
complications (van Acker et al., 2014). There are two main types of DM, type 1 and type 
2. Type 1 DM typically affects patients earlier in life and is a complex process whereby 
genetic and environmental factors produce an autoimmune response, leading to the 
destruction of pancreatic β-cells within the islets of Langerhans, resulting in an absolute 
insulin deficiency (Forbes&Cooper, 2013, Tamayo et al., 2014). In contrast, type 2 DM 
tends to affect people later in life and is characterised by a decline in pancreatic islet 
secretory function on one hand and tissue insulin resistance on the other (Forbes&Cooper, 
2013). This is the most common type of DM and has become a major global public health 
problem, particularly in low and middle-income countries (Bi et al., 2012).  
1.1.1 Complications and physiological changes associated with diabetes 
The prevalence of DM is increasing globally (Zimmet et al., 2014) and 
consequently, the number of associated complications is also set to increase. The main 
complications associated with this disease include nephropathy, retinopathy, 
cardiovascular disease, peripheral arterial disease and peripheral neuropathy. Diabetic 
nephropathy is the most frequent cause of renal failure in the developed world 
(Forbes&Cooper, 2013, Tamayo et al., 2014). It is characterised by the presence of 
proteins in the urine due to a deterioration of kidney function (nephropathy), which 
progresses over a long period of time, often over 10 – 20 years. Once nephropathy is 
established, typically most patients experience an increase in blood pressure, which itself 
is a major risk factor for diseases such as stroke and heart attacks (Forbes&Cooper, 2013). 
Diabetic retinopathy is also a frequent complication associated with diabetes and 
is the most common cause of acquired blindness in the western world (Forbes&Cooper, 
2013, Tamayo et al., 2014). It is characterised by a range of lesions within the retina and 
develops over many years, with almost all diabetic patients exhibiting some degree of 
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retinopathy after 20 years of the disease (Forbes&Cooper, 2013). There is a close 
association between diabetic retinopathy and diabetic nephropathy.  
Cardiovascular disease accounts for more than half of the mortality of the diabetic 
population. Interestingly, someone with diabetes is just as likely to have a heart attack as 
a non-diabetic with a previous history of heart attack, and three times more likely than 
the general population (Forbes&Cooper, 2013). The mortality derived by this 
complication represents more than half of the mortality seen in the diabetic population. 
In addition, peripheral arterial disease is characterised by several functional abnormalities 
of the microvasculature, which lead to capillary hypoperfusion and impaired development 
of collateral vessels, consequently, resulting in delayed, or even impaired, wound healing 
(Brownrigg et al., 2013). Furthermore, those with diabetes may experience peripheral 
neuropathy which is defined as “symmetrical, length-dependent sensorimotor 
polyneuropathy attributable to metabolic and microvessel alterations resulting from 
chronic hyperglycaemia and cardiovascular risk covariates” (Tesfaye et al., 2010). The 
normal development of this complication starts in the toes and gradually moves 
proximally. Numbness, cramps or deep pain are the most common symptoms and are 
generally worse at night. Initially, it will affect sensitivity and thermal sensation, then in 
the later stages, will progress to alter muscle and motor aspects of the lower limbs (Singh 
et al., 2014). 
1.1.2 Prevalence and cost of diabetes 
The prevalence of DM has been increasing exponentially over the last few years. 
The International Diabetes Federation (IDF) predicted a worldwide prevalence of DM in 
2013 to be 382 million (the figure previously expected for 2030) and that by 2035, this 
number would increase up to 600 million (Rayman, 2010). In the UK, more than 1 in 20 
people suffer from DM (both diagnosed and undiagnosed). In 2011, there were 2.9 million 
diagnosed worldwide with DM and the average prevalence of this disorder was 4.45%, 
with 10% of adults with DM diagnosed as type 1 and 90% with type 2 (Kurup&Thomas, 
2013). Focusing on the trends for each type of DM, serious and disturbing changes 
between the ages of disease presentation have been observed. For type 1 DM, incidence 
has been rising during the past decades and if this trend is maintained, the number of new 
cases in European children younger than five years will double by 2020, and prevalence 
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of cases in individuals younger than 15 years will rise by 70% (van Belle et al., 2011). 
Type 2 DM was traditionally a disorder of adults and elderly people, however, it has 
become more common, not only in young adults but also in adolescents and children, 
probably due to obesity as a result of bad life habits such as diet and a sedentary lifestyle 
(Zimmet et al., 2014). 
DM has become a serious global problem. Asian countries have high rates of DM 
prevalence and compared with Western populations, Asians develop DM at younger ages, 
at lower degrees of obesity, and at much higher rates given the same amount of weight 
gain (Chan et al., 2009). Furthermore, more than 75% of the people with this disease live 
in low-income and middle-income countries (Federation, 2012), representing a significant 
health challenge due to the lack of access to treatment because of their country’s lack of 
resources. Therefore, there will be an increase in the risk of premature morbidity and 
mortality in these countries, with a subsequent increase in treatment costs for these 
patients.  
This increase in DM prevalence has been reflected in the health care systems 
expenditures. In 2010, global health expenditure attributable to DM was estimated to be 
US$376 billion (12% of all global health expenditure). Moreover, by 2030, global health 
expenditure attributable to DM is expected to reach between $490 billion and $893 
billion, which represents an increase of 30 – 34% from 2010 (Zimmet et al., 2014). 
However, this expenditure varies hugely by region. For instance, more than 90% of global 
health expenditure on DM is in the world’s richest countries, 57% in North America, 28% 
in Europe, and 10% in the western Pacific (Zimmet et al., 2014). The direct and indirect 
costs associated with DM management in the UK currently stands at £23.7 billion per 
annum (Kurup&Thomas, 2013). This increase in DM-related expenses can be explained 
by the increased prevalence in the younger population, which leads to a longer evolution 
of the disease and therefore, more frequent, complex and serious complications which 
require hospital treatment.  
1.2 Diabetic foot syndrome 
One of the most serious and disabling diabetic complications is diabetic foot (DF). 
The World Health Organization (WHO) defines the DF as “The foot of diabetic patients 
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that has the potential risk of pathologic consequences including infection, ulceration and 
or destruction of deep tissues associated with neurologic abnormalities, various degrees 
of peripheral vascular disease and / or metabolic complications of DM in the lower limb” 
(Al Musa, 2013).  
The DF is characterised mainly by the convergence of two of the most common 
consequences of DM, neuropathy and peripheral vascular disease. More than half of 
diabetic patients who have been suffering from the disease for 15 years or more present 
with diabetic neuropathy (Boulton, 2010). On the other hand, peripheral vascular disease 
affects 8 – 13% of people with diabetes (Abbott et al., 2005), being present in most 
diabetic individuals who have had DM for more than 25 years. Moreover, in the presence 
of neuropathy, there is a lack of protective sensation that will increase the likelihood of 
ulcer formation and it has been shown that high plantar pressures are highly associated 
with skin breakdown and ulceration in people with DM and peripheral neuropathy (Lott 
et al., 2007). Also, with regard to equal occlusive arterial damage, a person with diabetes 
will develop distal ulcers or gangrene in up to 40% of cases, while in patients without 
diabetes this complication will appear in 9% of the cases (Kannel, 1994). Consequently, 
when these two conditions are present at the same time, they lead to DF syndrome and 
also predispose the patient to ulcer formation.  
1.2.1 Diabetic foot ulceration: the main complication of the DF 
A diabetic foot ulcer is defined as “any necrosis, gangrene, or full-thickness skin 
defect occurring distal to the ankle in a diabetic patient” (Schaper et al., 2012). Ulcers act 
as an entry for microorganisms that may lead to infections, leading to severe 
complications such as partial foot amputations, or, in the most severe cases, limb loss 
(Barshes et al., 2013). Furthermore, skin changes in diabetes may increase the risk of 
developing an ulcer (Hashmi et al., 2006, Hsu et al., 2009, Pai&Ledoux, 2010, Chao et 
al., 2011, Sun et al., 2011). People with this disease often have impairments in their 
immune system response, with a reduced ability to recruit inflammatory cells to damaged 
tissues, delayed wound healing and increased risk of infection (Leung, 2007).  
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1.2.2 Prevalence and costs to society of diabetic foot syndrome 
The worldwide incidence of DF varies between 0.5 and 3% per year, with 25% of 
patients with DM suffering an ulcer at least once in their life (Boulton, 2010). DF 
ulceration represents a major medical, social and economic problem all over the world. 
Complications of foot ulcers are the leading cause of hospitalisation and amputation in 
diabetic patients, accounting for more hospital admissions than any other long-term 
complication of diabetes, resulting in increased morbidity and mortality. Annually, 
people with diabetes who also have neuropathy will develop an ulcer in 7 – 10% of cases 
(Hashmi et al., 2006, Rathur&Boulton, 2007, Lepantalo et al., 2011), whereas those with 
additional risk factors, such as peripheral vascular disease, foot deformity, previous ulcers 
or previous amputation, this rate increases to 25 – 30% (Lepantalo et al., 2011).  
Regarding the UK national health system (NHS), this complication entails an 
increase in the expenditure and number of patients to be treated. The mean duration of 
DF patient’s hospitalisation is 59% longer than a patient with another disease (Ramsey et 
al., 1999). Also, there is a high impact on the patient’s quality of life after being diagnosed 
with DF syndrome (Garcia-Morales et al., 2011). Major amputation will be needed within 
one year in 5 – 8% of patients with diabetic ulcers (Lepantalo et al., 2011), and of all 
amputations, 85% are preceded by a foot ulcer which subsequently deteriorates to a severe 
infection or gangrene (Rathur&Boulton, 2007, Lepantalo et al., 2011, Bortoletto et al., 
2014). Studies from the UK have shown an increase in amputations in the last decade and 
it is estimated that 50% of non-traumatic amputations in hospitals in developed countries 
are due to DF (Carmona et al., 2005). Also, the rate of lower limb non-traumatic 
amputation is between 10 and 20 times greater in patients with DM (85%) when compared 
to patients without this disease (Aragon-Sanchez et al., 2009). Survival after amputation 
is lower in diabetic patients than in other amputees, being 40 – 50% between 3 and five 
years after the intervention. Furthermore, cardiovascular and respiratory complications 
are the leading causes of mortality in patients with DM and previous amputation (Aragon-
Sanchez et al., 2009, Aragon-Sanchez et al., 2010).  
With regard to the UK, 20 – 40% of healthcare resources spent on diabetes are 
related to the diabetic foot (Lepantalo et al., 2011). The total direct cost to NHS for DF 
complications was estimated to be £1.61 billion, which is approximately 10% of the total 
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annual direct cost associated with DM, equivalent to about £1 in every £175 spent by the 
NHS in England. Altogether, total expenditure on healthcare related to foot ulceration 
and amputation in diabetes in 2010 – 2011 in England is estimated at £580.5 million (Kerr 
et al., 2014). This cost is primarily for outpatient expenditure, increased bed occupancy 
and prolonged stays in hospital (Kerr et al., 2014, van Acker et al., 2014). However, 
ulceration and amputation also entail costs to individuals and their families through lost 
working days, reduced mobility and travel to surgeries and clinics (Kerr et al., 2014). The 
cost of treating DF ulcers increases as the severity of ulcers increases. Moreover, patients 
with both infection and peripheral vascular disease reported a longer hospital stay, a 
higher use of antibiotic therapy and more inpatient and outpatient care than patients 
without this complication (van Acker et al., 2014). The serious consequences of this 
complication added to the high costs to the NHS stress the need for enhanced management 
and preventative strategies. 
1.2.3 Overview of the thesis and the SMARTPIF project 
The DFU is a disabling complication for patients and a burden for the NHS. Given 
the costs, reduced quality of life and risk of foot amputation, there is an urgent need to 
understand how to manage diabetic foot syndrome more effectively. Therefore, the aim 
of this thesis was to explore different concepts within the context of diabetic foot 
syndrome. The research was funded by a larger 7th Framework European Union project 
named “SMARTPIF” (Smart tools for the Prescription of orthopaedic Insoles and 
Footwear).  
The purpose of SMARTPIF was to enhance the practice of orthotic footwear and 
insoles prescription through the development of a set of technological devices and 
computer tools that would facilitate effective therapeutic prescription. It was envisaged 
that this set of tools would allow a prediction of the pressures experienced by the foot 
during a gait cycle and also provide software which would automatically select an 
appropriate shoe/insole. In addition, the project aimed to produce visualisation software 
tools which could enable the patient to choose a shoe before manufacture. The idea was 
to develop the possibility for patients to virtually try-on the selected shoes using 
augmented reality techniques through a virtual mirror, without having footwear stocks 
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available at the podiatrist’s consulting office. Overall, there were four specific objectives 
for the full SMARTPIF project, these were to: 
1. collect morphological and biomechanics data on the feet of individual patients 
2. predict foot pressure during gait for different footwear designs 
3. integrate the pressure predictions with easy to operate insole design software 
4. enable patients to try-on in a virtual way their footwear choices 
The University of Salford’s role in the SMARTPIF project was to collect the 
morphological, biomechanical and pressure data from a cohort of medium or high-risk 
patients (objective 1). An aligned objective was to obtain insight into the factors which 
influence practitioner prescribing practices, and also the current role of technology in day 
to day clinical practice.  
The SMARTPIF project has provided a base framework for the different studies 
presented in this thesis. However, the remit of this funded project was very broad and did 
not specify which patient group should be investigated, nor did it specify the precise 
nature of the research. This gave the freedom to shape the project in a direction that fitted 
the author's professional experience as a podiatrist and which also answered important 
scientific questions on insole design. I first performed a literature search in order to 
identify a medium or high-risk population who would benefit from wearing customised 
insoles. The target population chosen was patients with diabetes and neuropathy, given 
the serious and disabling complications that this disease entails. As a podiatrist, I have 
always worked with patients with diabetes and witnessed the serious impact that 
ulceration and/or amputation has on their quality of life. Prevention is the key approach 
to avoid ulceration, and insoles are the most common preventative measure. However, 
there is little evidence and no consensus on the best insole design approach for ulcer 
prevention. This lack of research was the main motivation for me to embark on this PhD. 
Once the target population had been identified, I performed another literature 
search on the insole designs to be tested. I then developed a specification for the data 
which needed to be collected and also for the data collection protocol. I performed all 
data collection, processing and analysis independently at the University of Salford. Based 
on these data, it was possible to develop a set of studies focusing on the clinical 
management and insole design for people with diabetes within the context of this 
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externally funded project. In total, there are four separate studies completely independent 
from the EU project that conform this PhD. The first, a qualitative study, focused on the 
different factors that influence clinical decision making and, more specifically, the role 
of technology within the current clinical practice and how it could enhance orthotic 
prescription. This was followed by three biomechanical studies examining different 
aspects of insole design and plantar pressure measurement. 
Due to the different nature of the qualitative and quantitative work, a separate 
literature review has been presented for each aspect of the work. Chapter 2 provides an 
overview of the current clinical management of the diabetic foot syndrome, followed in 
Chapter 3, with a more in-depth review of the pathogenesis, key risk factors and 
preventative strategies for diabetic foot ulceration. Chapter 4 describes the qualitative 
study which focused on gaining an improved understanding of current clinical practice 
and the role of technology. One of the conclusions of this work was the need to enhance 
technology to be more usable in current clinical practice. Following on from this idea, the 
subsequent chapters describe three quantitative studies which examine different aspects 
of pressure measurement and the use of technology to design and prescribe insoles for 
people with diabetes. 
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2 Literature review - Section I: The 
clinical management of diabetic foot 
syndrome 
The diabetic foot is a serious complication that requires a proper professional 
management and prevention. This section presents a detailed literature review about how 
clinical practice should be, and the trends it presents. However, although there are general 
guidelines for some aspects of the clinical practice, there is a lack of publications about 
real influences and trends in clinical practice. Moreover, practitioner’s decisions tend to 
be based on experience and personal training rather than standardised guidelines. 
2.1 Current practice clinical decision-making  
Diabetic foot syndrome entails different serious complications, such as 
neuropathy, peripheral arterial disease, retinopathy or nephropathy. These complications 
put patients on different levels of risk of serious consequences such as foot ulceration, 
lower limb amputation or, in the most severe cases, death. Accordingly, interventions 
should offload high pressures, with the aim of preventing ulcer formation. Generally, 
insoles are prescribed by podiatrists to these high-risk patients; however, there is no clear 
algorithm for the construction of optimal foot orthoses. There are national guidelines that 
recommend that high-risk patients, such as diabetics, routinely see podiatric physicians. 
American Diabetes Association guidelines recommend foot screening for all diabetic 
patients at least every 12 months (Boulton et al., 2008), whereas those at greater risk for 
serious foot problems should visit podiatric physicians an average of 3.7 times a year 
(Gabbay et al., 2011) so that they can be assessed and prescribed preventative insoles 
when necessary. However, this is not an easy task, which if not carried out appropriately, 
could increase the risk of ulceration. 
Since Merton Root (1994) introduced the functional foot orthosis in the 1950s, 
many modifications and new techniques have been proposed to advance his original 
ideas. In addition to variations in the basic design of foot orthoses, numerous materials 
are used in the manufacturing process and foot orthoses can be manufactured in many 
different ways. Practitioners generally manufacture the orthoses themselves or use a 
commercial orthotic laboratory. Furthermore, there has been an increase in the use of 
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prefabricated foot orthoses given the lack of publications showing that customised insoles 
achieve better results than those which are prefabricated (Paton et al., 2012).  Given the 
huge amount of choice when prescribing insoles, and the important risks if this task is not 
performed properly, a better insight of the process followed by professionals when 
treating these medium and high-risk patients is needed. 
2.1.1 Patient assessment 
Clinical guidelines for diabetic foot care state that “all diabetic patients should be 
examined at least once a year for potential foot problems, and patients with demonstrated 
risk factor(s) should be examined more often (every 1 ± 6 months). The absence of 
symptoms does not mean that the feet are healthy since the patient can have neuropathy, 
peripheral vascular disease or even an ulcer without any complaints. The feet should be 
examined with the patient lying down and standing up, and the shoes and socks should 
also be inspected” (Apelqvist et al., 2000). The steps taken should address the various 
aspects as detailed in Table 2.1. 
History 
Previous ulcer/amputation, previous foot education, social 
isolation, poor access to healthcare, barefoot walking 
Neuropathy Symptoms such as tingling or pain. Loss of sensation 
Vascular status Claudication, rest pain, pedal pulses, discoloration 
Skin 
Colour, temperature, oedema, nails, ulcer, callus, dryness, 
cracks interdigital maceration 
Bone/joint Deformities or bony prominences. Loss of mobility 
Footwear/stockings Assessment of both inside and outside 
 
Table 2.1: Different aspects of the assessment of a patient with diabetes 
Once the history is fulfilled, and before prescribing an insole, a biomechanical 
evaluation of the foot and ankle is required to identify the key design features to include. 
Podiatrists, the main profession managing DF in the multidisciplinary teams, base their 
biomechanical evaluation of the foot and ankle on the description provided by Root et al. 
(1994), “estimating” rather than measuring foot or limb position and motion (Jarvis et al., 
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2012). In addition to their static assessment, podiatrists conduct a dynamic gait 
assessment focusing on observation at key events of the gait cycle (Jarvis et al., 2012). 
Podiatrists perform multiple clinical tests and measurements of the joints of the 
foot and leg (knee, ankle, subtalar, and metatarsophalangeal joints), both non-weight 
bearing and weight bearing. This is performed to identify if there is any alteration on the 
range of motion or alignment that can affect gait or can increase pressure (Tollafield, 
1995). The assessment process is complex and is influenced by many factors, including 
national or local professional knowledge, clinical experience and practical constraints 
(time available for an assessment, the range of orthotic prescriptions available to a 
clinician and the particular profile of patients the clinician sees in their practice) (Jarvis 
et al., 2012). 
Once the podiatrist has assessed and diagnosed the patient, a target for the 
treatment is set that will include the use of insoles. Clinicians must take into consideration 
the potential effects of many different factors when designing an insole; if not carried out 
appropriately, this difficult task may increase the risk of ulceration. To prevent ulcers, 
offloading insoles are normally prescribed by podiatrists to diabetic patients with 
neuropathy, as high peak pressures have been shown to predispose ulcer development 
(Paton et al., 2011, Patry et al., 2013). There is some research that supports the use of a 
variety of designs for the foot affected by diabetic complications, mainly with the aim of 
reducing the increased foot pressures (Hodge et al., 1999, Bus et al., 2004, Mueller et al., 
2006, Guldemond et al., 2007, Cheung&Zhang, 2008, Stolwijk et al., 2011). Up to 40% 
foot pressure reduction can be achieved providing protective benefits (Albert&Rinoie, 
1994, Guldemond et al., 2007). There has also been some attempt at evaluating different 
materials (Fauli et al., 2008, Healy et al., 2012).  
In the literature, the main aim of insoles for patients with diabetes is PP reduction 
(Hodge et al., 1999, Bus et al., 2004, Mueller et al., 2006, Guldemond et al., 2007, 
Cheung&Zhang, 2008, Stolwijk et al., 2011). Different insole designs and materials have 
been tested in order to establish their effect on PP, and a reduction of these is classified 
as a good insole performance or a positive response to the insole. Interestingly, Kang et 
al. (2006) found a significant correlation between peak pressure reductions and the 
corresponding decrease in pain levels on the subjects tested. Accordingly, in patients with 
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diabetes and neuropathy who cannot feel pain, a PP reduction would indicate a decrease 
in pain and its cause. It could be therefore considered as a positive response to the insole. 
Insoles are often prescribed to patients with similar conditions, however, not all 
of these patients have a positive response to the orthotics. Research has demonstrated 
considerable variability in the degree of plantar pressure reduction across different 
individuals (Bus et al., 2004, Tsung et al., 2004, Kang et al., 2006). This variation on 
peak pressure reduction could have an influence on the different clinical responses to 
insoles experienced by similar patients. Accordingly, when a pressure reduction is 
achieved, the patient had a positive response to the insole. On the contrary, if there is no 
pressure reduction, or there is an increase of pressures, the patient had a negative 
response. This approach was taken in the final quantitative study (Chapter 8) to classify 
participants as responders and non-responders (section 8.6.1). 
The main goal of preventative insoles prescribed for people with diabetes is 
pressure offloading, so the most reliable method to check if insoles are effective is through 
pressure measurement devices, which are normally used in research. These pressure 
devices have shown that insoles prescribed are an effective approach to pressure 
offloading (Ashry et al., 1997, Postema et al., 1998, Bus et al., 2004, Hsi et al., 2005, 
Mueller et al., 2006, Owings et al., 2008, Redmond et al., 2009, Koenraadt et al., 2012, 
Paton et al., 2012, Ibrahim et al., 2013). However, these new technological approaches 
are not commonly used in clinical practice due to high costs and their use is time-
consuming and complex (Williams et al., 2016). Therefore, as there is no quantitative 
approach to measuring the outcome of prevention using insoles, a better understanding of 
how clinicians follow this assessment, prescription and outcome measure is needed. 
2.1.2 Podiatrist’s and orthotist’s clinical decision-making 
In addition to podiatrists, orthotists may also provide insoles to patients with 
diabetes. Podiatrists and orthotists have distinct vocational training, meaning that they 
differ regarding diagnostic procedures, construction of orthoses and therapeutic approach. 
Although each discipline has a specific focus on particular foot problems, both provide 
foot orthoses and shoes to treat foot impairments associated with elevated plantar forefoot 
peak pressures (Guldemond et al., 2005). This anatomical region is of key importance as 
it is the most common area where high peak pressures occur (Lee et al., 2014). These 
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high peak pressures produce painful inflammation in the capsule of the 
metatarsophalangeal joints and are one of the most common reasons for consultation in 
female patients (Naraghi et al., 2014). However, patients with neuropathy cannot feel the 
pain produced by metatarsalgia, resulting in maintained high peak pressures under the 
metatarsal heads, a key risk factor for ulceration (Paton et al., 2012). 
The insole manufacturing process is subjective, studies have shown that there was 
almost no agreement between thirty foot experts on the location of high-pressure zones 
in three patients with metatarsalgia, not even between those of the same discipline 
(Guldemond et al., 2005, Guldemond et al., 2007). Furthermore, the design of the insoles 
made by thirty-one different foot experts for three patients with similar forefoot 
complaints varied greatly (Guldemond et al., 2006, Stolwijk et al., 2011). Although 
insoles are frequently used to reduce the plantar pressure under painful areas of the foot, 
there is still no consensus about the best way to manage high-risk patient’s complaints 
with insoles (Stolwijk et al., 2011). 
2.1.3 Role of technology in clinical practice 
In recent years there has been an exponential increase in the growth in the use of 
mobile devices and technology (Street et al., 2014). Along with this technology growth, 
mobile phone and tablet applications (apps) for self-control health and management have 
flourished. There is some evidence suggesting that information aimed at helping patients 
to understand their health risks has increased adherence to their treatment, as well as 
improved their communication and trust with their practitioner (Adams, 2010). However, 
providing customised information for each patient can be perceived as costly and time-
consuming. Nevertheless, the increasing availability of low-cost mobile phones and 
tablets could overcome this problem. These devices can be used as a new communication 
channel with the patient, to provide them with relevant and tailored educational 
information to check progress and outcomes of treatment. It can also enable the patients 
to access healthcare information and recommendations for their specific condition and 
enable contact with their practitioner in case of need. 
Technology that supports clinical decisions improve diagnostic and patient safety. 
Moreover, the availability of technology for health care professionals has grown in line 
with the increased prevalence of apps and smart mobile devices (Patel et al., 2015). 
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However, proven clinical effectiveness and patient safety do not seem to be sufficient to 
ensure adoption and implementation of new clinical technologies (Llewellyn et al., 2014). 
Introducing these new technologies initially raises providers’ costs as this requires 
training, interferes with the clinic workflow and patient management, and may result in a 
reduction in the number of patients seen in the short term (Jimbo et al., 2013, Llewellyn 
et al., 2014, Seifert et al., 2016, Turner, 2016). Given that the current funding regime for 
providers is based on payment by results and rewards activity, it is not surprising that 
providers often see new technologies as risky.  
Llewellyn et al. (2014) studied organisational and policy context for the adoption 
and implementation of clinical technologies. To this end, they performed a series of 
interviews and surveys of clinical staff, clinicians, managers and commissioners. They 
reported that providers could be one of the major obstacles to the adoption of new 
technologies. They also found that NHS providers did not perceive any central ‘push’ 
from the Department of Health or NICE to adopt or implement new clinical technologies. 
Moreover, negotiations over funding between providers and commissioners also delayed 
the implementation of these technologies. Finally, they found that clinicians without 
training or previous experience with technology did not understand its clinical need and 
utility.  
In another study, Seifert et al. (2016) investigated the use of mobile device apps 
by occupational therapists during their clinical practice. They found that more than half 
of the participants did not use apps in therapy, with "not having access to the technology 
at work" being the primary reason. The main outcomes clinicians sought using apps was 
to promote skill building, support the therapeutic process and accurate feedback. Apps 
were mainly selected based on peer recommendations. The authors concluded that more 
therapists might use this type of technology if potential barriers were reduced or 
eliminated, such as the availability of technology, improved therapist training, allowing 
therapist input into app development and an enhanced evidence base.  
Patel et al. (2015) studied the use of mobile device apps by junior doctors in their 
clinical practice. They found that junior doctors preferred using desktop-based computers 
because they found it challenging to read information on a small screen. Moreover, young 
clinicians with no previous experience of mobile device use in their clinical practice found 
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it difficult to integrate these into their normal workflow. Interestingly, participants 
preferred using mobile devices as a learning resource in their own time rather than as a 
tool exclusively for the workplace. Finally, some of the junior doctors felt that the use of 
these technologies in front of the patient or other senior colleagues could be perceived as 
being unprofessional. In contrast to this belief, patients reported positive perceptions 
toward their clinician using mobile device apps during their consultations.  
New technologies can also help patients to better understand their conditions, 
which can increase their treatment adherence. Patient education for those people 
with diabetes has been proven to enhance self-management and engagement in their 
treatment (Tricco et al., 2012). However, many patients with type 2 diabetes do not have 
access to this education or do not participate in self-management support programmes. 
This issue could be resolved through technology, as tele-education has the potential to 
improve accessibility and efficiency of care. Odnoletkova et al. (2016) explored the 
perceptions of patients, nurses and general practitioners regarding tele-coaching for those 
people with type 2 diabetes. To this end, 5 monthly telephone sessions of +/- 30 min were 
offered to 287 people with type 2 diabetes. The authors reported that 97.5% of patients 
available for a follow-up analysis declared that they were satisfied. They concluded that 
nurse-led tele-coaching of participants with type 2 diabetes was readily accepted by 
patients and providers.  
There are studies investigating the actual practicality and patients’ use of this type 
of technology (Hsu et al., 2005, Strayer et al., 2010, Sun et al., 2011, Ashurst et al., 2014, 
Ahern et al., 2016, Spat et al., 2016). Ashurst et al. (2014) conducted a study to design 
an app to help enhance the engagement of young patients with diabetes, regarding their 
appointments and management. This study had two different phases: in the first phase, 6 
different teams of developers (with at least one British person aged 16 – 25 with type 1 
diabetes) were asked to create an app. In the second phase, 56 patients, aged 16 – 25, with 
diabetes were asked to examine and try the 6 apps, choose one and use it in preparation 
for their upcoming clinic appointment. After the appointment, participants were asked to 
complete a questionnaire and add comments in a web-based forum. The authors 
concluded that apps are useful to engage young patients with their appointments. 
Moreover, they strongly suggested that young patients with diabetes should be asked for 
advice on the design process of apps.  
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One of the challenges of implementing technology in clinical practice is older 
people’s lack of knowledge and experience. They tend to find such technology alien to 
them and do not feel compelled to try it and engage with it. However, Ahern et al. (2016) 
recruited patients aged 32 – 71 who had very different experiences with technology, 
ranging from those who were very experienced to others not normally using technological 
devices. They were suffering from chronic obstructive pulmonary disease and were asked 
to test and give feedback regarding an app designed to support the assessment and 
management of their condition. They concluded that patients benefited from the 
portability and flexibility of the tablet device in the examination room, despite their 
technology knowledge. Furthermore, Spat et al. (2016) tested the prototype of a mobile, 
tablet-based client-server system for treatment decisions and workflow support 
(GlucoTab®). This system was designed to support clinicians administering insulin 
therapy. The authors found a significant reduction in hypoglycaemia when using a 
computerised system for workflow and treatment decision support, compared to a paper-
based process. Healthcare professionals accepted that the system was effective and 
patients adhered to its insulin dose suggestions. This supports earlier work that 
demonstrated that doctors found examination room computers a positive addition during 
assessment and management of patients (Hsu et al., 2005).  
Aligned with this idea, Strayer et al. (2010) explored the possible difference in 
patient’s attitudes towards the use of new tablets and mobile devices during their clinical 
appointments. They interviewed patients immediately following a visit to a clinician and 
asked about their attitudes toward the technology used during the appointment. Results 
showed mostly positive patient perceptions of the tablets regardless of age, gender, race, 
ethnicity and income. However, some patients reported that they had experienced a 
depersonalisation during the appointment. This lack of interaction was also found by 
Street et al. (2014) when practitioners used computers during the consultation. They 
concluded that clinicians multitask during the appointments, having to interact with both 
patients and the computer to retrieve data, gather information and create treatment plans. 
The different technological approaches have been explored in order to assist 
consultation. However, these approaches assist general consultation rather than to 
measure treatment outcomes. An example of this is the prevention of diabetic foot 
ulceration, through the use of insoles in order to achieve the greatest offloading possible. 
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However, Guldemond et al. (2006) showed that the clinical process for the identification 
of elevated plantar pressure performed by professionals appears to be insufficient. Plantar 
pressure devices are too time-consuming to set up and use, and the results they provide 
are too complex to interpret and use within the consultation. They also concluded that 
there is a lack of clinical devices that are user-friendly and focused on improving patient’s 
outcomes.  
Aspects of the physical examination, clinical reasoning and techniques for 
elevated plantar pressure screening have to be re-evaluated to improve this clinical 
process. Quantitative plantar pressure measurement is a valuable addition to screening. 
Although the cost of this equipment has decreased and easy-to-use software and hardware 
has become available, plantar pressure measurement is not standard in foot-care practices. 
There is also no prescription tool that helps podiatrists integrate data obtained from 
clinical assessment into their footwear and insole prescription. Furthermore, there is no 
technological solution capable of pre-calculating the expected pressure distribution on the 
plantar aspect of the foot. Therefore, and due to its serious implications, a technology-
based solution is needed for day-to-day clinical practice. Nonetheless, before this solution 
can be achieved, it is necessary to fully understand the professionals’ diagnosis and 
prescription process in order to design software to fulfil their needs. Further knowledge 
of the problems that practitioners face in their day-to-day practice would inform what is 
required in order to enhance treatment. 
For this reason, I carried out research which aimed to investigate the factors that 
influence practitioner clinical decision-making. This was approached with qualitative 
research methods and the three primary objectives were:  
1. To gain insight into the practitioners’ aims when providing foot orthoses in 
relation to foot geometry, motion control, pressure redistribution, accommodation 
of deformity, as well as their perception of the patient's clinical needs (usability, 
outcome)  
2. To identify what factors influence the assessment of patients and the specific 
design of the orthoses 
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3. To gain insight into how the aims of the prescription and the associated factors 
might then be prioritised and enhanced with the use of technological 
advancements. 
Before this aim and objectives can be achieved, a full exploration and critical 
evaluation of the research published in relation to the biomechanics of the ulcerated 
diabetic foot and insole design needed to be carried out. This is presented in the following 
chapter, which then leads to the qualitative investigation in Chapter 4. 
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3 Literature review - Section 2: The 
biomechanics of foot ulceration and 
insole design for people with diabetes 
A diabetic foot ulcer (DFU) is defined as “any necrosis, gangrene, or full-
thickness skin defect occurring distal to the ankle in a diabetic patient” (Schaper et al., 
2012). This complication entails serious consequences to the patient, such as reduction in 
the quality of life, amputation, and in severe cases, death. In the previous section, a 
detailed literature review was presented about clinical decision making and management 
of this complication. However, a better knowledge of its pathogenesis and risk factors is 
needed to understand if this management provided by professionals is optimum and how 
it may be enhanced. Therefore, this section will provide a detailed and critical evaluation 
of the literature published about diabetic foot syndrome, its risk factors and different 
treatments. 
3.1 Aetiology of ulceration in diabetes  
Ulceration in diabetic foot occurs when a combination of risk factors, mainly 
peripheral neuropathy and high plantar pressures, present at the same time (Guiotto et al., 
2013). Foot deformity and peripheral vascular disease are also important risk factors that 
can trigger ulcer formation (Lepantalo et al., 2011). Neuropathy in patients with diabetes 
has three aspects: sensory, motor and autonomic. Sensory neuropathy produces a loss of 
sensitivity that hinders the identification of traumas in the foot. Motor neuropathy leads 
to muscle degeneration, limited joint mobility and altered biomechanics of the foot, 
producing deformities that lead to imbalanced and increased pressures (Guiotto et al., 
2013). Autonomic neuropathy results in diminished sweating that makes the skin dry and 
more likely to crack. It also leads to callus formation which produces an increase in 
plantar pressures (Alavi et al., 2014). 
Due to neuropathic complications, the diabetic foot is not able to properly 
distribute high plantar pressures, leading to the maintenance of high pressures during 
walking, damaging the already altered soft tissue and subsequently leading to skin 
breakdown. This is compounded by peripheral vascular disease and an impaired immune 
 20 
 
response in patients with diabetes, which hinders wound healing leading to increased risk 
of ulceration, predisposing the foot to complications and infection (see Figure 3.1). 
 
Figure 3.1: Pathway to ulceration adapted from (Lepantalo et al., 2011) 
3.2 Epidemiology of foot ulceration in diabetes 
A patient suffering from DF syndrome will not develop and ulcer spontaneously, 
there is a combination of factors which will ultimately result in skin breakdown and 
ulceration. Therefore, it is of fundamental importance to identify the main risk factors 
leading to ulceration. 
3.2.1 Risk factors for foot ulceration in diabetes 
DFU are produced when two or more risk factors are present at the same time. 
The two main most common risk factors identified are peripheral neuropathy and 
abnormally high plantar pressures (Lepantalo et al., 2011). The presence of peripheral 
vascular disease and deformity are also risk factors for ulcer formation (Boulton, 2010, 
Malhotra et al., 2012, Fernando et al., 2013). Moreover, people with diabetes have an 
impaired immune response, with a reduced ability to recruit inflammatory cells to the 
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damaged tissues, delaying wound healing and increasing the risk of infection (Leung, 
2007). Other complications contributing to ulceration include poor vision, limited joint 
mobility and cardiovascular and cerebrovascular disease (Jeffcoate&Harding, 2003, 
Boulton, 2010, Turns, 2013). A higher risk of ulceration has also been observed among 
males and individuals within the inadequate glycemic control (Bortoletto et al., 2014). 
The American Diabetes Association (ADA) published a consensus for the main risk 
factors for ulceration and amputation in (ADA, 2013) (Table 3.1): 
Previous amputation Past foot ulcer history 
Peripheral neuropathy Foot deformity 
Peripheral arterial disease Visual impairment 
Diabetic nephropathy  Poor glycemic control 
Cigarette smoking 
Table 3.1: Risk factors for ulceration and amputation 
Hoffman et al. (2015) focussed on the health risks associated with smoking 
cigarettes; people with diabetes who smoke are at a higher risk of cardiovascular disease, 
premature death and increased rate of microvascular complications (ADA, 2013). 
Cessation of smoking was related to an improvement of the individual’s glycaemic 
control and reduced blood pressure in newly diagnosed type 2 diabetic patients. 
Interestingly, a reduction in the prevalence of both peripheral vascular disease and 
peripheral neuropathy (two of the main risk factors for ulcer formation) was shown in 
patients with diabetes that stopped smoking (Voulgari et al., 2011). This supports the 
hypothesis that smoking has an adverse influence on the glycaemic control, contributing 
to the final precipitation of ulceration risk factors. 
Diabetes is defined by high levels of blood glucose (hyperglycaemia), the control 
of which is fundamental to the management of diabetes. There is evidence of decreased 
rates of microvascular and neuropathic complications in patients with improved glycemic 
control (UKPDS, 1998a, UKPDS, 1998b), which are two of the main risk factors for ulcer 
formation. It has also been shown that glycaemic control decreases the risk of 
cardiovascular disease, lowering the mortality rate of diabetics due to coronary 
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complications (ADA, 2013). Lack of physical activity, combined with obesity, also 
increases the risk of developing DF (Lima et al., 2014). The most prevalent socio-
demographical risk factor is a sedentary lifestyle, followed by being overweight, which 
is normally as a result of the lack of exercise. Regular exercise has been shown to improve 
blood glucose control, reduce cardiovascular risk factors, contribute to weight loss as well 
as improve well-being. Furthermore, regular exercise may prevent type 2 diabetes in high-
risk individuals (ADA, 2013). 
3.2.2 Neuropathy  
Peripheral neuropathy represents the main risk factor for DF ulcers and may be 
sensory, autonomic or motor. Sensory neuropathy decreases or eliminates the protective 
sensation of the foot (Sriyani et al., 2013) so that individuals are unable to sense either 
repetitive or isolated trauma which may occur during walking or other activities, leading 
to skin damage. Motor neuropathy is associated with hyperextension of the 
metatarsophalangeal joints, clawing of the toes and distal migration of the fibro-fatty pad 
on the plantar aspect of the forefoot (Abouaesha et al., 2001). This process subsequently 
leads to increased forefoot pressures, one of the main risk factors for ulceration in the 
presence of neuropathy (Abouaesha et al., 2004). Autonomic neuropathy produces a 
decrease in sweating that can lead to skin breaks by dryness itself. Dehydrated skin loses 
its elastic mechanisms and therefore, its ability to adapt to feet movement, tending to 
crack easily. It also leads to callus build up under areas of increased pressure, which in 
turn, further increases plantar pressures (Abouaesha et al., 2001). Furthermore, 
neuropathy has a major influence on plantar pressure changes and behaviour. Ledoux 
(2013) found aberrant plantar pressure patterns in 7% of healthy subjects, 17% of the 
diabetic feet, 31% of the diabetic feet with neuropathy and 100% of the diabetic feet with 
a history of ulcers.  
3.2.3 Plantar pressure as a risk factor 
The development of a DF ulcer is a multi-factorial process which is primarily 
associated with neuropathy and high plantar pressures. Peak plantar pressure (PP) is 
typically defined as the highest localised pressure under the foot. Elevated peak plantar 
pressure has been shown to be a contributing factor to skin breakdown, especially when 
repeated at a specific area in patients with peripheral neuropathy (Abouaesha et al., 2001, 
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Patry et al., 2013). As explained above, increased peak pressure may result from a range 
of factors and complications derived from DM, such as deformities, plantar 
hyperkeratosis, lack of joint movement, tissue stiffness or history of previous ulcers or 
amputations (Waldecker, 2012, Healy et al., 2013). People with DM have higher peak 
pressures than healthy subjects (Patry et al., 2013). Moreover, these pressures are greater 
on the forefoot in patients with neuropathy when compared to non-diabetics without this 
condition (Ledoux et al., 2013, Patry et al., 2013). There are some factors that influence 
ulcer formation such as soft tissue characteristics, joint mobility and biomechanics (Payne 
et al., 2001, Barn et al., 2015). However, they also have a significant influence on plantar 
pressures. Moreover, if these factors influence both ulcer formation and plantar pressures, 
they are key risk factors in the whole process.  
3.3 Factors that influence pressure  
Plantar pressure is one of the main risk factors for diabetic foot ulceration (Patry 
et al., 2013), so it is important to gain a thorough insight and understanding of the 
different factors that may influence plantar pressures during walking. Diabetic 
neuropathy has been shown to produce several conditions on the foot, such as decreased 
joint mobility, altered muscle function and tissue stiffness. If these conditions are present 
at the same time, they result in foot deformities and alterations of foot motion that will 
also affect plantar pressures and balance. Given that plantar pressure is one of the key risk 
factors for ulceration, it is important to understand the factors which can influence 
differences in pressure between individuals. 
3.3.1 Soft tissue influence on plantar pressures 
Soft tissue on the plantar aspect of the foot has two layers, consisting of fatty and 
connective tissues. These function to absorb shock loading on the foot, particularly on the 
forefoot and heel regions (Ozdemir et al., 2004, Natali et al., 2010). The flexibility 
provided by collagen fibres can be altered by both repetitive trauma and diabetes 
(Cavanagh et al., 1993, Hsu et al., 2007, Hsu et al., 2009). Patients with diabetes and 
neuropathy present stiffer plantar tissues than healthy subjects (Sun et al., 2011) and this 
increase in stiffness leads to a decrease in its capacity for shock absorption (Crawford et 
al., 2007, Pai&Ledoux, 2012). Furthermore, repetitive loading while walking leads to a 
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local thickening of the epidermis due to accelerated keratinization (callus formation) in 
the epidermis (Wang&Sanders, 2003, Kim et al., 2010). Subsequent callus formation 
allows the skin to better resist repetitive traumas; however, it also increases the peak 
pressures on its location (Zhang, 2006). 
There is evidence of a stiffer soft tissue under the metatarsal heads in people with 
diabetes (Sun et al., 2011), meaning that the tissue less able to distribute pressure via 
deformation (Gefen, 2003). There is also a strong inverse relationship between plantar 
tissue thickness and dynamic foot pressures (Zheng et al., 2000, Abouaesha et al., 2001, 
Klaesner et al., 2002). Not surprisingly, tissue stiffening has been found to significantly 
increase plantar pressure, thereby, becoming an additional predictive factor of ulcer 
development (Abouaesha et al., 2001, Sun et al., 2011, Periyasamy et al., 2012, Patry et 
al., 2013).  
3.3.2 The influence of foot deformity and biomechanics on plantar 
pressures 
Foot shape and foot biomechanics influence plantar pressure, especially under the 
metatarsal heads. Plantar pressures are highest at the metatarsal heads during the push-
off phase of walking (80% of stance) as, at this point, weight bearing and push-off forces 
are greatest and the weight-bearing contact area is smallest (Kelly et al., 2000). Metatarsal 
head plantar pressures are typically higher in people with DM and peripheral neuropathy 
(Mueller et al., 2003). Also, soft tissues under the metatarsal heads tend to be thinner and 
stiffer in subjects with DM and peripheral neuropathy compared with healthy subjects 
(Periyasamy et al., 2012, Patry et al., 2013). These mechanical effects, directly as a 
consequence of DM and peripheral neuropathy, contribute to excessively high plantar 
pressures, which are not sensed by the individual and subsequently, lead to skin 
breakdown (Mueller et al., 2006).  
Foot morphology can play a role in determining the biomechanical behaviour and 
function of the foot (Guiotto et al., 2013). Diabetes and more specifically, diabetic 
neuropathy, has been shown to result in decreased joint mobility (Garcia-Alvarez et al., 
2013). Limited joint mobility plays a key role in the abnormal biomechanics of the foot 
and ankle in the diabetic patient (Mueller et al., 1989, Zimny et al., 2004). Structural 
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changes occur within the tendon and capsule of the diabetic patient, leading to decreased 
elasticity and tensile strength, which subsequently results in instability at joints causing 
subluxations or overall stiffness of the foot. In both cases, the result is poor foot 
biomechanics (Kim, 2013). It has also been widely demonstrated that people with 
diabetes are characterised by excessive ankle rigidity (Guiotto et al., 2013). Zimny et al. 
(2004) studied the relationship of joint mobility with plantar pressures in a cross-sectional 
study of 70 patients with diabetes and 30 healthy control subjects. They concluded that 
the ankle joint and first metatarsophalangeal joint (MPJ) mobility showed a strong inverse 
correlation with the pressure time integral of the forefoot. Moreover, joint mobility 
reduction of the ankle and first MPJ resulted in an elevated time-dependent load of the 
forefoot. This suggests that foot morphology affects plantar pressure and plantar pressure 
is related to ulceration, therefore, foot morphology is related to ulceration (Guiotto et al., 
2013, Ledoux et al., 2013, Fernando et al., 2014).  
The relationship between foot type, foot deformity and ulceration has been 
previously explored (Ledoux et al., 2005). Pronation of the foot is linked to neuropathy 
and is more prevalent in people who have a longer duration of diabetes (Formosa et al., 
2013). Those patients who exhibit excessive foot pronation also have limited joint 
mobility of the first MPJ. The limited joint mobility of the foot has a prevalence of 8% to 
58% in diabetes and may indicate risk of developing pronation. This pronation may, in 
turn, lead to other foot deformities, such as hammertoes or hallux valgus and altered foot 
mechanics (Pecoraro et al., 1990, Robertson et al., 2002, van Schie et al., 2004, Crawford 
et al., 2007, Allan et al., 2015, Bus, 2015) which produce increased pressures (Murray et 
al., 1996, Reiber et al., 1999). The metatarsal heads are a common site of foot ulceration 
and it has been shown that toe extension produces a significant increase in stiffness on 
the plantar soft tissues, which increased plantar pressures during the push-off phase of 
gait (Garcia et al., 2008). In support of this idea, recent foot models showed that soft 
tissue stiffness under the metatarsal heads is modified depending on the MPJ angle. 
Accordingly, soft tissues under metatarsal heads (MTH) exhibited in stiffness of up to 
20% in joint extension compared to neutral positions (Chen et al., 2003). Foot deformities 
and altered biomechanics have a direct influence on plantar pressures, and therefore on 
ulcer formation. 
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Peripheral neuropathy has a considerable effect on the biomechanics of the foot 
in people with diabetes (Pham et al., 2000). Human gait is a complex movement 
composed of a series of phases. The proprioceptive system informs the position and 
movement of the foot, providing it with a mechanical protection function that will detect 
any potentially dangerous movement or position while walking (Yu et al., 2011). The 
foot makes small adjustments during gait which depend on sensory feedback to avoid 
prolonged pressure to any one localised area (Kim, 2013). However, in the case of the 
diabetic foot, feedback from the proprioceptive system is poor (Yu et al., 2011), which 
leads to a delay, or complete absence, of these small adjustments. Some studies have 
found pressure patterns to be influenced by spatial-temporal gait variables including 
walking speed, cadence, and step length, as well as morphological characteristics such as 
height and bodyweight (Fernando et al., 1991, Cavanagh et al., 1997, Morag&Cavanagh, 
1999, Cavanagh et al., 2000, Mueller et al., 2003, Menz&Morris, 2006, Martinez-Nova 
et al., 2008). Limited joint mobility, produced by peripheral neuropathy, contributes to 
increased plantar pressures by limiting foot flexibility and restraining the forward 
progression of body weight during the stance phase of gait (Fernando et al., 1991, 
Fernando et al., 2013). An increase in unsteadiness has also been observed in patients 
with DM, most likely due to a thickening of the Achilles tendon and plantar fascia that is 
associated with a more rigid foot less adaptable to walking on different surfaces (Garcia-
Alvarez et al., 2013, Allan et al., 2015). Altered perception of the foot and lack of joint 
movement alter normal gait, leading to increased pressures and risk of ulceration. 
Motion and gait patterns are different between healthy subjects and those with 
diabetes, especially if they have neuropathy. Fernando et al. (2013) found that patients 
with neuropathy walked slower and had a reduced stride length when compared to 
diabetic patients and healthy subjects. They also found that people with neuropathy spent 
a longer period of time in the stance phase compared to subjects with DM. They 
demonstrated a reduced range of movement in patients with neuropathy when compared 
to healthy subjects, except for hip flexion. Therefore, it is probable that elevated plantar 
pressure, coupled with a longer period of time spent in stance in neuropathic patients, 
contributes to the susceptibility to skin damage through prolonged mechanical load on 
tissue, leading to skin breakdown and ulceration (Fernando et al., 2013). 
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Since foot structure can affect peak pressure (Ledoux et al., 2005, Guiotto et al., 
2013) and peak pressure can predict ulceration, it is possible that ulceration may be 
predicted by foot structure. In line with this, foot deformities, such as hammer/claw toe 
deformity or hallux limitus, have been associated with an increased risk of ulceration 
(Ledoux et al., 2005, Cowley et al., 2008). Guiotto et al. (2013) found a close relationship 
between foot morphological alterations and plantar ulcerations. This is in agreement with 
(Ledoux et al., 2005), who demonstrated that foot structure was one of the main factors 
which could explain differences in peak pressure. Moreover, there is a direct relationship 
between diabetes and changes in foot morphology, especially in the presence of 
neuropathy, due to its effect on muscles and tendons (Kim, 2013). A cavus foot was found 
to be frequent among patients with diabetes, and higher pressures were found when 
compared to non-diabetic feet (Ledoux et al., 2005). Therefore, there is evidence that foot 
morphology has the potential to impact on peak plantar pressures, which can ultimately 
mean that it may have an influence on ulcer development.  
Variability in PP in patients with diabetes is significantly related to the presence 
of neuropathy (Payne et al., 2001). This condition entails important complications such 
as increased soft tissue stiffness, reduced range of movement on the key joints of the foot 
and deformities due to muscle and ligament weakness. A small concurrence of these 
complications can be significant predictors of dynamic function (Payne et al., 2001). 
These factors are insufficient on their own but combined they will ultimately result in the 
formation of a diabetic foot ulcer (Reiber et al., 1999). Moreover, it is likely that some of 
these complications are present at the same time, given their high prevalence (over 40% 
for all of them) amongst people with diabetes (Chao et al., 2011, Allan et al., 2015). 
3.3.3 Plantar pressure thresholds for ulceration 
There have been attempts to establish a pressure threshold above which ulceration 
is more likely to happen. However, there are reports of different thresholds for ulcer 
development, ranging from 300 to 1100 KPa (Waldecker, 2012). Armstrong et al. (1998b) 
recruited 219 patients with diabetes in a case-control study to set an ulceration risk 
threshold; cases were patients with a recent history of ulceration and the controls 
comprised patients without a history of ulceration. Barefoot plantar pressures were 
collected with a novel Emed platform and they found higher pressures on the forefoot in 
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patients with a history of ulceration. They set the threshold for ulceration at 700 KPa, but 
the sensitivity and specificity were not high enough, leading them to conclude that there 
is no threshold, but that higher peak pressures lead to increased risk. 
Frykberg et al. (1998) studied a cross-sectional group of 251 patients of different 
ethnicities aiming to determine the risk of ulceration associated with high foot pressures 
and peripheral neuropathy in a large and diverse diabetic population. They collected 
barefoot pressure data in their group of 251 patients with diabetes and neuropathy using 
an F-scan mat system. They also performed neuropathy screening tests and tested joint 
mobility. Using a logistic regression between the different screening variables and 
pressure, they concluded that both high foot pressures and neuropathy are independently 
associated with ulceration, and this led them to suggest a threshold of 588 KPa.  
Owings et al. (2009) performed a cohort study and recruited subjects with diabetes 
and neuropathy from a database of 2625 eligible patients created over a period of 18 years. 
They identified 190 surviving patients with prior plantar ulcers of the forefoot and 49 
patients agreed to participate. All participants had had a yearly follow up appointment for 
at least five years and had remained healed at least for over 90 days. Barefoot and in-shoe 
plantar pressures were collected with Novel® devices. They concluded that barefoot peak 
pressure is a poor predictor of peak in-shoe pressure and that in-shoe pressure is a key 
variable that should be investigated for foot ulcer risk in diabetic patients. They reported 
a mean barefoot peak plantar pressure of 556 KPa but large inter-subject variability (107 
– 1,192 KPa) and a considerably lower mean in-shoe peak plantar pressure of 207 KPa. 
They could not establish a threshold for ulceration and recommended to provisionally 
adopt 200 KPa as previously suggested by Guldemond (2007). 
As yet, a peak pressure threshold for ulceration risk has not been definitively 
established (). The difficulty in establishing a PP threshold is mainly because DFU is a 
multifactorial process affected by direct vertical pressure but also by shear stress (Patry 
et al., 2013). Moreover, DFU is also influenced by other factors such as peripheral 
vascular disease, glycemic levels or activity and lifestyle (Patry et al., 2013, Fawzy et al., 
2014). As detailed previously, there are several factors that can influence plantar 
pressures. However, PP is only one factor in a multifaceted pathway to diabetic foot ulcer 
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formation, and, importantly, it has been shown that ulceration can occur in presence of 
normal PP (Armstrong et al., 1998a).  
Other factors which have been linked to ulceration include peripheral neuropathy, 
peripheral vascular disease, glycaemic levels, socio-economical background or activity 
level (Noor et al., 2015). The glycaemic state and the lifestyle of patients with diabetes 
depend on the self-management and can often be difficult to change because of poor 
compliance with lifestyle advice change (Abubakari et al., 2016). This low adherence to 
healthier lifestyles will result in increased risk factors for foot ulceration and other 
complications from DM such as retinopathy or nephropathy. Since many of these factors, 
such as neuropathy, are out of the direct control of the clinician, most conservative 
treatment approaches include reducing PP during walking and educating the patient 
regarding foot care to prevent ulceration (Stacpoole-Shea et al., 1999).  
Although many threshold values have been suggested for risk of ulceration, the 
only certainty for ulceration is that the risk increases as peak pressure increases. Another 
factor to consider are the large variations in systems and ways of measuring and recording 
PP, which make it difficult to arrive at a consensus regarding the best system and the best 
way of obtaining a sensible and reproducible measurement (Armstrong et al., 1998b). 
However, Guldemond et al. (2007) found that if peak pressures were lower than 200 KPa, 
ulceration did not occur. Therefore, this peak pressure could be set as a “safe” threshold 
for ulcer prevention until a more accurate ulceration threshold is determined. Importantly, 
previous studies have shown that in-shoe pressures can be reduced to the 200 KPa range 
with appropriately designed prescription footwear interventions (Owings et al., 2009).  
3.4 Plantar pressure measurement methods 
3.4.1 Devices 
There are two main devices used to collect plantar pressures: platforms (used for 
barefoot collection) and in-shoe pressure devices. Although pressures can be measured 
under either static or dynamic conditions, dynamic pressure measurement appears to be 
more sensitive and reliable for identifying at-risk feet (Patry et al., 2013). In-shoe devices 
are clearly advantageous over platforms as they allow in-shoe pressures to be investigated 
which are known to differ considerably from barefoot pressures (Chevalier et al., 2010). 
 30 
 
Also, barefoot peak pressure is a poor predictor of peak in-shoe pressure. Therefore, the 
in-shoe pressure is a key variable that should be examined for foot ulceration risk in 
diabetic patients (Owings et al., 2009). Accordingly, these in-shoe plantar pressure 
devices have been used over the last three decades to monitor the interaction between the 
foot and the shoe or insole, during either static or dynamic activities (de Castro et al., 
2014).  
Accurate measurement and assessment of plantar pressures are important to detect 
changes in pressure, which may be small, but still meaningful (de Castro et al., 2014). 
Also, in order to be able to assess individuals, the device used needs to be reliable 
(Atkinson&Nevill, 1998). Reliability can be defined as the consistency of measurements 
or the absence of measurement error (Jackson, 1990). In practice, some amount of error 
is always present with continuous measurements due to noise and human movement 
variability. Therefore, reliability could be considered as the amount of measurement error 
that has been estimated that does not bias the result (Atkinson&Nevill, 1998). 
The insole of the in-shoe plantar pressure device is composed of an array of 
sensors that quantify the pressure. These sensors are arranged in rows and columns 
(Cavanagh P. R., 1992) and enable monitoring of the entire plantar area of the foot during 
walking. These sensor insoles can be connected by cable to an electronic box, which sends 
the data to a computer via Bluetooth® telemetry. The insoles are made of a capacitive 
sensor with elasticity to conform well to the three-dimensional surface of the orthotics. 
These sensors are formed from two conductive electrically charged plates separated by a 
dielectric elastic layer when pressure is applied to the sensor, the dielectric elastic layer 
bends decreasing the distance between the two plates, producing a voltage change 
proportional to the pressure applied (Figure 3.2).  
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Figure 3.2: Capacitive sensor adapted from (Razak et al., 2012) 
3.4.2 Plantar pressure analysis and pressure outcome measures 
The first step when processing a continuous in-shoe plantar pressure measurement 
is to segment the data into different steps for each foot. A mask is then defined to divide 
the plantar aspect of the foot into different regions which are usually analysed separately. 
The most common masks regions are heel, midfoot, first metatarsal head, central 
metatarsal heads, fifth metatarsal head, hallux and toes. To define these regions, the 
corresponding sensors from the insole are identified and an appropriate mask defined 
(Figure 3.3). Once the masks are defined, different pressure calculations are performed to 
define a small number of outcomes which characterise plantar pressure behaviour. The 
outcome peak pressure is defined as the highest pressure in any sensor across a given 
mask (anatomical region) (Bus&Waaijman, 2013). In contrast, mean pressure is 
calculated as the average pressure across all the sensors in a given region. Finally, the 
pressure time integral is defined as the time integral of the mean pressure across all 
sensors in a particular region during one-foot step. This is calculated as the area under the 
mean pressure-time curve of a particular region (Waaijman&Bus, 2012).  
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Peak pressure and the pressure-time integral are the two most commonly used 
outcomes in studies investigating plantar pressure behaviour. There are several studies 
that show that these two outcomes are highly correlated. However, only peak pressure 
has been associated with ulceration in prospective studies (Frykberg et al., 1998, Pham et 
al., 2000), while the pressure-time integral has shown to influence ulceration only in 
retrospective studies (Stess et al., 1997). Interestingly, some authors consider the 
pressure-time integral a more relevant parameter than peak pressure because it 
incorporates pressure as well as time factors, which have been suggested to be important 
in ulcer formation (Soames, 1985, Hsi et al., 2002).  
3.4.3 Reliability of in-shoe plantar pressure measurement 
Reliable plantar pressure measurements are of key importance to assess the risk 
of ulceration. However, plantar pressure values vary from step to step and, even more, 
between separate days. There are many variables that may influence plantar pressure 
values, which are not only intrinsic to the subject but also dependent on the environment 
where the data collection is performed, or the device itself. Walking is variable, with no 
two steps the same (Putti et al., 2007), feet muscles and joints move in a very complex 
Figure 3.3: Pedar insole mask adapted from Bergstra et al. (2015) 
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motion to adapt to the ground and maintain balance. Also, while collecting data, subjects 
are asked to walk in an unusual laboratory environment which may influence their pattern 
of walking. In addition, physical changes can happen in the subject, such as inflammation 
or pain, or psychological states between separate testing days. On the other hand, all data 
collection will have some noise within the data that is produced by the device itself. Given 
the importance of plantar pressure measurement, the potential for variability in each 
subject’s walking pattern, devices that collect reliable data whilst minimising noise and 
errors are needed.  
Reliability of in-shoe plantar pressures has been studied by several authors. 
Ramanathan et al. (2010) recruited 27 healthy male subjects and asked them to walk over 
a 26-metre walkway. They used off-the-shelf running shoes without insoles and repeated 
the measurement one week later. Peak pressures and pressure-time integral were 
determined and showed high repeatability on all the masks. In another study, Putti et al. 
(2007) recruited 53 healthy subjects and also used standard running shoes. A mean of 12 
days passed from the first to the second data collection days. They also studied peak 
pressures and pressure time integral between other outcomes, obtaining good 
repeatability results. Another study by Godi et al. (2014) recruited 16 young healthy 
subjects, collecting data in two walking sessions, two days apart, wearing standard 
running shoes. They showed good repeatability for peak pressures across the whole foot. 
Finally, de Castro et al. (2014) recruited 40 young healthy participants and placed two in-
shoe devices, one on top of each other, inside standard ballet sneakers. They showed good 
repeatability results for peak pressures and pressure time integral. However, this approach 
may not be the best choice, as systems can interfere and influence each other’s 
measurement as they are in direct contact. Nonetheless, all studies came to the same 
conclusion that peak pressure and the pressure-time integral are reliable outcomes to 
report plantar pressures.  
One of the most popular and reliable in-shoe devices used to collect plantar 
pressures is the Novel Pedar® system. This in-shoe pressure device has been tested by 
several authors in the literature, showing promising and relatively reliable results 
(Quesada et al., 1997, Murphy et al., 2005, Hurkmans et al., 2006, Putti et al., 2007, 
Gurney et al., 2008, Chevalier et al., 2010, Ramanathan et al., 2010, Sawacha, 2013). It 
has been shown to have lower variance across sensors when compared to the F-scan 
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(Quesada et al., 1997). All of the authors concluded that the Pedar system is reliable, but 
there is some controversy between some of the papers in the midfoot area. Murphy et al. 
(2005) concluded that the system can be used to measure contact area and plantar pressure 
beneath the midfoot, with excellent reliability in multiple trials of the same subject. On 
the other hand, Ramanathan et al. (2010) and Putti et al. (2007) were in agreement that 
the Pedar is a reliable system, but that the pressure-time integral data derived from the 
midfoot region is the least repeatable. Putti et al. (2007) also point out that no two 
footsteps in a ‘‘normal’’ subject are identical, and therefore, the repeatability achieved by 
the Pedar system is clinically acceptable.  
In-shoe plantar pressure reliability has been studied by several authors using 
different approaches. Most of the studies conclude that peak pressure and the pressure-
time integral are repeatable and reliable outcomes. Furthermore, the Pedar in-shoe system 
has shown to be the most repeatable device for plantar pressure collection. However, all 
previous studies have collected plantar pressure data from healthy subjects. This cohort 
may have gait and pressure patterns which are more consistent and potentially different 
from patients with diabetes and peripheral neuropathy. Moreover, all studies used 
standard shoes with flat insoles inside, rather than the customised insoles that are typically 
prescribed for pressure offloading. This gap in the literature was the basis for the first 
quantitative study presented in this thesis, which aimed to quantify the level of 
reproducibility of plantar pressure measurements in individuals with diabetes and 
neuropathy using fully customised insoles. 
3.5 Footwear interventions for reducing pressure 
Given the key role of elevated plantar pressure in DF ulceration, different 
interventions have been employed to reduce pressure. These strategies include various 
types of footwear, insoles, orthotics and offloading surgery among others (Bus et al., 
2004, Cavanagh&Bus, 2010, Healy et al., 2013). Conservative methods are always 
preferable to surgical approaches, especially in high-risk populations. Therapeutic 
footwear and insoles have shown to be effective in pressure offloading (Luger et al., 
2001). Accordingly, they are normally prescribed to patients with diabetes in order to 
prevent ulcer formation. In the following sections, a brief literature review is presented 
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on both approaches so that the reader can gain a better understanding of their pros and 
cons.  
The use of specially designed footwear is a common approach for reducing plantar 
pressures with the aim of preventing ulceration (Cavanagh et al., 2000). The rocker shoe 
is the most commonly prescribed design (Schaff&Cavanagh, 1990) because it has been 
shown to be effective for offloading peak pressures (Uccioli et al., 1997). The sole of 
these rocker shoes is curved which helps the foot move forward during the last phase of 
the step. This shoe prevents MPJ extension during the step, thereby reducing peak 
pressures under metatarsal heads (Hutchins et al., 2009). There are two main types of 
rocker shoe which differ in sole shape, the traditional rocker and the curved rocker, with 
both types possessing a stiff sole to prevent it from bending (Figure 3.4). The contour of 
the traditional rocker has a sharp apex at approximately 55% of shoe length (Hutchins et 
al., 2009) where rocking occurs. On the other hand, the curved rocker shoe has a more 
gradual curve on the apex of the shoe where this rocking movement happens more 
gradually. 
 
Figure 3.4: Types of rocker shoe adapted from (Hutchins et al., 2009) 
Rocker shoes are commonly prescribed to patients with diabetes in order to 
offload pressures. The rocking motion of this type of shoe has shown to be effective 
reducing pressure when compared to normal oxford shoe (Healy et al., 2013). Moreover, 
there is evidence of pressure reduction on the central metatarsal heads with rocker shoes 
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(Waaijman et al., 2012, Chapman et al., 2013). However, there is some controversy in 
the efficacy of this type of shoe in ulcer prevention, for example, Uccioli et al. (1997) 
found evidence of ulceration rate reduction in patients using therapeutic footwear, 
whereas Reiber et al. (2002) did not find any reduction in the rate while using this type 
of shoe.  
The main issue that this type of footwear presents is patient compliance (Williams 
et al., 2007). Despite the beneficial properties of this shoe, it has been reported that 
patients want to have a choice in footwear according to their needs and are particularly 
focused on the appearance of the shoe. Therapeutic footwear may not meet those needs, 
instead, ending up in a cupboard (Williams et al., 2007). Williams et al. (2007; 2010) 
found that therapeutic footwear replacing normal shoes reinforces the stigma of foot 
deformity and disability. Above all, in female patients, the therapeutic shoe will influence 
and restrict their choice in clothes, which may hinder their adherence to this prescription 
(Williams et al., 2010). In modern society, external appearance is very important, 
especially for women, and the impact that this footwear has on appearance may lead to a 
negative emotional response in this group of patients (Williams et al., 2010). Therefore, 
therapeutic footwear may not be the best solution for pressure offloading and other 
options that do not influence footwear choice need to be considered. 
3.6 Insoles for reducing pressure 
Insoles represent a viable alternative to footwear for reducing in-shoe plantar 
pressures and there are two main different types of insoles, off-the-shelf and custom-
made.  
3.6.1 Off-the-shelf insoles 
Off-the-shelf insoles are mass produced standard insoles that are not specifically 
designed to fit the shape of the individual patient’s foot. There are two types of off-the-
shelf insoles, flat insoles and contoured insoles. Flat insoles consist of a layer of material 
with a varying thickness in the shape of the shoe and are normally made of cushioning 
materials, such as soft EVA. This type of insole can be bought from a high street shop 
and offers extra cushioning, over and above that provided by the sole of the shoe. 
Contoured off-the-shelf have a contoured shape to give support to the arch, and are made 
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to fit a generic foot shape, including a variety of arch heights. These insoles can be found 
in different materials of different densities, cushioning most frequently. They can also 
have other additions, such as wedges in order to try and mimic many of the physical 
characteristics of customised devices (Redmond et al., 2009). While off-the-shelf all-
purpose comfortable insoles may help to offer some cushioning, these are available in a 
limited number of shapes and materials and are hardly capable of fitting specific foot 
types and safety shoes (Caravaggi et al., 2016). 
3.6.2 Custom made insoles 
Custom made insoles or total contact insoles are tailor made to fit the shape of the 
patient’s foot, offering support across the whole plantar aspect of the foot. This type of 
insole is thought to accommodate deformities and relieve areas of excessive pressure by 
evenly distributing pressure over the entire plantar surface (Mueller et al., 2006). Total 
contact insoles maximise the contact area with the foot and provide arch support in the 
midfoot region, which has been shown to help to unload the metatarsal and heel regions 
(Ibrahim et al., 2013). These insoles are usually more expensive than off-the-shelf insoles 
since the design requires an in-depth examination with a podiatrist and additional 
measurements, but the user generally experiences a greater uniform pressure distribution, 
increased comfort, and less pain (Caravaggi et al., 2016) 
3.6.2.1 Casting technique 
In order to fabricate custom-made foot orthoses, a negative model of the foot is 
used to create a positive plaster mould which can be modified and used as a template 
around which the foot orthoses are shaped. The classic casting technique is the non-
weight bearing plaster of Paris, which is widely used and is considered by many to be the 
gold standard (McPoil et al., 1989, Trotter&Pierrynowski, 2008). For this technique, the 
foot is held in neutral position by the caster. The degree of accuracy of the plantar 
geometry and the correct alignment of the foot is heavily influenced by the skill of the 
clinician and casting can be a time-consuming and difficult task (Trotter&Pierrynowski, 
2008, Carroll et al., 2011).  
Furthermore, placing the foot in different alignment positions for casting will have 
implications for the plantar surface contours and the position that the resultant foot 
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orthoses will place the foot in (Chuter et al., 2003). The semi-weight bearing posture with 
foam box is probably the most popular casting technique because it is quicker and cleaner 
than plaster (Carroll et al., 2011). Recently, 3-dimensional (3D) surface scanners and 
digitizers, able to scan the foot directly have become available, meaning that accurate 
computer models of the foot shape can be generated (Guldemond et al., 2006, Stajer et 
al., 2011, Telfer et al., 2012). 
The casting technique is not the only factor which can influence cast quality, 
hence the functionality of the final orthosis; the final product can also be affected by the 
practitioner’s ability and experience. There are several studies which have investigated 
the influence that the practitioner may have in the casting process. Interestingly, Chuter 
et al. (2003) did not find a statistically significant difference between the experienced and 
inexperienced clinicians. However, in another study, Trotter et al. (2008) found that foot 
care professionals are consistent with themselves (intra-caster) but, both methods show 
poor reliability between practitioners (inter-caster). Carroll et al. reported an increased 
measurement error in the forefoot to rearfoot alignment, both within and between the 
raters, when casting with the neutral suspension technique (Carroll et al., 2011). 
3.6.2.2 Manufacturing process 
Once the cast is taken, there are two common approaches to manufacturing, 
traditional and CAD/CAM. For the traditional approach, the cast is filled with plaster to 
obtain a positive copy of the foot, which is then used to mould the insole. Following the 
prescription, the material for the shell of the insole is heated in an oven to make it 
malleable. It is then applied on top of the plantar aspect of the positive cast of the foot 
and introduced in a vacuum device to adapt the material to the shape of the cast. Once the 
first layer of material has cooled and is no longer malleable, more layers are applied on 
top of each other until the shape and height of the insole under the rear and mid foot is 
reached. The forefoot region (starting just proximal to the metatarsal heads) is flat, 
normally made with layers of cushioning materials to reduce PP. The insole is then 
finalised by glueing on a top and/or cover if required. 
In the CAD/CAM manufacturing technique, the cast can also be filled in with 
plaster and this positive reproduction of the foot is scanned in a 3D scanner to obtain a 
3D file. Another approach is to scan the foot of the patient rather than using a foam box 
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or plaster of Paris. This 3D file is then loaded into the insole design software, where a 
template of an insole is loaded and modified to replicate the plantar aspect of the foot. 
Then, the different additions are added and the file is sent to a milling station that will 
mill the insole out of a block of material.  
3.6.3 Customised insoles for reducing pressures 
There are many studies supporting the idea that the effectiveness of custom-made 
insoles is superior to that of off-the-shelf insoles (Postema et al., 1998, Bus et al., 2004, 
Mueller et al., 2006, Owings et al., 2008, Redmond et al., 2009, Paton et al., 2012, 
Ibrahim et al., 2013). For example, Ibrahim et al. (2013) found a significant reduction in 
the mean plantar pressures under the metatarsal heads with total contact insoles. This 
pressure reduction under the metatarsal heads, when using customised insoles, has also 
been found by other authors (Lord&Hosein, 1994, Brown et al., 1996, Kato et al., 1996, 
Postema et al., 1998, Bus et al., 2004, Tsung et al., 2004, Owings et al., 2008, Paton et 
al., 2012). Reduction in the soft tissue strain under the forefoot has also been reported 
(Lott et al., 2007, Ibrahim et al., 2013), with a reduction in the mean pressure in the same 
areas. Many authors suggest that this pressure reduction results from a corresponding 
increase in total surface area (Albert&Rinoie, 1994, Bus et al., 2004, Mueller et al., 2006, 
Raspovic et al., 2012).  
A medial arch support has proved to be highly effective in transferring load from 
adjacent regions to the medial midfoot (Novick et al., 1993, Brown et al., 1996, Bus et 
al., 2004). However, although Paton et al. (2012) found a significant increase in the total 
contact area, it was reduced by 50% at six months follow-up. This contact area reduction, 
linked to the fact that the pressure remained lower, led them to question the association 
between the contact area and pressure. However, other authors found no significant 
changes in peak pressures at this location (Ashry et al., 1997, Uccioli et al., 1997, Postema 
et al., 1998, Bus et al., 2004). These differing results are likely related to the use of 
different insoles, subjects, as well as experimental procedures, making it difficult to 
compare these studies. Nonetheless, there is sufficiently strong evidence to suggest that a 
medial arch support should be a consistent feature in the design and fabrication of insoles 
for patients with diabetes and neuropathy (Bus et al., 2004). Consequently, an accurate 
cast is of key importance to achieve the best replica of foot morphology. 
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3.6.4 Evidence of ulcer prevention and pressure offloading with insoles  
Customised insoles with additions are an effective in preventing ulcers and 
metatarsal bars are a commonly used addition in offloading insoles. This addition is a 
raised area behind the metatarsal heads to lift the metatarsal heads, thereby reducing the 
peak pressures which tend to occur under the metatarsal heads (Hsi et al., 2005, Kang et 
al., 2006, Mueller et al., 2006), just in front of the metatarsal bar (see section 3.6.3.). It 
has been suggested that the best approach for offloading a diabetic foot, and therefore 
preventing ulceration, is by using a combination of customised insoles and a therapeutic 
shoe (Owings et al., 2008). However, insole design is a complex task, as there are 
different types of insoles that offer different advantages. Furthermore, there are different 
additions that can be integrated to the insoles to achieve the treatment goal, including 
changes in the shape of the insole, such as a metatarsal bar. In addition, a range of 
materials can be used for insole manufacture, each with different properties, thus there is 
potential for a wide range of insole designs and therefore, choices available to the insole 
designer. For that reason, it is of key importance to have an in-depth understanding of 
how insole design features can affect in-shoe plantar pressures.  
3.6.5 Cushioning materials 
A broad range of materials is available for manufacturing insoles and their 
mechanical properties, including the abilities of force distribution, shock absorption and 
durability, should be carefully considered to achieve the maximal therapeutic effect 
(Kang et al., 2006). Increasing the thickness is an effective approach to reducing plantar 
pressure. However, the maximum thickness of material that can be used under the 
metatarsal heads is limited by footwear depth because excessive depth can depend on the 
shoe, putting the patient at risk for dorsal ulceration (Owings et al., 2008). The use of soft 
and cushioning materials has been studied and been shown to be effective for pressure 
offloading (Healy et al., 2012). In 2007, Paton et al. (2007)published the results of a study 
examining the physical properties of 15 materials used to prevent ulcers in diabetic 
patients with neuropathy. Of these materials, 6 mm Poron was the most effective, 
followed by ethyl vinyl acetate (EVA) (Fernandez et al., 2013). 
Many of the studies showing that soft and cushioning materials are effective for 
pressure offloading (Kang et al., 2006, Healy et al., 2012, McCormick et al., 2013) have 
 41 
 
used the materials to make complete insoles. An important limitation of these studies was 
that they did not only use softer materials on the forefoot to improve the offloading. The 
combination of different material densities would allow both offloading and pressure 
redistribution. In this thesis, cushioning materials will only be used under metatarsal 
heads, where higher peak pressures and ulceration are more common. This design is 
explained in detail in Chapter 5.  
3.6.6 Metatarsal bars 
A total contact insole, on its own, may not be sufficient to reduce pressure and 
prevent re-ulceration (Hastings et al., 2007). However, when combined with other 
additions (e.g. changes to the surface shape of the insole), the offloading effect of the 
insole can be improved. The most common addition is a metatarsal bar which is a convex 
shaped form positioned in the region of the metatarsal heads (Hsi et al., 2005). The 
metatarsal bars are placed just proximal to the metatarsal heads and can redistribute the 
plantar pressure, decreasing the stress and soft-tissue compression at the metatarsal head, 
by lifting the bone or not allowing it to plantarflex during the toe-off phase of the gait 
(Hsi et al., 2005, Kang et al., 2006, Mueller et al., 2006). Metatarsal bars are commonly 
used in combination with a void, which is a partial cut out under the peak pressure areas. 
This void is typically located just distally from the metatarsal bar to enhance metatarsal 
head offloading (Figure 3.5).   
 
 
Figure 3.5: Metatarsal bar and void design and position in the insole 
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Several authors have studied metatarsal bar offloading properties in high-risk 
patients (Ashry et al., 1997, Bus et al., 2004, Hsi et al., 2005, Mueller et al., 2006, 
Koenraadt et al., 2012), concluding that metatarsal bars are an effective for offloading 
pressures under the metatarsal heads, an area that has been associated with ulceration and 
the presence of high pressures (Ledoux et al., 2005, Patry et al., 2013). However, it is 
difficult to separate the effect of the metatarsal bar from the effect of the rest of the 
custom-made insole. Other studies, that have investigated the effect of a metatarsal bar 
on plantar pressures in healthy people without foot impairments, report highly variable 
results on the pressure decrease under the metatarsal heads (Holmes&Timmerman, 1990, 
Hayda et al., 1994, Ashry et al., 1997, Bus et al., 2004, Kang et al., 2006, Mueller et al., 
2006). The variation in the published results may be explained by the variability in the 
subject’s response to the metatarsal bar and metatarsal bar differences (shape, size, 
location, and material properties).  
The precise position of a metatarsal bar can have a considerable influence on the 
pressure reduction under the metatarsal heads, for example, Hsi et al. (2005) showed that 
small changes in the metatarsal bar position led to large changes in pressure. The 
clinically accepted position of a metatarsal bar has traditionally been 5 mm proximal to 
the metatarsal heads (Brodtkorb et al., 2008), however, several authors have investigated 
optimal positioning (Hayda et al., 1994, Hsi et al., 2005, Kang et al., 2006, Mueller et 
al., 2006, Hastings et al., 2007, Brodtkorb et al., 2008, Koenraadt et al., 2012).  
Hayda et al. (1994) tested 10 healthy subjects, using 3 different metatarsal pads: 
large foam, large felt and small felt. They tested each metatarsal pad at 3 different 
positions: at the metatarsal head base, 5 mm proximal and 5 mm distal. The small felt pad 
was found to be most effective for offloading, with the distal position associated with the 
greatest decrease in pressure for all types of pads. In another study, Hsi et al. (2005) 
recruited 10 male participants with a previous diagnosis of metatarsalgia. They tested all 
subjects with a foam rubber metatarsal pad, in the shape of a domed teardrop, initially 
placed immediately proximal to the metatarsal head with metatarsalgia and moved by 4.4 
mm distally 6 times. They concluded that the greatest pressure reduction was obtained 
when the metatarsal bar was placed just proximal to the peak pressure. In another study, 
Brodtkorb et al. (2008) recruited 22 healthy subjects taking measurements on one foot 
that was chosen at random. They tested 2 metatarsal pads, 5 mm and 10 mm high, made 
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of EVA 55º Shore-A. The metatarsal pad was attached to a Pedar insole just behind the 
2nd metatarsal head and moved consistently 5 mm proximally, with the subject instructed 
to stand on one leg during data collection. They established that when the metatarsal bar 
was positioned 5 – 25 mm proximal to the metatarsal heads, forces under the 2nd 
metatarsal head and the toes decrease, while pressures at the metatarsal support region 
increase. These data support the idea that a correctly placed metatarsal bar will 
redistribute the plantar pressure from metatarsal heads to the area where the metatarsal 
bar is placed (Koenraadt et al., 2012). 
In a study investigating metatarsal bar position, Hastings et al. (2007) found the 
pressure reduced consistently when the metatarsal bar was positioned between 6 mm and 
11 mm proximal to the metatarsal head line. These findings show that variations of more 
than 6 mm in the metatarsal bar position can have an important effect, significantly 
decreasing the offloading properties. However, other research has demonstrated that 
positioning of the metatarsal bar can be inconsistent when placed by either podiatrists or 
orthotist (Hastings et al., 2007). This inconsistency may explain the variability in the 
individual response to metatarsal bars observed in other studies (Chang et al., 1994, Ashry 
et al., 1997, Mueller et al., 2006). Given the importance of accurately positioning the 
metatarsal bar and the potential for error with manual methods of positioning, metatarsal 
bar placement should be customised based on quantifiable data, such individual plantar 
pressure measurements. However, all of the studies described above used standard 
metatarsal pads instead of customised metatarsal bars based on plantar pressures.   
3.6.7 Full insole customisation  
To date, there has been only one study by Owings et al. (2008), which customised 
not only the insole but the metatarsal bar shape for an understanding of barefoot plantar 
pressure patterns. This approach of using pressure data to design the insole may improve 
offloading as it achieves a more accurate positioning of the metatarsal bar. Owings et al. 
(2008) recruited 22 participants with diabetes and neuropathy to comprehensively 
evaluate the potential of fully customised insoles by comparing three different insole 
designs for each participant. Barefoot plantar pressures and foam impression were taken 
to fully customise the insoles. The first of which was designed with a shell of 
polypropylene and a plastazote cover, incorporating a standard metatarsal bar. The second 
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insole was made from 45º shore A EVA and incorporated a plastazote top cover and 
standard metatarsal bar. The final design was a fully customised insole (35º shore A Micro 
Puff EVA) based on a foot cast and plantar pressure data with a poron top cover. The 
metatarsal bar shape was designed using an algorithm that identified a pressure contour 
and positioned behind peak pressures (Figure 3.6). They also incorporated a void 3 mm 
deep underneath regions where peak pressures were higher than 1,000 KPa.  
 
 
Figure 3.6: Metatarsal bar design process followed by Owings et al. (2008) 
Subjects were tested with the three insoles in two different shoes: an extra deep 
shoe, and a rigid rocker version of the same shoe. Also, a control condition was set using 
the extra deep shoe with its standard insole. Pressure data was collected with the Novel 
Pedar in-shoe system at each participant’s own speed over a 20-metre walkway. However, 
only pressures from the first walking step were used for the data analysis. All the trials 
were averaged for each foot and pressure outcomes were derived from the 1st metatarsal 
head, 2nd metatarsal head and 3rd-5th metatarsal heads. Any region with pressures higher 
than 450 KPa was considered as a region of interest. In total, 70 regions of interest across 
the three masks from each foot of the 22 subjects tested were identified. From these 70 
regions, 54 were under the 1st or 2nd metatarsal heads and the customised insole 
significantly reduced pressures with the pressure based metatarsal bar in 64 of the 70, 
with 32% more offloading than the polypropylene insole and 21% more than the 45º shore 
A EVA insole.  
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These results demonstrate the potential opportunity provided by new technologies 
for custom insole prescriptions to enhance offloading. In their study, they used a fully 
customised insole based on foot shape and plantar pressure measurement, however, the 
plantar pressure data used for the insole design was taken from the first walking step taken 
by the subject and is not representative of plantar pressures, as several steps are needed 
to characterise representative plantar pressure patterns (Melvin et al., 2014). Furthermore, 
in the design process, a 3 mm deep region was removed under areas that the authors 
considered being high pressure. They defined high pressure as being greater than 1,000 
KPa, which may have been too high and they may have missed other areas with high 
pressures, lower than 1,000 KPa, but still placing the foot at high risk. Moreover, they did 
not investigate the effect of material as an additional design characteristic for reducing 
pressure and only studied one metatarsal bar position rather than systematically varying 
the bar position. Given the limitations of this study, our study was designed to answer the 
following research questions: 
1. What is the effect of systematically varying the metatarsal bar position in 
combination with cushioning material on in-shoe plantar pressures? 
2. What is the mean optimum design? 
3. What is the effect of each insole configuration when compared to the control 
condition? 
4. How much additional value is there is in individually choosing specific design 
features? 
3.7 Prediction of the response to insole design 
3.7.1 Factors that predict plantar pressures 
Plantar pressure is complex and influenced by multiple factors. Although some of 
these factors are difficult to measure accurately, others may help us understand and 
predict plantar pressure behaviour, for example, foot structure can affect peak pressure 
(Ledoux et al., 2005, Guiotto et al., 2013) and peak pressure can predict ulceration, so it 
is possible that ulceration may be predicted by foot structure. This concept has led some 
researchers to study different factors to predict plantar pressure behaviour based on feet 
structural characteristics. In one study, Payne et al. (2001) recruited 50 subjects with 
diabetes and collected socio-demographical variables, different radiographic angles, soft 
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tissue properties and joint mobility at the ankle and 1st metatarsophalangeal joint, as well 
as data on neuropathy. They used stepwise regression modelling and found that positive 
neuropathy scores explained differences in peak pressures under the hallux, 1st metatarsal 
head and heel. However, they did not obtain any significant results for the pressure-time 
integral (PTI) prediction from any of the variables studied. 
Foot deformity has been found to be a strong predictor of peak pressures. Indeed, 
Mueller et al. (2003) found the presence of hammer-toe on the hallux predicts peak 
pressures under the metatarsal heads and hallux. In their study, they recruited 20 subjects 
with diabetes and neuropathy, collecting measures of the foot from spiral x-ray computed 
tomography and dynamic peak pressures. They used hierarchical multiple regression 
analysis to predict regional peak pressures under the hallux and each one of the metatarsal 
heads, finding that the metatarsophalangeal joint angle is the most important predictive 
pressure variable. Another study, published by Barn et al. (2015), suggested that “local 
variables” such as foot deformity were stronger predictors that “global features” such as 
Body Mass Index (BMI) or age. For this study, demographic data, foot structure and 
function were collected from subjects with diabetes, neuropathy and a history of 
ulceration, and analysed using multivariate linear regression. They concluded that the 
presence of a local deformity was the largest contributing factor to barefoot dynamic 
pressures in high-risk diabetic patients. However, they warned that a significant amount 
of variance in pressure was not explained by the model, suggesting that plantar pressure 
measurements are required in clinical settings to properly assess an individual patient’s 
risk.  
Another approach adopted in the literature is to predict plantar pressures based on 
biomechanical and spatiotemporal data. Morag&Cavanagh (1999) recruited 55 healthy 
subjects and collected data on foot characteristics, as well as 3D foot motion and 
electromyography (EMG) while walking. They found that foot motion influenced 
pressures under the 1st metatarsophalangeal joint and that hallux pressures were highly 
influenced by the 1st metatarsophalangeal joint range of movement (ROM). Payne et al. 
(2001) studied 50 subjects with diabetes and neuropathy, also showing that the 1st 
metatarsophalangeal joint ROM is important in determining pressures under the hallux. 
In addition, the neuropathy-related variables can influence plantar pressure under the 
diabetic foot.  
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Taken together, the results of the studies described above illustrate that plantar 
pressures can be influenced by a range of different factors, including individual 
characteristics, such a neuropathy, as well as specific structural variables, such as those 
describing foot structure and deformity. In addition, biomechanical variables describing 
movement characteristics, such as the ROM of the 1st metatarsophalangeal joint have also 
been found to influence plantar pressures. It is possible that, as well as directly influencing 
pressure, these factors may also dictate individual responses to different insole designs. 
If this is the case, then clinical decision tools are required which can measure appropriate 
variables and use this information to identify the best insole design for a given patient. 
This concept is explored in more detail in the following sections.  
3.7.2 Mathematical models for predicting individual plantar pressure 
responses to an insole design 
It has been suggested that computational models may be an effective tool for 
predicting plantar pressure responses to a specific insole design (Actis et al., 2006). In 
line with this, several studies have used finite element models (FEM) to predict the effect 
of different insole designs. Finite element modelling is based on the fact that complex 
geometries, such as the surface of an insole, can be divided into very small subdomains, 
each of which is modelled individually. For the problem of predicting plantar pressures, 
the insole is divided into small subdomains and the mathematical equations which 
describe how the insole material responds to an applied load are solved in each domain. 
These solutions are then matched together to obtain a mathematical description of 
pressure distribution across the insole for a given foot shape and set of insole 
characteristics (surface geometry, compressibility, etc). Using this approach, it is possible 
to investigate the effect of different insole designs without extensive experimental work. 
Using 3D FEM analysis, Barani et al. (2005) compared offloading properties of 
different insole materials. They concluded that silicone gel was the optimum material to 
reduce stress concentration and was also good for shock absorption, with Polyfoam and 
Plastozote being viable alternatives. In another study, Goske et al. (2006) investigated 27 
insole designs with combinations of three insole conformity levels (flat, half conforming, 
full conforming), three insole thickness values (6.3, 9.5 and 12.7 mm) and three insole 
materials (Poron Cushioning, Microcel Puff Lite and Microcel Puff). Their FEM model 
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was developed to predict pressures during the early support phase of gait and predicted 
plantar pressures were validated through comparison with experimental data collected 
from a single subject. Although predicted peak pressures were slightly higher than those 
measured experimentally, Goske et al. (2006) demonstrated the potential that FE models 
have for furthering understanding the effects of different insole design characteristics. 
Chen et al. (2003) used FE modelling to investigate the effects of total contact 
insoles on plantar stress distribution. They concluded that total contact insoles can reduce 
high pressures at regions, such as the heel and the metatarsal heads, and also redistribute 
the pressure to the midfoot region when compared with flat insoles. In another study, 
Cheung&Zhang (2005) used FE models to investigate the effect of material stiffness of 
flat and custom moulded insoles on plantar pressures and stress distribution in the bone 
and ligamentous structures during balanced standing. They established that a custom-
moulded shape was more important for reducing peak plantar pressure than the stiffness 
of the insole material. Actis et al. (2006) developed a range of FE models of the foot and 
showed that bone, tendon and fascia structure, as well as soft tissue properties, need to be 
incorporated into the model if plantar pressures are to be predicted accurately. With these 
components, their model was able to accurately predict pressure distribution in both 
barefoot and with shoe and insole in the metatarsal head region.  
The studies described above demonstrate the potential of using mathematical 
models to predict plantar pressures. Given that these models incorporate structural 
characteristics of the foot; they offer the potential to predict individual patient responses 
for a range of insole designs. However, these models are complex to implement, requiring 
precise structural characteristics of individual feet and the computations can take long 
periods of time. Therefore, in their current form, they are not appropriate for wide-scale 
clinical use. However, the aim of this work is to facilitate the development of a clinical 
decision-making tool which can guide clinicians on insole design choice. As such, a more 
in-depth understanding of the effects of individual factors which may lead to differences 
in pressure responses to the same insole design is required. To date, there has been limited 
work in this area which, as explained above, has focused almost exclusively on finite 
element models. Many different factors could influence the response to insole design and 
given the paucity of research in this area, a study was designed to investigate the potential 
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modifying effect of a number of different variables. A rationale for how and why each of 
these variables may modify insole design is provided below. 
BMI (body mass index): A higher BMI indicates a higher weight for a given 
height and would be expected to lead to higher pressures under the foot. Interestingly, 
previous research has only found weak correlations between BMI and peak plantar 
pressures (Barn et al., 2015) in patients with diabetes and peripheral neuropathy, 
indicating that increased body weight is somehow redistributed across the plantar surface 
of the foot, minimising local peak pressures. It is possible that this redistribution may lead 
to differences in the way individuals respond to the same insole design. 
Arch height: Foot structure has been shown to be a predictor of plantar pressure 
(Barn et al., 2015). One of the most common foot deformities is a change in arch height, 
and this characteristic (cavus foot) is common among patients with diabetes (Ledoux et 
al., 2005). A higher arch height entails a smaller contact area of the foot with the ground 
while walking, resulting in redistribution of peak pressures across the foot. Again, this 
redistribution may lead to differences in the way individuals respond to the same insole 
design. 
Ankle joint mobility: The presence of neuropathy can reduce the mobility of 
selected joints in the foot, with the ankle joint being the most commonly affected (Guiotto 
et al., 2013). This lack of mobility has been associated with high peak pressures and also, 
a higher PTI on the forefoot (Zimny et al., 2004). Moreover, lack of mobility In the ankle 
can lead to an elevated time-dependent load of the forefoot (Fernando et al., 1991), a 
variable which has previously been found to be one of the predictors of plantar pressure 
(Payne et al., 2001). Given its influence on peak pressure, ankle joint mobility may also 
affect individual responses to insole design. 
1st MPJ mobility: Similarly to the ankle, the 1st MPJ is one of the most common 
joints of the foot affected by neuropathy (Guiotto et al., 2013). Birke et al. (1995) reported 
that when this joint becomes restricted, PP under the 1st metatarsal head rises in patients 
with diabetes. However, Bryant et al. (1999) reported that peak pressure under the 1st 
MPJ was significantly reduced in subjects with hallux limitus compared to controls. The 
relationship between the 1st MPJ ROM and PP behaviour is controversial, but several 
authors have concluded that it acts as a PP predictor (Payne et al., 2001, Menz&Morris, 
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2006, Turner et al., 2007, Rao et al., 2010). Given the important function role this joint 
plays during the push-off phase of the gait, it may also influence the response to a given 
insole design. 
Subtalar joint mobility has been documented to have reduced passive mobility 
in subjects with diabetes (Fernando et al., 1991), which may result in a reduced calcaneal 
eversion and inversion ROM during walking. This loss of mobility may entail a decrease 
in the forefoot mobility because it is believed to ‘‘unlock’’ the midfoot to allow greater 
mobility (Blackwood et al., 2005). Rao et al. (2007) found decreased eversion ROM in 
subjects with diabetes. Subsequently, they reported associations between decreased 
subtalar ROM and PP increase on the medial forefoot (Rao et al. (2010). 
Tissue stiffness: plantar soft tissues, particularly on the forefoot and heel regions, 
are specially structured to provide cushioning and shock absorption during walking. 
Stiffening of these tissues is associated with diabetic neuropathy and has been found to 
significantly increase the plantar pressure and internal stress, thus has been proposed to 
be an additional predictive factor of ulcer development (Pai&Ledoux, 2010, Sun et al., 
2011, Periyasamy et al., 2012, Patry et al., 2013), specifically increased tissue stiffness 
has been associated with higher peak pressures and ulceration. DM has also been shown 
to lead to a stiffening of the soft tissues on patient’s feet. However, this effect of the 
stiffening will vary between individual patients and so may affect how individual feet 
respond to different insole designs. 
Ankle joint maximum angular velocity: the decrease on ankle joint ROM 
present in patients with diabetes and neuropathy leads to an abnormal joint motion 
(Fernando et al., 2013). This lack of mobility in the ankle can also lead to an elevated 
time-dependent load of the forefoot (Fernando et al., 1991), a variable which has 
previously been found to be one of the predictors of plantar pressure (Payne et al., 2001). 
Moreover, Rao et al. (2010) found decreased ankle moment and power, which were 
associated with increased plantar loading in patients with diabetes.  
1st MTJ joint maximum angular velocity time: as with ankle joint velocity, 
there is a reduction in joint mobility on the 1st MPJ on patients with diabetes and 
neuropathy (Fernando et al., 2013). The ROM in this joint and its motion during gait has 
been previously associated with PP (Turner et al., 2007, Barn et al., 2015). Given the 
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consequences that prolonged PP may have in neuropathic tissues, it is important to further 
understand the influence of this variable in PP.  
The variables identified above all have the potential to influence individual 
responses to different insole designs. Moreover, each of these factors is amenable to 
measurement in a clinical scenario, either via a simple clinical test or with a miniaturised 
gait laboratory (Mifsud et al., 2014). More insight into how these factors affect individual 
plantar pressure responses would facilitate the development of a clinical decision tool 
which could guide clinician’s choice of insole design characteristics. This idea is explored 
in Chapter 8, which investigates the factors that influence the patient’s response to insole 
design. 
3.8 Scope and limitations of the project 
This thesis has been designed based on the framework given by the European 
Union project SMARTPIF. The University of Salford’s role in the project was to collect 
the morphological, biomechanical and pressure data from a cohort of high-risk patients. 
Given the external nature of the funding, the project had two main limitations; the first 
being that the focus should be on pressure offloading using insoles, however, the project 
did not stipulate the specific design of the insoles. The other limitation was the study 
sample, the target population was defined as “high risk”, but did not state which groups 
of medium or high-risk patients should be chosen. The author took the lead on all the 
different arrangements needed to design the different studies for this thesis, the 
recruitment and data collection, processing and analysis.  
First, a literature search was performed in order to identify a high-risk population 
that would benefit from wearing customised insoles. Patients with diabetes and 
neuropathy were selected as the target population given the serious and disabling 
complications that this disease has on their feet. This population can be classified as low, 
medium or high-risk population based on the different complications that they suffer 
according to the NICE guidelines (NICE, 2016). Therefore, it was decided to recruit 
subjects with diabetes and neuropathy, but with no history of ulceration, which are 
considered as medium risk population. The aim behind this choice was to prevent the 
ulceration, that would move them into the high-risk population group, with the use of 
 52 
 
insoles which have been shown to prevent ulceration (Owings et al., 2008). Accordingly, 
a further literature search was then performed in order to identify the most commonly 
used insole designs to prevent ulceration, but no consensus was found regarding the insole 
design. The most common approaches were metatarsal bars and cushioning materials, but 
there were no reports of them being used in combination to understand their effects. 
Accordingly, they were selected to further investigate their effect when combined.  
The project had some specifications about the data to be collected, such as plantar 
pressures and motion data. However, it was decided to also include clinical tests required 
to select the insole design for each participant and to better define the sample. Once the 
data set and the protocols were defined, an NHS ethics application was submitted. When 
the ethics approval was granted (REC: 13/NW/0331), the recruitment was started with 
the help of a radio advert and the NHS. All patients included in this study regardless of 
how they were recruited underwent a screening process (explained in detail in section 
5.1.2). All data collection, processing and analysis for this thesis were performed at the 
University of Salford. 
The four main studies which constitute this PhD are summarised below: 
Study 1: An exploration of current practice in relation to engagement with 
technology 
Insoles are normally prescribed to patients by podiatrists as part of their care 
package. In clinical practice, the choice of treatment tends to be based on what is 
considered appropriate for the foot deformity and/or symptom, the type of footwear worn 
by the patient and the practitioner’s preferences. Moreover, there is no consensus on what 
treatment should be provided to achieve optimum results. However, although there are 
general guidelines that foot orthosis and pressure relief should be provided to medium 
and high-risk patients, they are not detailed or standardised. Consequently, the diagnosis 
and prescription process is currently an experience-based trial and error task. Moreover, 
no factors have been identified which influence the professional’s decision making. These 
influencing factors and the different steps taken by the professional to treat and prevent 
the serious consequences of this disease need to be clarified. Furthermore, it is important 
to ascertain which variables the practitioners base their prescriptions on, what the process 
of assessment and diagnosis is, and where technology fits within current practice. 
 53 
 
Study 2: Reproducibility of plantar pressure collection using a wireless in-shoe 
pressure device 
Reproducible pressure measurement methods are required to interpret the findings 
of studies aimed at quantifying differences in plantar pressure between different insole 
designs. However, previous reproducibility studies have focused on healthy subjects and 
tested flat insoles, rather than insoles contoured to match the shape of the foot. It is 
possible that subjects with diabetes and neuropathy may have a less repeatable gait pattern 
than the healthy subjects studied in previous reproducibility research. Therefore, this 
study was undertaken to quantify the level of reproducibility of plantar pressure 
measurements in patients with diabetes and neuropathy. A total of nine subjects were 
tested using ten insole designs (Chapter 6), and SEM and ICC statistics were used to 
quantify the level of reproducibility for each design. Subsequently, this was used to 
facilitate interpretation of the results from quantitative Studies 2 and 3, outlined below. 
Study 3: Understanding the effect of systematically varying insole design 
characteristics on in-shoe plantar pressure 
Customised insoles and metatarsal bars have been shown to be effective for 
offloading peak pressures in people with diabetes and neuropathy. However, previous 
studies have not tested individually positioned metatarsal bars, nor is there a complete 
understanding of where the metatarsal bar should be positioned relative to the region of 
peak pressure. Furthermore, although cushioning materials have been shown to reduce 
peak pressures, it is not clear how to combine specific cushioning materials with a 
customised metatarsal bar for optimal offloading. For these reasons, this study sought to 
understand the effect of systematically varying the position of a fully customised 
metatarsal bar and the type of cushioning material. A total of ten insole designs were 
produced (Chapter 7) and tested on a total of sixty subjects with diabetes and neuropathy. 
The results of this study were then used to make clinical recommendations on insole 
design for people with diabetes. 
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Study 4: Identifying variables which may affect an individual’s response to insole 
design 
Previous research has shown that there can be differences in the way individual 
patients respond to the same insole design. It is possible that these differences are the 
result of different structural and biomechanical characteristics which have the potential 
to influence pressure behaviour and therefore, the magnitude of offloading. However, 
although previous research has investigated factors which may predict plantar pressure 
during barefoot walking, there is little research aimed at understanding which factors 
could determine individual patient responses to different insole designs. Therefore, this 
study (Chapter 8) was designed to investigate how a range of variables, including joint 
stiffness, tissue stiffness and joint movements, impacted on pressure responses. This 
information was then used to make recommendations in Section 8.7.3.  
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4 An exploration of current practice in 
relation to engagement with technology 
 
4.1 Introduction 
A number of systemic conditions present with complications that place the foot at 
risk of developing limb-threatening conditions, such as ulceration. One of the commonest 
conditions is type 2 diabetes, which is associated with neuropathy and altered foot 
architecture, resulting in the foot being at ‘high risk’ as the subsequent ulceration can lead 
to amputation (Paton et al., 2011, Hennessy et al., 2012). Elevated plantar peak pressures 
(PP) have shown to be a risk factor for ulceration in the diabetic foot, particularly when 
in presence of foot deformity and peripheral neuropathy (Bennetts et al., 2013). Insoles 
represent an effective approach to offloading PP and therefore, to help to prevent ulcer 
formation (Paton et al., 2011). Accordingly, in order to prevent ulceration, podiatrists 
may prescribe insoles as part of the care plan for such patients. However, insole design is 
a challenging task that, if not carried out appropriately, could increase the risk of 
ulceration in diabetes. Clinicians must take into consideration the potential effects of 
many factors when designing an insole, including the patient’s weight, occupation and 
footwear. In addition, it is often the case that when similar foot pathologies are prescribed 
the same type insoles, the response varies between individuals (Kang et al., 2006). In 
clinical practice, the choice of the insole is directed by what may be considered 
appropriate for the specific foot disorder, that is, the type of footwear worn by the patient 
as well as the practitioner’s preferences (Williams et al., 2016). Hence, there is no 
consensus insole design for maximum foot health improvement.  
There are general guidelines that recommend the use of insoles and pressure relief 
strategies in high-risk patients (Pinzur et al., 2005, Group, 2014). However, these 
guidelines are based on expert opinion and experience as opposed to empirical research, 
consequently, they lack specific insole design criteria, leading to variable clinical practice 
as practitioners base their decisions on personal preferences and experience which results 
in variable clinical practice.  
 56 
 
The Root model of foot function (Root, 1973, Root et al., 1977) forms the 
foundation of biomechanics training for preregistration podiatrists and is continued to be 
used in post registration practice. Interestingly, Jarvis et al. Jarvis et al. (2012) found that 
practitioners change their practice and decide which protocols they want to use as they 
gain experience, for example, the use of the Foot Posture Index (Redmond et al., 2006). 
Another factor that may influence practice is the use of technology to enhance patient 
care given that there is evidence to suggest that 3D foot scanning is more repeatable and 
reliable than plaster of Paris and foam impression boxes (Telfer et al., 2012). In addition, 
devices that collect plantar pressure data may improve the accuracy of both the diagnosis 
and insole design procedures. However, this technology is not readily available in the 
clinical setting and appears to be limited to research environments. Nevertheless, the final 
decision lies with the practitioner, which is often based on personal experience and 
preferences concerning the choices in relation to tools for the assessment, diagnosis, and 
prescription of orthoses. This may also change between patients and categories of 
patients. 
This freedom in prescribing can hinder the standardisation of orthotic 
prescriptions and the creation of guidelines. However, although the theoretical base of 
their practice is relatively consistent, all the factors and experiences that influence the 
decision-making are less so. Despite insoles being one of the most popular treatments for 
certain foot pathologies (Landorf&Keenan, 2000), the decision-making processes and 
tools used for designing insoles remain unclear. Therefore, there is a need for a better 
understanding of the different tools available to professionals, as well as the decision-
making processes, that aid in the diagnosis of foot pathologies and the design of 
appropriate orthotics. This study aimed to identify 1) what variables practitioners base 
their prescription design on, 2) what processes are used for assessment and diagnosis of 
structural foot pathologies and 3) how technology fits within current practice. A 
qualitative research method was employed to obtain the relevant data.  
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4.2 Objectives 
This study addressed three primary objectives: 
1. To gain insight into the aims of the practitioners when providing insoles in relation 
to both theirs (foot geometry, motion control, pressure redistribution, 
accommodation of deformity) and their perception of the patient's clinical need 
(usability, outcome).  
2. To identify which factors influence the assessment of patients and the specific 
design of the insole (including the materials used in their manufacture). 
3. To gain insight into how technologies can facilitate the achievement of patient 
and practitioner goals.  
4.3 Methods 
4.3.1 Recruitment 
Ethical approval was obtained from the University of Salford ethics committee 
(HSCR12/62). A total of 17 podiatrists with a broad expertise on lower limb pathologies 
and insole prescription were actively recruited to take part in this study. These participants 
were members of the North West Clinical Effectiveness group and the National Podiatry 
Network. Also, orthotists were recruited to participate in the study to represent the other 
main profession that normally prescribes insoles to their patients in the UK. All 
participants invited to take part in the study prescribed insoles in their day to day clinical 
practice and had a minimum of two years of clinical experience. An information sheet 
explaining the aims of the project and their role within it was sent to each participant after 
they agreed to take part in the study. Prior to the focus group and once they read the 
information sheet, all the participants were asked to provide informed written consent.  
4.3.2 Data collection 
Focus groups were selected to provide the qualitative approach for this study and 
were considered appropriate to answer the research questions. There are other qualitative 
approaches such as one-to-one interviews or Delphi models, but they were deemed 
inappropriate for this type of study. One-to-one interviews illustrate the opinions and 
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preferences of only one practitioner as opposed to a group. On the other hand, the main 
aim of the Delphi approach is to reach a consensus from a group of participants. However, 
the main purpose of this study was to gain a better understanding of what influences 
clinical practice and the role of technology rather than achieving consensus. Therefore, a 
focus group provided the ideal environment for a friendly, open dialogue where different 
ideas, habits and preferences on diagnosis and prescription were presented and discussed, 
but not necessarily agreed on. 
There were two sets of focus groups with eight participants in each set (one 
participant could not attend on the day he was assigned). The focus group was led by a 
co-researcher who was an academic with previous experience in conducting focus group 
discussions and with clinical experience in this area. The dialogue was digitally recorded 
and field notes were taken by myself and an additional co-researcher. Each focus group 
commenced with a presentation of the main aim of the study and the latest technological 
developments for insole and footwear provision. Also, an explanation of the format of the 
discussion was given, including an agreement that all participants should be allowed a 
voice and that all opinions should be respected to ensure that there was no conflict. Then, 
an opening question was used to initiate discussions: 
 “What factors influence the orthotic or footwear prescription in relation to your 
aims and the patient’s expectations?” 
Further trigger questions were used to help guide the dialogue including: 
 What types of foot orthoses and footwear would you prescribe for these specific 
conditions? 
 What designs of foot orthoses do you use and why?  
 What casting methods do you use? 
 In relation to terminology - When does bespoke become bespoke?  
 Is the term right? Should it be customised v off the shelf - As both could be 
considered bespoke in relation to a ‘bespoke prescription’  
 Do you use any technology in the assessment of your patients? 
 What materials do you use for functional foot orthoses and why? 
 What materials do your use for accommodative foot orthoses and why? 
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 What influences the footwear choice? 
 What about the specific design features of the footwear? 
 What influences this decision in relation to the patient’s medical history? 
 What are the influences in relation to foot / lower limb structure and function? 
 What are the main steps of your assessment of a patient? 
 Are there any other patient focused influences on your decision making?   
 What variables in orthotic prescription do you think predicts success?  
 How do you measure /evaluate outcomes? 
 What Problems in the assessment and prescription process do you find are the 
most challenging? 
 What do they think patient’s opinions of their foot problems and treatments are? 
 What factors influence their understanding and engagement with foot orthoses/ 
specialist footwear? 
 What would technology/Tools you like to have in your practice? 
 Why don’t you have them? 
 What do you think the benefits would be? 
The presentation introducing the focus group topic lasted for about 15 minutes, 
and the discussion after lasted between one hour and a half to two hours, depending on 
its evolution.  
4.4 Data analysis 
The data generated from the dialogue were transcribed verbatim by a specialist 
transcription service. The transcripts were then analysed using an iterative approach to 
thematic analysis as described by (Attride-Stirling, 2001, Darlington, 2002).The results 
were analysed and presented in two stages. First, the preliminary themes were identified 
from my field notes only and secondly, the preliminary themes were then compared with 
those found by the co-researchers. After discussion, an agreement was reached providing 
the final themes, subthemes and a final global theme as an overall conclusion (section 
4.5).  
Following data analysis, the results were sent to the focus group participants for 
verification and any additional comments. All participants agreed that the different 
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themes extracted represented the discussion and that the interpretation was correct. There 
were no additional comments. The participant names were then replaced with a 
pseudonym in order to maintain anonymity for the purposes of this thesis and any 
subsequent publications. 
4.5 Results 
The preliminary themes identified were developed using the iterative method into 
final themes (Table 4.1). 
Preliminary themes Final themes 
Materials used What current practice behaviour is based on 
Casting techniques Components of current practice 
Insole design 
Influences on choice of foot orthosis 
 Materials 
 Casting techniques 
 Design of insoles 
Types of insoles and 
footwear 
Barriers to engagement with technology 
Technology 
Perceptions as to how technology could enhance 
insoles/footwear design 
Difficulties 
Perceptions as to how technology could enhance the 
evaluation of orthosis 
What they want 
Perceptions as to how technology could provide 
information for practitioner and patient 
- 
Perceptions about the usability of technology in 
clinical practice 
Table 4.1: Preliminary and final results obtained from the reiterative analysis of 
the data collected during the focus groups 
 
4.5.1 Preliminary themes 
As mentioned previously, the transcripts were analysed using an iterative 
approach to thematic analysis and I conducted the first analysis from my field notes 
recorded during the focus groups, resulting in seven different themes:  
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Preliminary theme 1 – Materials used: 
Practitioners often experience problems acquiring some materials due to budget 
or distributor restrictions. EVA is most commonly used and is considered to be a 
‘traditional’ material for many orthotic designs. Practitioners feel EVA works well and 
know how to combine it with other materials to achieve good results. It is also relatively 
cheap and easy to obtain. However, it deforms easily, which highlights the importance of 
using the right material density. Plastazote is another popular material which is effective, 
light, long lasting and more flexible and easy to work with than other materials such as 
polypropylene. Combining different materials in order to obtain control and cushioning 
is a common approach, with practitioners often realising these different combinations by 
trial and error. Accordingly, they use specific combinations of materials rather than trying 
new materials. 
Preliminary theme 2 - Casting techniques: 
The semi-weight bearing foam box is the most popular casting technique because 
it is relatively fast and clean. Plaster of Paris, on the other hand, is only used for complex 
patients. Traditional casting techniques are more popular than 3D scanners because they 
allow the practitioner to correct the foot position, which is key to achieving the 
prescription’s target. In addition, 3D scanners are very expensive to acquire, so most 
practitioners in the public sector cannot afford them. 
Preliminary theme 3 - Insole design: 
The first step in the insole design process is the identification of the origins of the 
problem and the treatment approach for that particular problem. This is a difficult task as 
many variables should be considered that may influence the prescription’s effect, such as 
activity, joint mobility, medication or comorbidities (e.g. rheumatoid arthritis). 
Furthermore, practitioners agree that “normal” does not exist so there is no need to set the 
foot in a perfect biomechanical position. Consequently, if the patient has altered 
biomechanics of the foot with no symptoms, no treatment will be prescribed.  
The practitioner’s experience influences the prescription, but they agree that 
simple prescriptions normally work better than those that are more complex. Also, most 
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patients can be treated with simple insoles which are more likely to fit the patient’s 
expectations and will enhance adherence to the treatment, as many of them are reticent to 
wearing insoles.  
Preliminary theme 4 - Types of insoles and footwear: 
Standard insoles are effective for most patients; they are also cheaper, faster and 
easier to obtain than customised insoles. Therefore, they are often the first option for 
patients without deformities. However, each patient is different and these differences 
have to be considered when prescribing.  
Footwear restricts insole design and patients are not likely to wear therapeutic 
footwear. Therefore, it is best to show the patients pictures of the footwear they should 
wear to make sure they know how it looks and agree to wear it. 
Preliminary theme 5 - Technology:  
Devices, including pressure platforms or in-shoe pressure devices, and technology 
such as CAD-CAM are too time-consuming to use and are therefore rarely utilised, often 
only used for complex patients. Furthermore, 3D scanners are too expensive and require 
specific software and training before use. Practitioners also find that technology can have 
too much influence on their decision-making processes whilst prescribing and they prefer 
to make their own diagnoses and prescriptions. 
Preliminary theme 6 - Difficulties: 
Practitioners tend not to try new methods because they feel more comfortable with 
those familiar to them. Also, dissemination of practice among practitioners is not very 
common because their prescriptions are based on experience rather than science. An 
additional problem they face is the limited budget in the public sector, where patient 
satisfaction is the main goal. 
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Preliminary theme 7 - What do they want: 
Practitioners would like to be able to make custom-made insoles for all patients 
with no budget or material restrictions and with good communication with the 
laboratories. 
Regarding technology, they would like to see what happens inside the shoe when 
the patient is walking with and without the treatment; to assess it and to be able to show 
the patient. Also, they would like wireless, fast, simple devices for clinical practice only, 
without complex outcomes, which could be time-saving in predicting prescription 
outcomes. 
4.5.2 Final themes 
The independent first analysis that each of the researchers performed were then 
combined and discussed. A final agreement was reached with eight different main themes 
and a final global topic. There were three themes in relation to current practice (1-3) and 
five on contextualised opinions on the use of technology in clinical practice (4-8). 
Final theme 1 - What current practice behaviour is based on 
All practitioners agreed that current practice behaviour is experience based, 
influenced by “trial and error”. Also, how and where they were trained is a major factor, 
for example, podiatrists have a symptomatic approach to treatment whereas orthotists also 
treat the biomechanics whether symptomatic or not. As Duncan said: 
“…I trained at XXX but my colleague trained at XX and we do differ in our 
approach and choice of materials in particular…” 
Also, Mary said: 
“…once you have been trained then it’s a matter of trial and error…what works 
gets repeated and what doesn’t…well you bin that idea. Then all this becomes your 
personal preference.” 
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They take published research and make sense of it in their own practice, which 
gives them a feeling of ownership rather than being told what to do by researchers. The 
workplace also has a significant influence on their practice behaviour. In line with this, 
Adam added: 
“…we need to feel that there is a sense of ownership rather than being told what 
to do by researchers… when I read papers I have to apply it to what I know works and 
often that is in conflict… I then dismiss the research.” 
Additionally, the type of service they work in (e.g. MSK or ICAT) or political 
issues, such as changes in the service structure, may influence the way they diagnose and 
treat patients. As Sarah said: 
“…you have to retain your professional identity, and so this leads to behaviours 
becoming entrenched rather than changing to keep up with new practice…” 
Final theme 2 – Components of Current Practice  
Listening to the patient and history taking represents a huge part of the 
consultation and is seen as the foundation of success. It helps to focus on the patient and 
fit what he wants with what the practitioner wants. As Joan stated: 
“Listening to the patient and history taking is a huge part of the consultation 
(time)…it is part of getting to the correct diagnosis and patients expect it and I see it as 
the foundation of success… then the ‘hands on’ bit has to be quick, so I tend to use foam 
boxes for casting or off the shelf insole.”  
Others agreed with this and Dan added, 
“…the consultation is where you can educate the patient, and that is as important, 
if not more so, than the orthotic…if they understand then they will change their footwear, 
and then that’s half the battle.” 
The main target of the prescription is to ensure that the patient is happy and reach 
an agreement with them, in particular about footwear, as Sam commented: 
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“…we listen to what patients want and then make that fit with what we want. I 
spend a lot of time engaging with the patient…counselling them on the effect of weight 
and things like their type of activity…” 
The first treatment option is the simplest, to achieve the maximum correction with 
the simplest and most comfortable insole design. However, clinical practice is very 
variable as it is based on the practitioner’s experience and training. All agreed with what 
Joan said: 
 “…this may sound expensive and time-consuming…at least we can give 
something on the day, or if you are unsure of whether an orthotic is going to work then, 
you can give it a go with the temporary one.” 
Final theme 3 - Influences on the choice of insole: 
Sub-theme – materials 
EVA is the most commonly used material as it is durable, easy to use and acquire 
and is cheap. Furthermore, practitioners are accustomed to using this material, they are 
familiar with how to work with it and know that it is effective for their prescription targets. 
Therefore, despite knowing about new materials they continue to use EVA. 
Material choice is based on the clinical aim of the prescription and the 
combination of hard and soft materials is a popular approach to providing both motion 
control and cushioning. In addition, patient’s characteristics, such as activity and weight, 
are important when choosing materials. The underlying pathology determines the aim of 
the orthotic and the length of time the patient is required to use it (e.g. short term for 
plantar fasciitis or long-term for rheumatoid arthritis or diabetes). 
Sub Theme - casting techniques: 
The aim of the orthotic is one of the main factors for the choice of casting 
technique. Joint mobility also has to be taken into consideration as the foot has to be 
mobile in order to achieve correction. Therefore, Plaster of Paris is commonly used for 
feet with low mobility, while a foam box is used for feet with good joint mobility. In 
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addition, the practitioner’s preferences and habits strongly influence the casting technique 
selected. 
The simplest approach is always preferred in daily practice, consequently, casts 
are only used for complex patients. On the other hand, patients without deformities or 
who are not high risk will be most likely prescribed standard insoles that do not require 
taking a cast. 
Sub Theme - design of insole 
The main factors influencing design are the diagnosis, the aim of the treatment 
and the treatment outcomes that the patient expects. For non-complex pathologies, 
standard insoles are the first choice as they are cheaper and easier to fit and patients do 
not have to change footwear. Standard insoles are also much quicker to supply as the wait 
for appointments is lengthy. 
“…I often compromise... Don’t always do a full correction…an example is the 
height of the arch as it may irritate, shoe choice may not be suitable, so full correction 
isn’t possible.” 
Adam agreed and added: 
“…we may be aiming for pressure redistribution, improve function, reduce shock 
and shear or combinations of all of these…this defines what type of device and the 
materials.” 
Patients’ characteristics such as activity, joint mobility or BMI are important when 
choosing the insole material. Also, medication plays a major role in reducing the patient's 
symptoms.  
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The following themes emerged from the part of the focus group conversations 
around technology. 
Final theme 4 – Barriers to engagement with current technology:  
The main barrier to engaging with technology is that it is too time-consuming to 
set up and use, requiring specific training as stated by Robert: 
“We are not trained in technology…we would spend too much time to set up and 
to interpret, I don’t think patients expect it…this makes it slow to use, and maybe wrong 
information will be collected.” 
In addition, devices are only compatible within the same brand and the cost is too 
high. Furthermore, technological devices are not designed for clinical purposes and 
provide many complex, unnecessary data. Aligned to this Sarah said:  
“…it provided too much info…its ok for research but for clinical use it is difficult 
to navigate through all of it…you normally use 10% of the software because most of the 
information is not useful for clinic, it is for research…it also doesn’t replicate the foot in 
sufficient detail. The manufacturers don’t produce a kit that is clinically useful”. 
Practitioners only find technology useful for complex patients or those with 
problems with the treatment prescribed. They also feel that rather than enhance their 
skills, technology replaces them.  
Final theme 5 – Perceptions as to how technology could enhance insoles/footwear 
design   
They agreed that an algorithm to evaluate the insole and footwear effect while 
being used by the patient would help inform the patient and assess the outcomes of the 
prescription, as well as the effect on the upper limb or back. It would also assist with 
mapping foot types, patient activities and orthotic design trends, as well as the patient’s 
adherence to the treatment.  
Basic templates of insoles and shoes that can be modified (adding or removing 
additions) depending on the patient’s needs was another popular idea. These templates 
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should be based on real foot shape, providing a “perfect fit for the foot and the shoes”. As 
Dan said: 
“Shoes have to be an essential component… we need an algorithm for insoles 
AND shoes in the context of the patient’s life…also something to inform the patient what 
a good shoe is and then the insole would go into retail footwear based on foot dimensions 
and volume.” 
Graham agreed and added: 
 “…templates so you just have to introduce foot measures without casting, and 
that the software tells you the best design and material”. 
In addition to this, Peter suggested a library of shapes (overall design and 
additions) but  
“… not too many as it would get too complicated to navigate through in the time 
we have”. 
Finally, they also suggested that technology could enhance the characterisation of 
the properties of materials, as well as provide information on how combinations of 
materials (two or more together) could be used. This improved characterisation of 
multiple layers of different materials would help in deciding what the optimal 
combinations would be for specific cases.  
Final theme 6 - Perceptions as to how technology could enhance the evaluation of 
orthoses 
Practitioners agreed that a device that helps assess the effect of the insoles before 
the patient leaves the clinic would be of great help. This would contribute to reducing the 
number of appointments and increase the patient’s satisfaction with the treatment. 
Aligned with this idea Neal said: 
“…to be able to assess how the insoles are working before the patient leaves the 
clinic… in order to make adjustments that would normally be done at the review when 
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problems might have occurred…could predict this…and very useful when you don’t have 
a review appointment.” 
There was agreement that being able to see what happens inside the shoe while 
the patient is walking, before using the insoles and after, would help both practitioner and 
patient.  
The other main suggestion was a system to predict outcomes from both the shoe 
and insoles. Also, they were interested in having a better understanding of the effect that 
each one of the additions has on the insoles. They think that only the effect of the insoles 
can be predicted, not the success, as there are too many extrinsic factors that influence it 
as Joan commented: 
“…. you can only predict the effect of the orthoses, not the success as there are 
too many extrinsic factors that influence this…you can have the same foot type, but if you 
put that in two different patients there is a chance that you will get two completely 
different responses by doing exactly the same thing”. 
Final theme 7 – Perceptions as to how technology could provide information for 
practitioner and patient 
To support the practitioners continued education, it was agreed that it would be 
useful to interpret or translate the research into the clinical setting. Also, a tool that would 
help them share practices and results with each other (in the same professional language) 
across different services and professionals would be helpful.  
To help provide information to patients about their pathology and the treatment 
they have been prescribed, practitioners think that visual schemes of what comprises the 
treatment, how they work and their final look, would be the best approach. Pictures of 
appropriate footwear would be useful tools to help patients understand the footwear 
options available to them. Donna said: 
“…If we could check if the insoles are working inside the shoe, and that way be 
able to show the patient the treatment is working correctly…it may increase compliance.” 
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Aligned with this, Lesley suggested: 
“A visual for what is a good shoe (components identified and then jigsaw together 
as a whole picture…patients see shoes as a whole unit, not the component parts, and so 
this ‘deconstruction’ would be a useful visual aid.” 
A system that allows the follow-up of patients would be helpful to avoid 
unnecessary appointments. Also, a system which can ‘flag up’ which patients require 
referral to specific practitioners (such as physiotherapist) would be beneficial. 
Final theme 8 – Perceptions about the usability of technology in clinical practice 
Any device used in clinical practice must be fast and easy to use, providing results 
that are simple to interpret with simple clinical terminology. Technology should save time 
and be reliable in order to be a good investment. It should also be customizable with 
bespoke menus and templates so that each practitioner can have their own setup. One of 
the main ideas was the need for a wireless in-shoe pressure device without cables. 
Global theme 
The final global theme was agreed between myself and co-researchers and endorsed 
by the participants as reflecting the meaning of all the results. 
Current orthotic practice does not embrace technology, with choices in orthotic 
design being variable between practitioners and subject to many influences. The 
overarching barrier to their engagement with current technology is that it is not fit for 
purpose in the clinical environment, while practitioners do have a desire for technology 
that is usable and enhances the assessment, the interventions, the clinical outcomes and 
patient engagement throughout these processes.  
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4.6 Discussion 
The aim of this study was to gain a better insight into the main components of 
orthotic practice. To this end, the different factors that influence clinical decision-making 
and the role of technology within it were identified. In order to achieve this main 
objective, focus groups were selected as the best methodological approach. Other 
qualitative methods were considered but dismissed as they were not considered 
appropriate to address the research objectives. One method contemplated was one-to-one 
interviews, but they would only illustrate one participant’s opinion or belief at a time, 
which would not be representative of all the practices across the country. The Delphi 
method was also considered given that this approach requires experts to reach an 
agreement. However, the aim of this study was to gain a better insight into the different 
components and influences of current clinical practice, without the need for agreement. 
Therefore, focus groups set a perfect framework for discussion, including very different 
experiences and opinions from the different participants. Also, the discussion was 
considered to be enriched by the participants’ various experiences. The results obtained 
show that foot orthoses prescriptions are variable and that there is no fixed process. 
Current clinical decision-making is integrated by an array of factors, which are mainly 
influenced by training and experience as well as patient expectations, however, when 
present, technology plays an insignificant role.  
Practitioners base their clinical decisions mainly on their education and 
background. However, these habits change as they gain experience due to “trial and 
error”. These variations on clinical procedures illustrate the influences that real patients 
have on their understanding of foot structure, biomechanics and orthotic principles, which 
can be viewed as an enhancement of the practice. They are also influenced by the type of 
patients they treat, which is defined by the different clinical suites they practice in. 
Furthermore, there is a large difference between the private and the public sectors, for 
instance, the time available for each patient and budget issues, among others. However, 
research has little impact on their clinical practice as it is often difficult to interpret and 
apply to day-to-day practice, so they continue with what is familiar to them.  
Within this experience-based clinical practice, listening to the patient and history 
taking represents a fundamental part of the consultation. They invest time in listening to 
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the patient and the main aim of the treatment seems to have shifted towards reaching 
patient’s expectations, often comprising biomechanical corrections. This diagnosis and 
prescription approach shifts away from the traditional goals of achieving biomechanical 
correction. It evidences the influence of experience over training, whereby practitioners 
attempt to achieve patient adherence to the treatment, as well as comply with the policies 
of the services they work in. This trend where practitioners change their clinical decision 
making based on their experience rather than their training has been referred to before 
(Jarvis et al., 2012). Furthermore, other health care professions such as nursing show the 
same transitions, where students found big differences between what they learnt and what 
they observed in clinical practice (Kyrkjebo&Hage, 2005). This was endorsed by the 
discussion which made clear that the outcome they seek is the patients’ perception of the 
treatment being successful, rather than biomechanical correction as defined in textbooks.  
Discussions showed that in addition to orthotic prescription, practitioners referred 
to “counselling” and advising patients about wider issues such as activity and weight 
management, which also influence lower limb health. Informing patients about their 
disorder and how to improve it is also part of their role and has been shown to be an 
effective approach to enhancing the patient’s adherence to the treatment and recovery 
(Ronnemaa et al., 1997). However, practitioner knowledge of the success or failure of the 
treatment prescribed is determined by patient behaviour. Furthermore, they assume that 
patients are happy if they do not return to the clinic, and therefore, deem the treatment to 
be efficient and consequently, a success. However, this “non-return” by the patient can 
be influenced by many factors, such as a change in activity or medication, rather than a 
successful treatment. Moreover, it is common for patients to attend a different practice or 
to go to private practitioners when treatments are not effective (Malkin et al., 2008). 
Accordingly, to avoid this lack of knowledge about the treatment effectiveness, some GP 
practices have started using patient’s online access to their health records (de Lusignan et 
al., 2014). This is one of the fields where technology could enhance clinical practice 
(Boonstra et al., 2014). 
Listening to the patient helps the practitioner reach a diagnosis and then to 
prescribe a treatment. Furthermore, during this prescription process, there are many 
factors to be considered by the practitioner. However, in the discussions, it remained clear 
that the simplest approach is taken initially. They agreed that most patients do not need 
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complex treatments and that standard insoles are effective for them. Also, it helps provide 
the patient with a treatment on the same day of the consultation, rather than having to 
book another appointment. This approach facilitates two of the main problems that 
practitioners have to face in their day-to-day practice, as well as low budget and time 
restrictions. Standard insoles are usually easier to fit in normal shoes which help with 
treatment adherence as patients are reticent to change their footwear to therapeutic shoes 
(Malkin et al., 2008, Williams et al., 2010, Williams&Graham, 2012). Often standard 
insoles fulfil both main goals of the treatment, which are patient happiness and 
biomechanical/symptom correction. However, this prescription habit contrasts with 
Australia and New Zealand, where the most popular insoles prescribed were customised 
(72% of the total insoles prescribed) (Landorf et al., 2001). 
In more complex cases, customised insoles have to be prescribed, particularly for 
patients with diabetes or rheumatoid arthritis. This approach entails insole design 
decisions to be made by the practitioner, such as casting technique or material choice. 
Regarding the choice of casting technique, foam box casting was the most popular 
approach agreed by practitioners during the discussion, because it is cheap, clean, fast 
and allows for correction of the foot position. In relation to materials, many factors 
including activity, BMI or underlying disease of the patient are considered. EVA was the 
most commonly used material by all participants in the focus groups. This is because it is 
cheap and easy to obtain, most practitioners have low budgets and their providers have a 
limited range of materials available. Also, EVA is very versatile as it can be obtained in 
different densities that comply with the different aims of treatments, such as 
accommodative in lower densities or motion control in harder ones. This material has 
been previously referred to as the most popular amongst practitioners in the NHS as well 
as in Australia and New Zealand (Landorf et al., 2001, Malkin et al., 2008). It is also easy 
to combine with other materials to enhance its effects depending on the treatment goal. It 
was agreed in the discussions that they knew how to combine different materials based 
on a “trial and error” approach and that they normally adhered to them rather than trying 
new materials reported in research publications. 
Practitioners did not seem to follow research outcomes in general, not only 
regarding material innovations. Despite the general belief that published clinical 
guidelines are the best approach for clinical practice, the results obtained in this study 
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revealed that the influence of these guidelines on orthotic practice is limited. Practitioners 
agreed on experiencing difficulties in understanding and transferring research into day-
to-day practice. This lack of use of guidelines and evidence-based practice seems to be 
shared by chiropractors in other countries such as Australia (Walker et al., 2013). This 
reluctance towards guidelines tends to be based on the perception of these as “cookbooks” 
for clinical practice and podiatrists appear to have an “in my hands” mentality (Young, 
2007). However, although other health care sectors base their clinical practice more on 
research outcomes than podiatrists (Young, 2007), there is still need to ensure that the 
evidence is relevant to the context in which it is being applied (Sandars&Heller, 2006). 
A similar opinion was portrayed concerning the use of technology, where it was 
agreed that it was more research than clinical focused and has no place in day-to-day 
practice. One of the main issues that practitioners have is a lack of time per patient and 
they all agreed that technology is time-consuming to set up and calibrate to be worth 
using. Many of them stated that cupboards in their clinics were full of devices that were 
not used. They felt that currently available technology does not enhance their practice but 
replaces it, and they prefer having a feeling of ownership over their work. Also, devices 
give too many complex data, only a portion of which is actually used. Therefore, given 
the complex, time-consuming and costly reality of technology, it is not present in current 
orthotic practice despite the benefits it could provide. Consequently, there is a need to 
design technology according to the requirements and preferences of clinicians. This 
perception of technology differs from other health care professions, such as GPs, which 
find technology helpful and not time-consuming (Hayward et al., 2015).  
Despite not using technology in their practices, participants agreed that 
technology has the potential to enhance all aspects of orthotic practice. However, 
technology has to evolve and add value to clinical practice without adding to the burden 
of work. It was agreed in the discussions that the creation of templates that can be 
modified by the practitioner would speed up the process, adding certainty to design 
quality. These templates could also help to standardise the prescriptions within services 
and assess practitioners prescribing habits and outcomes. Also, the material 
characterization was discussed and it was agreed that it could enhance the combination 
of materials to achieve the treatment goals.  
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Evaluation of insoles before the patient leaves the clinic was another area 
identified where technology could help practitioners on a day-to-day basis. If treatments 
could be evaluated and tested for effectiveness on the same day of the consultation, it 
would help to avoid unnecessary appointments. It would allow the practitioner to make 
any corrections to the insoles before the patient commences the treatment and guarantees 
the success of the treatment as well as the happiness of the patient. Another matter that 
was agreed in the discussions was the possibility of “seeing” what happens inside the shoe 
when the patient is wearing the treatment. This information would improve their 
understanding of the way insoles work and would be able to identify potential issues more 
easily. 
The need for further information for both practitioner and patient about the 
treatment outcomes was agreed. Aligned with this, practitioners stated that visual 
diagrams and representations of the treatment, including insoles, footwear and the way 
they work, would help the patient better understand why the treatment is necessary and 
how it works, thereby achieving better treatment adherence. Regarding what they, as 
professionals, would require from technology is a system to follow up the patient, with 
detailed information about how the treatment is working, how it is being used and the 
need for further appointments, therefore avoiding unnecessary appointments. This type 
of technology is being developed and adopted by some practitioners and trusts in the UK, 
where devices allow patients to evaluate their satisfaction while leaving the clinic (Wright 
et al., 2016). Other approaches are mobile based with text messages or applications that 
allow the patients to inform their GP about their disorder state or check-ups (Bell et al., 
2012). Also, a platform that supports the practitioners’ education, translating research 
outcomes into information applicable to clinical practice that can easily be made sense of 
and apply when necessary. 
The need of clinically focused technology is an issue that clearly stood out during 
the discussions, which was agreed by all participants. There have been attempts by 
practitioners to integrate technology into their practice, but they all had negative 
experiences and led to the devices not being used. The reality in clinical practice is that 
time is limited per patient and technology should help speed up the diagnosis and 
prescription processes by giving clear, easy to understand data for both the practitioner 
and patient. It also should be easy to use and set up, with reliable data collection. There 
 76 
 
are many new technologies for health care being developed to help practitioners in their 
day-to-day clinical practice. However, it seems that podiatry may not be one of their main 
profession targets.  
4.6.1 Conclusion 
The results obtained in this study show that clinical orthotic practice is mainly 
based on training and experience, with the variations between practitioners reflecting the 
integration of education with local factors. Decision making for a prescription involves a 
combination of the patient’s needs and expectations, as well as the correction aims from 
the practitioner. Interestingly, the influence of research and evidence-based guidelines on 
their diagnosis and prescription habits is limited. Technology is mainly absent, being 
described as too complex and time-consuming. Measuring outcomes from their practice 
is significant for practitioners, but there are no current means of achieving this. This 
investigation has provided a novel insight into clinical orthotic practice, but further 
research is needed to obtain a broader understanding of the different factors that influence 
clinical practice. 
Practitioners agreed that they did not generally follow research outcomes and 
general guidelines. This was surprising as the literature is considered as the main resource 
for practitioners to find out about new treatments or materials to use. Moreover, rather 
than basing their clinical practice on the literature or their training, it is based on their 
experience the demands of patients. This finding on its own is not surprising, but it shifts 
the decision making from theory to patient expectations. The clinicians’ practice appears 
to change with experience, becoming a more personal interaction with the patients in an 
attempt to fulfil their expectations and often comprising biomechanical aims.  
4.6.2 Limitations 
An important limitation of this study is that all the participants were selected from 
health services in the UK which could affect the extrapolation of the results to other health 
care professionals and other care settings. However, the participants were selected based 
on their broad clinical experience, as well as their knowledge of other practitioners within 
their own services and networks. Furthermore, the main objective of this study was to 
gain a better insight into current orthotic practices from a personal and professional 
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perspective, which was the reason to select experts on the provision of insoles. However, 
this study was the first step in understanding the variations and factors that influence 
clinical practice, consequently, the results are limited. There is still a lack of information 
about the provision of insoles, including how it may vary among all the professional 
groups involved in orthotic design and manufacture. Hence, further research is needed to 
have a more in-depth understanding of the different factors that influence clinical orthotic 
practice. 
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5 Overview of experimental data 
collection and insole design process 
 
Three separate studies were designed to address the research questions defined at 
the end of Chapter 3. For the three quantitative studies, a single group of 60 patients with 
diabetes and peripheral neuropathy were recruited and visited the laboratory on a number 
of occasions (see details below). This chapter provides details of all the processes 
common to all three quantitative studies, such as participant recruitment and data 
collection. A full detailed description of each experimental data collection and processing 
is presented subsequently in the corresponding chapter. This chapter also describes the 
design process for the insoles tested in this PhD thesis.  
5.1 Overview of recruitment and experimental testing for the 
quantitative studies (2-4) 
5.1.1 Inclusion and exclusion criteria  
People with diabetes mellitus (DM) and peripheral neuropathy were recruited for 
studies 2-4 who fulfilled the following criteria: 
 Inclusion criteria  
o > 18 years of age 
o diagnosed with DM 
o diagnosed with neuropathy 
o be able to travel to the University of Salford on three different occasions 
o be able to walk for 1.5-2 hours  
o be able to understand both written and spoken English 
 Exclusion criteria  
o any partial or full foot amputation 
o a major foot deformity sufficient to limit activity or prevent the wearing 
of off-the-shelf shoes 
o any skin condition which could be affected by adhesive marker tape 
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o suffer from any disorder which affects balance or mobility and/or a history 
of falls, or walk with stick or clutches 
o lack of joint mobility (which may make them unsuitable for our insole 
designs) 
o previous history of ulceration 
These exclusion criteria positioned our subjects as medium-risk within the UK 
NICE guidelines for the assessment and foot risk classification of patients with diabetes 
(NICE, 2016). According to these, the presence of neuropathy is a risk factor, but the 
absence of previous ulceration makes them not high-risk locating them on the medium-
risk group. 
5.1.2 Approaches to recruitment  
Two different methods were used to recruit participants, recruitment through local 
GPs and via radio advertisement. Ethical approval was sought from the NHS ethics 
committee and obtained in September 2013 (REC number 13/NW/0331). Following NHS 
ethics approval, adoption from the NHS portfolio was requested.  
The Global Company was contacted to arrange a radio advert. Considering the 
target population needed for the study, they recommended running the advert (see the 
script in Appendix 8) with Capital FM and Gold Manchester. The advert was aired for 
the first time in January 2014, continuing for four weeks. People interested in taking part 
in the study sent text messages to the number provided in the advert, and the radio 
company forwarded their phone numbers. A total of 350 people showed interest in the 
study. They were phoned by the researchers and underwent a phone screening 
questionnaire (see Appendix 9). Following this questionnaire, a total of 30 subjects were 
deemed suitable for the study. Accordingly, and following NHS ethics requirements, a 
podiatrist was sent to their homes with their permission, to perform a neuropathy 
screening to confirm their suitability to take part in the study. Only those who showed 
signs of neuropathy were invited to the University to take part in the study. A total of 14 
eligible participants out of the 30 subjects screened on the phone were deemed suitable 
(Figure 5.1) and were booked in for an appointment at the University for the first visit 
data collection. 
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A total of eight different GPs made contact to help with recruitment. The 
inclusion/exclusion criteria were sent to each practitioner to enable them to perform an 
electronic database search. All potential eligible participants were then contacted by post 
and provided with a letter of invitation and a participant information sheet (see 
Appendices 6&7). Those interested in participating in the study were asked to make 
contact with the research team. A total of 1190 letters were sent to patients, of which 98 
made contact. To ensure that no ineligible participants were invited, each person who 
responded was asked some simple questions (see the document in Appendix 9) over the 
phone. Those who appeared to satisfy the criteria (n = 48) and were happy to participate 
after better understanding what the testing entailed, were subsequently visited by a 
podiatrist at their own home for a complete neuropathic screening. All participants 
deemed neuropathic after this screening (n = 46) were invited to participate in the study 
(see Figure 5.1). 
 
Figure 5.1: Recruitment process 
A total of 60 participants satisfied the inclusion/exclusion criteria and were 
recruited. The participants included 40 males and 20 females, with a mean age of 65.9 ± 
12.6 years, ranging from 25 to 87 years old. They were overweight to obese, with a mean 
body mass index (BMI) of 29.41 ± 5.2 kg/m2. This sample was representative of patients 
with diabetes and neuropathy, who are normally of old age, overweight, and more 
commonly men (Zimmet, 2014). Each participant visited the laboratory on at least two 
occasions (first visit and second visit), see Figure 5.2 below. During the first visit, a range 
of different variables (biomechanical, clinical and demographic) were measured. These 
data were used to design the nine insoles (described in Section 5.2.3) which were 
subsequently tested (plantar pressure measurement) during the second visit. Also, a total 
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of eight subjects (from the original 60) attended for testing on a third occasion. During 
this third visit, plantar pressure data collection protocol from visit two was repeated to 
address the first research question relating to reproducibility.  
 
Figure 5.2: Overview of the tests performed during the study visits 
 
5.1.3 Data collection visit 1 
All participants underwent a neuropathy screening, in a lying position, to confirm 
their suitability to participate in the study. Light touch and vibration sensibility were 
tested using a monofilament and a tuning fork. In addition, subjective symptoms were 
recorded using the Diabetic Neuropathy Symptom Score. These screening tests were 
chosen because they are commonly used in day-to-day clinical practice to test neuropathy 
(Dixit, 2014). Once subjects were confirmed as suitable, they read the information sheet 
and were invited to ask questions, after which they provided informed consent to 
participate by signing the consent form. Socio-demographical variables were then 
recorded, including gender, date of birth and height, weight and BMI.   
5.1.3.1 10 g Semmes-Weinstein Monofilament 
Light touch sensitivity loss was assessed using a 10 g Semmes-Weinstein 
monofilament. Nylon monofilaments are constructed to buckle when a 10 g force is 
applied and loss of ability to detect pressure at the point of buckling, at one or more 
anatomic sites on the plantar surface of the foot, has been associated with loss of large-
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fibre nerve function (Boulton et al., 2008). This approach is common practice and has 
been used in a number of prospective studies which have reported that loss of pressure 
sensation is highly predictive of subsequent ulceration (Boulton, 2010, Dixit&Maiya, 
2014). Moreover, it has also been shown to be highly reproducible (85%) (Tan, 2010) 
when compared with pulse palpation. Several studies report using the monofilament on 
only four different sites of the forefoot, and test being positive when one or more of these 
was not felt. Currently, there is no consensus on the protocol for the use of the 
monofilament with regard to the location and number of test sites, as well as the number 
of insensate sites to be classified as the presence of neuropathy. Testing 10 sites (Figure 
5.3) evaluates all dermatomes of the foot and may improve the sensitivity and specificity 
compared with testing 4 sites (Singh et al., 2005). 
In this study 10 different sites on the foot were tested in random order: 1st, 3rd and 
5th toes, 1st, 3rd and 5th metatarsal heads, internal arch, external arch, heel and dorsum 
between 1st and 2nd toes (Figure 5.3). Participants were asked to close their eyes and 
identify the site that the monofilament was being applied to. Areas of hard skin were 
avoided as it was felt that they might bias the result of the test. The test was taken to be 
positive for neuropathy if the patient could not feel the monofilament at one or more sites 
(Feng et al., 2011). The approach taken in this study was more conservative including the 
rear foot and the test considered positive when one or more of these was not felt.  
 
Figure 5.3: Monofilament test areas 
5.1.3.2 128 Hz tuning fork 
A 128 Hz tuning fork was used in order to test vibration sensitivity as it has been 
shown to be sensitive to neuropathy (Al-Geffari, 2012). It has been found that an inability 
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to sense vibration at different sites is clinically indicative of peripheral neuropathy 
(Takahara et al., 2014). Furthermore, in combination with the monofilament, it has been 
shown to be a good predictor of patients who later developed foot ulceration (Feng, 2011). 
The tuning fork was applied to bony prominences bilaterally: internal and external 
malleoli and 1st and 5th metatarsal heads (Al-Geffari, 2012). The participant had their eyes 
closed throughout and they were asked to indicate when they could sense the vibration. 
The test was considered positive for neuropathy when one or more of the vibrations could 
not be sensed (Dixit&Maiya, 2014). 
 
Figure 5.4: Example of tuning fork test on the 1st MPJ 
5.1.3.3 Diabetic Neuropathy Symptom Score 
The Diabetic Neuropathy Symptom Score was used to assess the subjective 
symptoms of neuropathy, which are important as they reflect the complaints of the patient 
and may be of additional diagnostic or prognostic value. Although several scores have 
been developed to assess symptoms of diabetic neuropathy, such as the Neuropathy 
Symptom Profile, the Michigan Neuropathy Screening Instrument (MNSI) and the 
modified NSS scores of Veves and Young (Dyck et al., 1986, Veves et al., 1993, Young 
et al., 1993, Feldman et al., 1994), the Neuropathy Symptom Score has been widely 
studied and accepted as valid and sensitive to detect neuropathy (Meijer et al., 2002).  The 
Diabetic Neuropathy Symptom Score tests the following areas: unsteadiness in walking, 
pain, burning or aching in legs or feet, prickling sensations in legs or feet, and numbness 
in legs or feet. The presence is scored 1 and absence 0, with the presence of any symptoms 
in any of the areas considered indicative of neuropathy. 
At least two of the screening tests described above had to be positive for a definite 
diagnosis of neuropathy. Once the diagnosis of neuropathy had been confirmed, and the 
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participant deemed eligible for the study, a range of further measurements were taken 
(see Table 5.1) to provide the biomechanical and clinical variables required to address 
Study 3 (Chapter 8) and also to produce the manufacturing specification for the different 
insole designs tested in Study 2 (Chapter 7). Table 5.1 provides a reference to the 
subsequent section in which the tests are described in more detail and the chapter 
presenting the data. 
Measurement 
Study/Insole 
design 
Chapter 
Number 
Socio-demographical variables 3 8 
Characterisation of foot segment lengths 3 8 
Skin stiffness characterization 3 8 
Joint mobility (ankle, subtalar, and 1st MPJ) 3 8 
Lower limb motion 3 8 
3D foot scan Insole design only 5 
Barefoot standing plantar pressure Insole design only 5 
 
Table 5.1: Different data sets collected on day one and details of study used in and 
where it is within this thesis 
5.1.4 Data collection during visit 2 and 3 
All participants returned for a second visit approximately 4-5 weeks after their 
initial visit. During this intervening period, customised insoles were manufactured for 
each participant, a process which is explained in more detail in Section 5.2.3. During the 
second visit in-shoe pressure data was collected while participants walked in a standard 
Oxford shoe for males and wedged shoe for females (Figure 5.5) using each of the nine 
separate insole designs. Further details on these pressure testing measurements are 
provided in Chapter 6. 
Standard shoes with a removable insole were used to test the insole conditions 
designed for the different studies presented in this thesis. It was decided to not use 
orthopaedic shoes because the participants had no significant deformities or history of 
amputation. In addition, such participants tend to be reluctant to change their normal 
footwear for aesthetic reasons (Williams et al., 2007, Williams et al., 2010). Accordingly, 
one of the study aims was to investigate the PP reduction that could be achieved with 
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fully customised insoles, based on technology, with a standard shoe. For males, an Oxford 
shoe with laces (Figure 5.5) was chosen as this style is a popular choice among most men, 
as well as being an appropriate type of shoe for these patients. For females, a wedged 
Mary Jane shoe with a buckled strap and a lycra forefoot was selected (Figure 5.5) as it 
provides enough room to fit the insole and the foot comfortably, as well as being 
aesthetically appealing for women. Also, the buckled strap allowed the shoe to be fastened 
and adapted to the individual foot shape and size. The main difference between the male 
and female shoes was the pitch. However, the female shoe had a platform under the 
forefoot which made the heel pitch smaller than it appeared and only 1.5 cm greater than 
the male shoe. Recent research (Melvin, 2014) has shown that heel pitch only has a 
significant effect on PP when it is higher than 3.5 cm. Therefore, the difference in pitch 
between the male and female shoes is unlikely to have affected the findings presented in 
this thesis. 
To address the research question relating to repeatability a total of 8 participants 
returned to the laboratory for a third visit, typically 3-5 weeks after their second visit, 
during which the in-shoe pressure measurement protocol, outlined above, was repeated. 
 
Figure 5.5: Standard shoes used with the customised insoles for in-shoe pressure 
measurement 
5.2 Customised Insole designs for studies 2-4  
Previous research has shown that customised insoles with a standard metatarsal 
bar (i.e. same design for all patients) can effectively offload plantar pressures from the 
forefoot of people with diabetes (Mueller et al., 2006, Guldemond et al., 2007). There 
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has been only one study by Owings et al. (2008) which has evaluated the benefits of a 
customised metatarsal bar shape in a fully customised insole, using plantar pressure 
distribution to determine metatarsal bar shape and location. However, this study did not 
investigate optimal proximal/distal placement of the metatarsal bar in relation to the 
location of pressure, choosing only to place the bar immediately proximal to the areas of 
highest pressure. Furthermore, they did not explore the effect of different cushioning 
materials used under the area of highest pressure, just distal to the custom metatarsal bar.  
Studies 3 and 4 (Chapters 7 & 8) were designed to address this limitation by 
testing the effect on peak pressure of different metatarsal bar locations relative to peak 
pressure data and different materials distal to the bar. All the insoles tested as part of this 
work were individually designed and manufactured using computer-aided design and 
manufacture (CAD-CAM) technologies to ensure accuracy in the design and 
manufacturing process. The inputs to the CAD-CAM process were 3D foot shape and a 
barefoot plantar pressure profile collected during standing. These data were used in the 
CAD software to produce a digital geometric model of each insole which was then sent 
to a CAM software-driven milling station that milled the insoles from an EVA block. The 
following sections document this design process in more detail. 
5.2.1 Capturing foot shape information 
The precise individual foot shape was obtained using a 3D scanner during the first 
visit. This scanner incorporated four separate 2D cameras and had a total scanning volume 
inside the scanner of 81 dm3, external dimensions of 420 x 160 x 120 mm and shape 
capture accuracy of +/- 1 mm. The scanner has a platform around it that allows the subject 
to stand in a normal comfortable position while placing one foot inside the scanner and 
the other outside (Figure 5.5). For this test, the subject was asked to stand normally, with 
one foot inside the scanner and the other foot on the platform, with their weight distributed 
equally between their two feet. This process was repeated for each foot.  
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Figure 5.6: Subject in a normal standing position 
Once data capture was complete, the scanner software integrated the data recorded 
from each of the 2D cameras, creating a 3D image from hundreds of data points forming 
a point cloud. From this point cloud file, the software created a solid 3D image of the foot 
by connecting all the data points with a continuous surface (see Figure 5.7). This solid 
mesh file was saved and then imported into the CAD software used to design the insoles. 
 
Figure 5.7: 3D foot shape taken from the 3D scanner 
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5.2.2 Recording the static plantar pressure map 
The Barefoot plantar pressure during standing was collected during the first visit 
using an Emed® pedography platform, an electronic system for recording and evaluating 
pressure distribution under the foot. The technical specification of the platform is given 
in the table below: 
Platform size: 700 x 403 mm² Sensor area: 475 x 320 mm² 
Number of sensors: 6,080 Sensor resolution: 4 sensors/cm² 
Measuring range: 10 - 1,270 KPa Maximum total force: 193,000 N 
Recording frequency: 50 Hz Accuracy: ± 5 % ZAS        
Table 5.2: Technical specifications of the Novel Emed platform 
The pressure platform was embedded in an 8 m EVA mat, which had the same 
thickness as the platform to ensure a consistent height surface, therefore, allowing the 
subject to stand normally (Figure 5.8). Participants were asked to stand placing only one 
foot at a time on the platform, with the other one on the EVA mat and to keep their weight 
equally distributed between their two feet. Data was then collected for 5 seconds and the 
Novel Emed software calculated the peak pressures. 
 
 
Figure 5.8: Emed platform layout 
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5.2.3 Insole design process 
Following the measurement of foot shape and static pressure during the first visit, 
9 pairs of customised insoles were manufactured for each subject. These allowed for the 
three bar locations (proximal, middle, distal) and three material options in each location 
(Poron, EVA, void).  
The design process was performed using a plug-in for the Rhinoceros software 
(Robert McNeel & Associates, USA) in the five stages below: 
1. creation of a customised insole from the 3D foot shape data 
2. overlay of the static pressure map onto the 3D foot shape data 
3. location the plantar pressure data points which define the position of the 
metatarsal bar and the void in the insole 
4. projection of the defining points onto the customised insole and creation of the 
customised base metatarsal bar and void 
5. adjustment of the metatarsal bar and void positions to allow for the 9 variations 
in insole design.  
5.2.3.1 Step 1: Creation of a customised insole from the 3D foot shape data 
The 3D foot shape was imported into the CAD software, which then identified the 
insole whose length would best fit the foot from a range of standard insoles (based on 
Salfordinsole geometries). Once this insole template was loaded, it was then customised 
by adapting the curves that defined the top surface of the insole to the plantar aspect of 
the foot mesh (Figure 5.9). The foot shape determined the orthotic shape up to the end of 
the medial arch, and after that, the insole was flat. The insole was modified to be 5 mm 
thick under the forefoot to accommodate the 3 mm deep void that would be added later 
(described in Step 5).  
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Figure 5.9: Insole customization from the 3D image of a foot 
5.2.3.2 Step 2: Overlay of the static pressure map onto the 3D foot shape data 
The position of the metatarsal bar and void, and thus, the location of the 
cushioning materials, Poron and EVA, was dictated by the plantar pressure distribution 
which was required to align with 3D foot shape and orthotic shape data. The pressure data 
was first mapped onto the 3D foot shape data and then, the position of the bar and void 
was specified from this pressure map. A bespoke Rhinoceros plug-in, specially developed 
to accurately match the pressure map file and the foot shape file (Foot Pressure Viewer, 
developed in European Union project SSHOES), was used to position the static pressure 
map over the 3D foot shape. This allows a designer to understand the relationship between 
foot shape and plantar pressure location (Figure 5.10).  
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Figure 5.10: 3D foot shape and plantar pressure map aligned using a Foot Pressure 
Viewer with the colour scale based on pressures (KPa) 
 
5.2.3.3 Step 3: Define the position of the metatarsal bar and the void  
Once the static pressure map was aligned with the 3D foot shape data, the position 
of the metatarsal bar and the void space for the base insole design were defined. 
Metatarsal bar design: To standardise the pressure maps, each subject’s data was 
normalised such that the maximum pressure was 300 KPa, to ensure consistency of the 
colour maps between participants (Figure 5.11). A medial-lateral line was then defined 
by 5 points proximal to the peak pressures, where the pressure was 77% of the peak 
pressure. On the regions where peak pressures were lower than 77% of peak pressures, 
the points were located in the 33% value of peak pressure (Figure 5.11). This line defined 
the proximal border of the void and the distal border of the metatarsal bar and is referred 
to as the metatarsal bar defining line in Figure below.  
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Figure 5.11: Design of the five defining points for the metatarsal bar and void 
 
Void design: Once the metatarsal bar defining line had been specified, a further 
5 points were used to define the distal border of the void. These 5 points were located at 
the point where the pressure dropped below 10% of the peak pressure, as shown in Figure 
5.12. The two lines (void defining line and the metatarsal line) are shown in Figure 5.12 
above and defined the void region.  
 
Figure 5.12: Void design and position 
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5.2.3.4 Step 4: Projection of the defining points onto the customised insole and 
creation of the base metatarsal bar and void 
The CAD software loaded a standard metatarsal bar onto the customised insole 
created in Step 1. The distal edge of this bar was then customised in shape to match the 
metatarsal bar defining line and the metatarsal bar line (Figure 5.12) was projected from 
the foot shape onto the insole. This line was then used to define the distal border of the 
metatarsal bar. All metatarsal bars were designed with a maximum height 2% of the foot 
length, for example, a participant with a size 7 had a bar of height 5 mm = 0.02 x 250 mm 
(size 7).  
The void defining line (Figure 5.13) was then projected onto the insole so that the 
geometry of the void space could be defined. As explained above, the void was situated 
directly distal to the metatarsal bar with a distal boundary corresponding to the void 
defining line. The depth of the void was set at 3 mm for all participants.  
 
Figure 5.13: Void design 
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5.2.3.5 Step 5: Definition of variations in the metatarsal bar and void positions  
Once the baseline design of the metatarsal bar and void was completed, two 
further designs were created by moving the metatarsal bar proximally and distally by 2% 
of the foot length. This percentage was chosen as it corresponds to a distance of 5 mm on 
a size 7 insole and 5 mm is a typical distance used in previous studies of metatarsal bars 
(Hayda et al., 1994). In the proximal and distal designs, the line defining the distal 
boundary of the void was kept constant and the proximal line defining the void adjusted 
accordingly in the CAD software. This resulted in a large void for the proximal designs 
and a small void for the distal designs. 
5.2.3.6 Manufacture 
CAM and direct milling of EVA blocks in the manufacturing process ensured 
accurate recreations of the insoles being tested. Insoles were manufactured by Todo Para 
Sus Pies S.L. (TPSP), a Spanish company specialising in customised shoes and insoles. 
Insoles were made of medium density EVA (50º Shore A) and manufactured with CAM 
software, which imported the insole files into a milling machine.  
The idea was to use a different cushioning material in this void region. However, 
to minimise costs and the need to produce a large number of different insoles, it was 
decided to create a cutout, with a depth of 3 mm, in which different materials inserts could 
be placed, as shown in Figure 5.14. With this approach, one insole was used with three 
insert options (Poron, EVA & empty void). Two different cushioning materials (3 mm 
Poron and 3 mm low-density EVA) were used to fill the void and form two of the three 
material conditions (the third being an empty void). These are two of the most common 
materials used by podiatrists when designing insoles for patients with DM (Fauli et al., 
2008). Each material insert was manually cut to match the shape of the void on a patient 
by patient basis. 
The design and manufacture process above created nine different pairs of insoles 
for each participant, which were then combined with the flat insole that came with the 
shoe to produce a total of ten different conditions (Table 5.3): 
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 Condition Metatarsal bar position Forefoot material 
1 D + EVA Base metatarsal +2% of foot length Soft EVA 
2 B + EVA Base metatarsal line Soft EVA 
3 P + EVA Base metatarsal -2% of foot length Soft EVA 
4 D + Poron Base metatarsal +2% of foot length Poron 
5 B + Poron Base metatarsal line Poron 
6 P + Poron Base metatarsal -2% of foot length Poron 
7 D + Void Base metatarsal +2% of foot length Void 
8 B + Void Base metatarsal line Void 
9 P + Void Base metatarsal -2% of foot length Void 
10 Sshoe Flat insole condition - 
Table 5.3: The ten different insoles conditions used in this study. P: proximal 
metatarsal bar; B: base metatarsal bar; D: distal metatarsal bar; SShoe: standard shoe 
 
 
Figure 5.14: The different insoles used for the study with different cushioning 
materials 
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6 Reproducibility of plantar pressure 
collection using a wireless in-shoe 
pressure device 
 
6.1 Background 
One of the key objectives of this thesis is to understand the effect of different 
design features of a fully customised insole on plantar pressures in people with diabetes 
and neuropathy. To develop this understanding, it is necessary to quantify pressure 
offloading across a range of different insole designs and from these data, identify the best 
performing insole design. However, this approach requires plantar pressure measurement 
which is both precise and repeatable. Repeated measurements of 
physiological/biomechanical variables, such as plantar pressures, are associated with 
some variability. This variability can arise from variability in an individual’s capacity to 
repeat a given task as well as from errors/variability in the measurement processor, the 
circumstances under which the measurements take place (de Vet et al., 2006). Therefore, 
to be able to interpret correctly the results of subsequent chapters which examine the 
effects of different insole designs, it is necessary to have a clear understanding of the level 
of reproducibility of plantar pressure measurement in people with diabetes and peripheral 
neuropathy. 
There are two main approaches to quantifying reproducibility referred to as 
agreement and reliability (de Vet et al., 2006). Agreement and reliability parameters focus 
on two different questions: 
1. ‘‘How good is the agreement between repeated measurements?’’ This concerns 
the measurement error and assesses exactly how close the scores for repeated 
measurements are. 
2. ‘‘How reliable is the measurement?’’ which characterises how well patients can 
be distinguished from each other despite measurement errors. 
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Reliability is the extent to which measurements can differentiate between patients, 
despite any measurement errors that may influence measured values. In contrast, 
agreement defines how close repeated measurements are to one another and is quantified 
in the actual unit of the measurement (de Vet et al., 2006). 
The calculation of the Standard Error of Measurement (SEM) is based on the 
measurement from a single subject taken an infinite number of times. In this scenario, 
each of the individual measurements would be slightly different because of measurement 
error. However, the distribution of these measurements can be described by a normal 
distribution and will be observed to cluster around a ‘true’ mean value with a variability 
characterised by a within-subject standard deviation. The more reliable the measurement 
response, the less variability and so the smaller the within-subject standard deviation 
(Bruton, 2000). The SEM is calculated by averaging the spread of measurements for each 
individual across the whole group. This calculation takes into consideration the possibility 
that some of the observed change may be due to random measurement error. Therefore, 
it can be used to define the difference needed between separate measures on a subject for 
the difference in the measures to be considered real (Weir, 2005). 
The Intraclass Correlation Coefficient (ICC) is used to quantify reliability by 
relating the measurement error to the variability between individuals in the population 
under study. It is defined as the ratio between the variability from true differences in the 
measured variable between individuals and the total variability, which is the sum of the 
true variability and the measurement error. Therefore, the ICC does not just reflect the 
measurement error but also the characteristics of the sample chosen. Consequently, the 
results have to be interpreted regarding the sample used. For example, it would be 
inappropriate to calculate the ICC from measurements on a group of healthy individuals 
(which is common in the literature because it is generally easier) and then apply the results 
to a particular patient group (Baker, 2013). An early paper suggested that values of the 
ICC as low as 0.6 should be regarded as indicating ‘substantial’ agreement and over 0.8 
as ‘almost perfect’(Landis&Koch, 1977). More recent reports are less generous 
suggesting that ‘for many clinical measurements, reliability should exceed 0.9 to ensure 
reasonable validity’ (Portney, 2009). 
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Reproducibility of in-shoe plantar pressure collection has been previously studied 
by some authors who have demonstrated high agreement and reliability (Ramanathan et 
al., 2010, Sawacha, 2013, de Castro et al., 2014). These studies have used the most 
popular in-shoe devices, Novel Pedar, Walkinsense and F-Scan, with the Novel Pedar 
system regarded as having the best reproducibility. Amongst the studies testing Novel 
Pedar reproducibility, all reported good results in healthy subjects while wearing standard 
shoes with no insole inside (Murphy et al., 2005, Putti et al., 2007, Ramanathan et al., 
2010). However, these findings may not extrapolate to patients with diabetes and 
neuropathy who often use complex contoured insoles. This patient group are likely to 
have impairments in balance associated with their neuropathy (Allet et al., 2008) which 
may affect cadence and foot biomechanics leading to inconsistent gait patterns (Allet et 
al., 2008). 
Another limitation of previous studies investigating the reproducibility of plantar 
pressure data is that they have tended to focus on flat insoles (Putti et al., 2007, 
Ramanathan et al., 2010). It is therefore not clear whether similar levels of repeatability 
would be observed with contoured insoles, especially if worn by people with diabetes and 
neuropathy. Accordingly, the aim of this study was to develop a precise understanding of 
the agreement and reliability of pressure data collected from customised insoles in people 
with diabetes and peripheral neuropathy. 
6.2 Study design 
To investigate the reproducibility of plantar pressure collection, pressure data was 
collected on two separate occasions from eight individuals with diabetes and peripheral 
neuropathy. For each participant, a total of nine different insole designs (Chapter 5) were 
tested along with a standard contoured control insole in a controlled laboratory 
environment. The data from the two sessions were compared using SEM and ICC to 
quantify reproducibility. 
6.3 Data collection 
A total of 8 participants with diabetes mellitus and peripheral neuropathy were 
required to visit the Human Performance Laboratory located at Brian Blatchford Building 
at the University of Salford on two separate occasions. On both visits, plantar pressures 
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were collected using Novel Pedar in-shoe pressure device while wearing standard shoes 
and different fully customised insoles. The same speed and walking conditions were 
applied on both occasions, and the same shoes and insoles were used. 
6.4 Plantar pressure measurements 
Novel Pedar insoles were used to collect in-shoe plantar pressure data. This 
system was chosen as it has been shown to be the most reproducible device for plantar 
pressure collection during dynamic activities (de Castro et al., 2014). The Pedar insoles 
have a matrix of sensors arranged in rows and columns which enable monitoring of the 
entire plantar area of the foot during walking. The insoles are made of capacitive sensors 
with elasticity to conform well to the three-dimensional surface of the orthotics. These 
sensor insoles are connected by cable to body-mounted transmitter box which sends the 
data to a computer via Bluetooth® telemetry. These data can then be observed in real-
time on the computer screen.  
For the data collection, all the nine insoles designed for each participant (Chapter 
5) were tested in a standard oxford shoe for males and wedged shoe for females (Figure 
6.1). This shoe has an internal insole that could be removed to allow the customised 
insoles to be accommodated within the shoe. In addition to the nine different customised 
insoles (Figure 6.2), data from a standard insole was also collected and set as the control 
condition (Figure 6.3), meaning that a total of ten conditions were tested on each subject. 
For each one of the conditions, the participant was asked to along a 20 m walkway at 
their self-selected speed. This speed was determined with the control insole and 
measured using optical timing gates. For the following trials, speed was monitored using 
optical timing gates and only trials within ±10% of normal speed were considered 
acceptable, however, trials within ±5% of average speed were selected when possible. A 
total of 18-25 steps were collected from each walk, with a minimum of five walks at the 
correct speed, giving approximately 100 steps per insole condition. 
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Figure 6.1: Standard shoes used for testing 
 
Figure 6.2: Different insole conditions used 
 
 
Figure 6.3: Standard insole set as the control 
 Each of the eight participants returned to the laboratory for repeat testing 
approximately one month (between 3-5 weeks) after the initial test. This repeated testing 
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followed the same protocol as the initial testing with the same set of ten insoles and the 
same walking speed. Again, speed was monitored using optical timing gates and only 
trials with 5% of the target speed considered acceptable. 
6.5 Data analysis 
6.5.1 In-shoe pressure data processing 
Data collected with the Pedar system was exported to Matlab for further analysis 
with a custom Matlab programme written by a fellow researcher at the University of 
Salford. This program was developed to analyse the PP data for a previous European 
Union project (SSHOES) and was modified slightly to analyse the data from this study. 
Despite being used at University, this Matlab program has not been published or shared 
with any other institution. The program first separated the data for each insole condition 
into separate blocks, corresponding to a continuous set of steps (approximately 17-22 
steps per block) (Figure 6.4.). Each block was then subdivided into individual steps by 
setting a threshold value above which the foot was assumed to be in contact with the 
ground. This threshold was set manually for each set of data to just above the highest 
values of PP between steps, but never higher than 20 KPa. The first and last two steps 
were removed from each trial as these represented gait initiation and termination. 
Following trial and step division, the information was saved in a mat file format and 
subsequent processing was used to define appropriate pressure outcomes for each step. 
 
Figure 6.4: Step selection from walking graphs 
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Peak plantar pressure and the pressure time integral during the stance phase of 
walking was used to characterise the effect of varying the design features. This outcome 
was calculated for the 1st, 2-4th and 5th metatarsal heads as well as the hallux, regions 
reported to be the locations at most risk from ulceration (Weijers et al., 2003). To define 
each mask region, specific sensor markers were selected (Figure 6.5) using the 
measurements of Cavanagh et al. (1994). The peak pressure (PP) and pressure-time 
integral (PTI) were calculated for each area. These outcomes were calculated for each 
step of each walk and then averaged across all steps to give a single value for each region. 
 
Figure 6.5: Pedar mask used in the study 
These processed data were then exported to Excel so that the PP and PTI data 
were available for each visit, each region, each side and each condition. All these data 
were then combined on another excel sheet to allow the comparison between both visits 
per mask area, side and condition. SEM and ICC were then used to quantify the between-
day variations in peak pressure and the pressure time integral across the different 
anatomical regions for each condition.  
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6.5.2 Statistical analysis 
The SEM can be used to quantify how accurately repeated measurements can be 
obtained across a range of individuals. It quantifies this agreement as an average within-
subject standard deviation, obtained by averaging the spread of measurements for each 
individual across the whole group. It can be quantified as the SD of the differences 
between repeated measurements (SDd) (Weir, 2005, Ramanathan et al., 2010) 
𝑆𝐸𝑀 =
𝑆𝐷𝑑
√2
 
ICC, on the other hand, quantifies the extent to which measurements can 
distinguish between patients despite measurement errors. The difference between this 
measurement and the SEM is that SEM only captures the actual variability in the 
measurement; it does not distinguish between patients. The ICC ranges from 0 to 1, with 
0 indicating a large degree of inconsistency and 1 showing perfect reliability. It is 
important to understand that reliability captures the size of the measurement error relative 
to the variability across the group. This means that the higher the error, the lower the ICC. 
Accordingly, ICC can be calculated from SEM as follows: 
𝐼𝐶𝐶 = 1 − (
𝑆𝐸𝑀
𝑆𝐷
)2 
 
SEM and ICC were calculated for PP and PTI for all conditions, for each side and 
anatomical region. SEM results for PP and PTI are displayed in the next section within a 
table in the units of the pressure measurement, KPa. Also, average PP and PTI values are 
also presented in order to illustrate how reproducibility compares to typical pressure 
values. Low SEM values demonstrate good agreement between measurements, whereas, 
ICC values range from 0 to 1, with values close to 1 representing high repeatability. 
Finally, to have a representative value characterising the overall reproducibility for all 
contoured insoles, values of ICC and SEM were averaged across sides and all conditions. 
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6.6 Results 
6.6.1 Sample and variables included 
In this study (n = 8) there was a total of 5 males and 3 females, with a mean age 
of 59.5 ± 16.76 years, ranging from 25 to 78 years old. The participants were overweight 
to obese, with a mean body mass index (BMI) of 29.58 ± 4.4 kg/m2 ranging from 23.05 
to 34.11 kg/m2.  
In this study, the PP values for each one of the different insole conditions collected 
on the second and third visits were analysed and are presented in the next sections. The 
different functional tests and motion data collected on the first visit were only analysed 
in the last study presented in this thesis (Chapter 8). 
6.6.2 First metatarsophalangeal joint (1st MPJ) 
The reproducibility under the 1st MPJ showed relatively low SEM values. 
However, these SEM values were approximately 15-20% of the mean PP, but 
approximately 20% for PTI (Table 6.1). The SEM values did not appear to differ 
substantially between the different insole conditions, nor was there any clear difference 
in agreement between the standard shoe and the contoured insoles (Table 6.1).  
 
SEM 
Left PP 
(KPa) 
Right PP 
(KPa) 
Mean PP 
(KPa) 
Left PTI 
(KPa*s) 
Right PTI 
(KPa*s) 
Mean PTI 
(KPa*s) 
D + EVA 54.32 61.20 303.7 8.76 8.03 40.34 
B + EVA 47.2 59.73 307.12 7.74 9.02 38.12 
P + EVA 58.54 61.65 302.8 10.04 6.57 41.16 
D + Poron 61.98 45.54 292.47 9 7.56 38.8 
B + Poron 53.22 53.09 291.7 7.44 7.75 36.72 
P + Poron 55.53 41.27 294.64 9.02 7.74 41.97 
D + Void 46.27 49.94 315.11 8.77 9.27 39.85 
B + Void 44.73 69.4 313.19 8.15 8.82 39.67 
P + Void 44.98 57.24 316.89 8.57 7.94 43.26 
SShoe 57.87 54.44 301.41 11.47 7.97 39.22 
Average 52.46 55.35 
303.9 
8.896 8.067 
39.91 
Total average 53.91 8.4815 
Table 6.1: Average SEM results for the 1st metatarsal head per side. PP: peak 
pressure; PTI: pressure-time integral; P: proximal metatarsal bar; B: base metatarsal bar; 
D: distal metatarsal bar; SShoe: standard shoe. 
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For the 1st MPJ, ICC values were low to moderate, ranging between 0.4 and 0.7. 
Similar to the SEM data, the ICC values did not appear to differ substantially across the 
different insole conditions. However, a difference between sides was found for both PP 
and PTI, with the resulting PTI differences greater than those for PP. In terms of the 
reliability, the mean ICC for PP (0.62) was slightly higher than that for the PTI (0.56). 
However, both would be considered moderate reliability (Table 6.2).  
 
ICC 
Left PP (KPa) Right PP (KPa) Left PTI (KPa*s) Right PTI (KPa*s) 
D + EVA 0.57 0.67 0.41 0.68 
B + EVA 0.67 0.64 0.37 0.59 
P + EVA 0.55 0.7 0.46 0.76 
D + Poron 0.5 0.73 0.45 0.7 
B + Poron 0.63 0.6 0.45 0.67 
P + Poron 0.51 0.75 0.5 0.69 
D + Void 0.69 0.63 0.42 0.65 
B + Void 0.75 0.55 0.49 0.56 
P + Void 0.48 0.68 0.5 0.7 
SShoe 0.56 0.59 0.44 0.71 
Average 0.591 0.65 0.449 0.671 
Total average 0.62 0.56 
Table 6.2: Average ICC results for 1st metatarsal head per side. PP: peak pressure; 
PTI: pressure-time integral; P: proximal metatarsal bar; B: base metatarsal bar; D: distal 
metatarsal bar; SShoe: standard shoe. 
6.6.3 Central metatarsophalangeal joints 
SEMs for PP and PTI under the metatarsal heads were relatively low. Although 
there were some side-to-side differences for PP, typical SEM values were around 15-20% 
of the mean PP for the left foot and 20% of the average for the right foot (Table 6.3). 
These differences between sides were not found in PTI, where SEM values were 
approximately 20% of the mean. For the PTI, there were no striking differences between 
SEM values across different conditions tested or for the control condition.  
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SEM 
Left PP 
(KPa) 
Right PP 
(KPa) 
Mean PP 
(KPa) 
Left PTI 
(KPa*s) 
Right PTI 
(KPa*s) 
Mean PTI  
(KPa*s) 
D + EVA 31.82 47.75 243.71 8.12 7.28 40.66 
B + EVA 35.86 53.93 224.05 7.93 8.97 37.34 
P + EVA 43.13 32.26 243.67 8.93 8.94 43.32 
D + Poron 29.49 41.1 227.22 6.92 7.34 39.71 
B +  Poron 34.15 53.21 217.47 7.31 6 36.63 
P + Poron 45.14 35.34 248.98 9.12 6.24 43.36 
D + Void 38.39 48.6 248.7 9.42 7.2 38.33 
B + Void 38.08 61.65 239.02 8.5 9.79 37.62 
P + Void 52.03 39.52 270.81 7.46 8.44 43.49 
SShoe 46.14 71.38 252.14 7.65 8.51 39.84 
Average 39.423 48.474 
241.57 
8.136 7.871 
40.33 
Total average 43.94 8.0035 
Table 6.3: Average SEM results for central metatarsal heads per side. PP: peak 
pressure; PTI: pressure-time integral; P: proximal metatarsal bar; B: base metatarsal bar; 
D: distal metatarsal bar; SShoe: standard shoe. 
Under the central metatarsal heads, the values for ICC were low to moderate, 
ranging between 0.4 and 0.7 (Table 6.4). In line with the findings for the SEM, the PTI 
appeared to be a slightly more reliable measure (higher ICCs) that PP. Again, there was 
minimal variability of ICC across the different insole conditions. 
 
ICC 
Left PP (KPa) Right PP (KPa) Left PTI (KPa*s) Right PTI (KPa*s) 
D + EVA 0.53 0.46 0.48 0.63 
B + EVA 0.49 0.39 0.46 0.42 
P + EVA 0.41 0.63 0.39 0.48 
D + Poron 0.56 0.54 0.64 0.62 
B + Poron 0.53 0.34 0.51 0.63 
P + Poron 0.39 0.58 0.49 0.65 
D + Void 0.57 0.48 0.44 0.71 
B + Void 0.56 0.38 0.47 0.42 
P + Void 0.48 0.55 0.6 0.52 
SShoe 0.44 0.42 0.53 0.54 
Average 0.496 0.477 0.501 0.562 
Total average 0.4865 0.5315 
Table 6.4: Average ICC results for central metatarsal heads per side. PP: peak 
pressure; PTI: pressure-time integral; P: proximal metatarsal bar; B: base metatarsal bar; 
D: distal metatarsal bar; SShoe: standard shoe. 
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6.6.4 Fifth metatarsophalangeal joint (5th MPJ) 
The reproducibility of plantar pressures under the 5th metatarsal head showed 
relatively small SEM values (Table 6.5). Nevertheless, both PP and PTI values for the 
SEM were approximately 25-30% of the mean PP (Table 6.5). Similar to the other 
regions, there was minimal variability in the SEM across conditions for both PP and PTI 
and the standard shoe did not appear to be associated with better reproducibility. 
 
SEM 
Left PP 
(KPa) 
Right PP 
(KPa) 
Mean PP 
(KPa) 
Left PTI 
(KPa*s) 
Right PTI 
(KPa*s) 
Mean PTI 
(KPa*s) 
D + EVA 34.74 32.98 124.53 12.24 9.3 31.62 
B + EVA 29.12 30.45 122.49 8.84 8.94 29.27 
P + EVA 35 32.35 121.16 12.32 9.64 29.42 
D + Poron 24.04 30.39 115.46 11.53 7.22 27.39 
B + Poron 25.75 31.31 115.77 7.8 7.23 26.56 
P + Poron 31.71 30.3 123.02 11.32 7.7 30.93 
D + Void 30.12 32.33 122.29 10.04 9.56 29.39 
B + Void 35.49 28.71 126.1 12.05 10 32.05 
P + Void 30.06 26.82 124.75 10.29 9.46 31.86 
Sshoe 33.00 20.47 108.98 8.24 6.18 38.56 
Average 30.90 29.61 
120.45 
10.467 8.523 
30.70 
Total average 30.26 9.495 
Table 6.5: Average SEM results for 5th metatarsal head per side. PP: peak pressure; 
PTI: pressure-time integral; P: proximal metatarsal bar; B: base metatarsal bar; D: distal 
metatarsal bar; SShoe: standard shoe. 
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ICC values under the central metatarsal heads were low to moderate, ranging from 
0.4 to 0.8, slightly higher than other anatomical regions. However, in line with the 
findings from other areas, reliability was slightly higher for the PTI and there was also 
minimal variability between conditions. 
 
ICC 
Left PP (KPa) Right PP (KPa) Left PTI (KPa*s) Right PTI (KPa*s) 
D + EVA 0.61 0.45 0.49 0.61 
B + EVA 0.7 0.44 0.66 0.59 
P + EVA 0.61 0.51 0.49 0.44 
D + Poron 0.7 0.49 0.62 0.64 
B + Poron 0.7 0.54 0.73 0.65 
P + Poron 0.69 0.46 0.68 0.65 
D + Void 0.68 0.45 0.66 0.66 
B + Void 0.67 0.5 0.6 0.49 
P + Void 0.71 0.5 0.7 0.51 
SShoe 0.75 0.61 0.67  0.82 
Average 0.682 0.495 0.63 0.606 
Total average 0.5885 0.618 
Table 6.6: Average ICC results for 5th metatarsal head per side. PP: peak pressure; 
PTI: pressure-time integral; P: proximal metatarsal bar; B: base metatarsal bar; D: distal 
metatarsal bar; SShoe: standard shoe. 
 
 
6.6.5 Hallux 
The hallux showed the highest SEM results across all the masks studied 
illustrating low levels of reproducibility. SEM values for both PP and PTI were 
approximately 35-40% of the mean PP. However, variability across conditions was also 
low for both PP and PTI. 
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SEM 
Left PP 
(KPa) 
Right PP 
(KPa) 
Mean PP 
(KPa) 
Left PTI 
(KPa*s) 
Right PTI 
(KPa*s) 
Mean PTI 
(KPa*s) 
D + EVA 77.01 102.34 245.84 16.53 16.06 42.24 
B + EVA 73.49 93.49 240.31 17.14 14.35 41.7 
P + EVA 76.88 100.54 260.89 18.65 15.74 42.43 
D + Poron 79.31 89.76 225.12 17.54 15.52 41.05 
B + Poron 70.66 85.84 240.11 17.9 14.68 40.43 
P + Poron 73.43 89.53 247.72 16.56 14.58 42.53 
D + Void 70.91 96.73 248.64 16.83 13.8 41.79 
B + Void 74.18 102.13 244.92 19.08 15.73 42.4 
P +Void 69.22 96.66 250.6 16.6 16.61 36.32 
SShoe 90.8 88.61 212.09 15.93 12.32 43.93 
Average 75.59 94.56 
231.62 
17.276 14.939 
41.45 
Total average 85.08 16.1075 
Table 6.7: Average SEM results for hallux per side. PP: peak pressure; PTI: 
pressure-time integral; P: proximal metatarsal bar; B: base metatarsal bar; D: distal 
metatarsal bar; SShoe: standard shoe. 
ICC values under hallux were the lowest obtained across all anatomical regions, 
ranging from 0.4 to 0.6. However, slightly higher ICCs (better reliability) were observed 
for PTI in comparison to PP. The variability of the ICC results across the different 
conditions was low and, again there was no clear difference between the standard and 
contoured insole conditions. 
 
ICC 
Left PP (KPa) Right PP (KPa) Left PTI (KPa*s) Right PTI (KPa*s) 
D + EVA 0.46 0.5 0.38 0.56 
B + EVA 0.47 0.53 0.41 0.59 
P + EVA 0.45 0.51 0.39 0.53 
D + Poron 0.45 0.52 0.44 0.57 
B + Poron 0.52 0.52 0.39 0.61 
P + Poron 0.44 0.46 0.42 0.62 
D + Void 0.52 0.5 0.44 0.66 
B + Void 0.51 0.5 0.4 0.54 
P + Void 0.45 0.51 0.51 0.55 
Sshoe 0.43 0.52 0.43 0.66 
Average 0.47 0.507 0.421 0.589 
Total average 0.48 0.505 
Table 6.8: Average ICC results for hallux per side. PP: peak pressure; PTI: pressure-
time integral; P: proximal metatarsal bar; B: base metatarsal bar; D: distal metatarsal 
bar; SShoe: standard shoe. 
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6.7 Discussion 
6.7.1 Overview of the main findings 
The main aim of this study was to investigate the agreement and the repeatability 
of plantar pressure measurement in people with diabetes and neuropathy. Agreement 
calculations establish how accurately the same measurement on separate occasions can 
be taken across subjects. SEM is an agreement statistic that is expressed in the same units 
as the outcome. Therefore, the results were presented along with the average PP and PTI 
to interpret variability in the context of typical pressure values. The SEM data 
demonstrated a moderate level of experimental error, especially in the PP values. 
Importantly, these values were relatively large when compared with the average mean 
pressures. Specifically, SEMs under the 1st metatarsal head, central metatarsal heads and 
under the 5th metatarsal head were around 25-30% of the average PP in the corresponding 
region. Notably, the overall magnitude of the SEM values for PTI was similar. For both 
metrics (PTI and PP), reliability was found to be poor in the hallux region, with SEM 
values of 35-40% of the mean and PP of 30-35% of the mean for PTI.   
SEM values for PTI were very similar to those observed for PP measurements in 
all of the regions. The high correlation between PP and PTI has been established 
previously (Keijsers et al., 2010, Waaijman&Bus, 2012) and the added value of reporting 
both outcomes has been questioned (Bus&Waaijman, 2013). Most papers published 
discuss the results for PP rather than PTI and the added value of PTI is minimal when 
both are reported (Bus&Waaijman, 2013). The region where the PTI may add some value 
is the heel, probably because the variability in the shape of the peak pressure-time curve 
is higher in the heel than in other regions given the foot progression during gait 
(Bus&Waaijman, 2013). In studies where differences between PTI and PP were found, 
these were not explained or not meaningful for the study (Bus&de Lange, 2005, Bacarin 
et al., 2009, Bus et al., 2009, Rao et al., 2010). Furthermore, there are different 
approaches to calculating PTI, which has to be taken into consideration when comparing 
results with published literature. Overall, our results show that reproducibility of both 
outcomes is similar, further supporting the consensus that there is no added value in 
reporting PTI in addition to PP. 
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ICC was calculated to quantify reliability and expressed from 0 to 1, with an ICC 
of above 0.8 demonstrating excellent reliability. Our results for ICC were quite similar 
across the different anatomical regions tested for both PP and PTI, ranging from 0.4 to 
0.6. However, for all of the regions, no distinct differences were observed between the 
PP and the PTI ICCs. Overall, the ICC results across all anatomical regions showed 
relatively low values indicating only moderate to poor reliability. This illustrates that it 
may be difficult to differentiate between subjects given the level of error in the 
measurement. However, there did appear to be sufficient consistency in the measurement 
to potentially identify differences between different insoles designs. These ideas are 
discussed in more detail below. 
An interesting finding of this study was that the SEM was considerably higher for 
the hallux region when compared to the metatarsal head areas. One possible explanation 
for this difference might be related to the biomechanical function of the hallux, which 
acts to maintain balance during walking (Hughes et al., 1990, Miyazaki&Yamamoto, 
1993, Hall&Nester, 2004). Most of the insoles investigated in this study incorporated a 
metatarsal bar, which will result in flexion of the metatarsophalangeal joints and therefore 
alter the normal position of the hallux. This altered position could lead to a more variable 
walking pattern and consequently, higher SEMs and lower ICCs. 
Reproducibility results were not very high but were stable across all conditions 
and most of the mask regions, implying that the low reliability resulted from the 
participants rather than the device or the different insoles tested. This idea is consistent 
with the observation that SEM values were similar between the contoured and flat insoles. 
The participants in this study were relatively elderly people with diabetes and neuropathy 
(59.5 ± 16.76 years) (see section 6.6.1.). This group may have inconsistent gait patterns 
because of their age and neuropathy (Allet et al., 2008). Indeed, there is evidence of an 
altered and less efficient gait in patients with diabetes and neuropathy (Ko et al., 2011, 
Martinelli et al., 2013). Lalli et al. (2013) compared gait variability for step length and 
velocity of healthy subjects and subjects with DM and neuropathy, concluding that the 
cohort with diabetes and neuropathy had a more variable gait that the healthy group. 
These findings support the idea that the variability in this study is due to the subject rather 
than the device or protocols used for plantar pressure collection. Interestingly, all previous 
studies investigating the reproducibility of plantar pressure collection recruited healthy 
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subjects rather than high-risk patients such as subjects with DM and neuropathy. 
Therefore, their results may not extrapolate to medium or high-risk populations for whom 
plantar pressure measurements are of key importance. Accordingly, plantar pressure 
measurements should be interpreted carefully when testing patients with diabetes and 
neuropathy. 
The most surprising aspect of the results from this study was the considerably 
lower reproducibility in plantar pressure observed in this study in comparison to the 
reproducibility reported in the literature(Murphy et al., 2005, de Castro et al., 2014, Godi 
et al., 2014). However, this difference may be explained by the characteristics of the 
sample rather than the measurement device or the data collection protocol followed. As 
explained above and which will be explored in more detail in the following sections, the 
study participants were old with neuropathy. Both conditions have a significant effect on 
the gait and balance of the subject, which could have an impact on the reproducibility. 
6.7.2 Comparison of findings with previous repeatability research 
Several other studies have assessed the repeatability of plantar pressure collection 
with Pedar and other in-shoe measurement systems. These investigations have used a 
range of different statistical tests in order to establish reliability (Hurkmans et al., 2006, 
Putti et al., 2007, Ramanathan et al., 2010), with some using the ICC (Murphy et al., 
2005, Gurney et al., 2008, de Castro et al., 2014, Godi et al., 2014), but none using the 
SEM. SEM was selected for this study as it provides a clear indication of the difference 
between repeated measurements across subjects. Furthermore, the SEM is in the units of 
the measurement, helping interpretation and comparison with the data collected. This test, 
in combination with the ICC, provides a better understanding not only of the measurement 
error but the differences between subjects. 
Ramanathan et al. (2010) studied the repeatability of Novel Pedar insoles using 
the coefficient of variation. They recruited 27 healthy male subjects and tested the insole 
in off-the-shelf running shoes on two occasions separated by one week. The coefficient 
of variation uses the SEM, dividing it by the mean of all measurements and multiplying 
it by 100 to express the typical error as a percentage of the mean. This statistical approach 
is correct, but an individual SEM would have been to test agreement on the 
measurements. They concluded that PP and PTI are repeatable under the metatarsals 
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heads and hallux with a coefficient of variation of 9.1 – 17.4 for PP and 18.4 – 31.9 for 
PTI. Although they showed overall higher agreement, the pattern across the different 
regions was consistent with the findings from this study, with greater repeatability under 
metatarsal heads in comparison to the hallux. However, it is interesting that they found 
PTI to be less repeatable than PP, which may be due to study participants; they used 
healthy young subjects, our study focused on patients with diabetes and neuropathy. 
The coefficient of repeatability has also been used to quantify repeatability of 
Novel Pedar insoles. Putti et al. (2007) used standard running shoes with 53 participants 
and two test sessions 12 days apart. They performed a repeated measures ANOVA test to 
investigate possible differences between days, followed by calculation of the SD of the 
between walk differences to determine the coefficient of repeatability, expressed as a 
percentage of the mean. This approach is problematic as ANOVA analysis is designed to 
test for statistical differences between repeat testing rather than to quantify the absolute 
error in repeated measurements. Putti et al. (2007) also used the coefficient of 
repeatability, which is the value below which the absolute differences between two 
measurements would lie, with 0.95 probability. It is calculated by multiplying the SEM 
by 2.77 (2 times 1.96). They expressed the coefficient of repeatability as a percentage of 
the mean PP. With this approach, they found high levels of repeatability with the hallux 
being the least repeatable, with a 7.7% of the mean PP. Again, they observed similar 
trends to our data, with better reproducibility under metatarsal heads than the hallux. 
Interestingly, like Ramanathan et al. (2010), they found better repeatability for PP than 
PTI, which was not observed in our study. 
Three different studies have used the ICC to quantify repeatability of repeated 
plantar pressure measurements. Murphy et al. (2005) recruited sixteen healthy subjects, 
collecting data on two separate days with the subjects wearing their own shoes. In their 
analysis, they did not use the peak pressures or pressure time integrals but instead 
calculated normalised pressures for each masking area across the whole foot. They 
divided the combined pressure in each region by the total pressure beneath the entire foot 
at midstance. To calculate the masking areas, they used percentages of foot length and 
width, which may not be the most appropriate approach. One problem with this 
calculation is that sensors located on the metatarsal heads may have been included within 
the toes region. Despite this limitation, Murphy et al. (2005) obtained similar levels of 
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reproducibility to our study with ICCs in the forefoot areas of 0.6 and 0.7 compared to 
0.5-0.6 in the current study. 
Godi et al. (2014) also quantified the repeatability of in-shoe pressure collection 
using the ICC. To this end, they recruited 16 young healthy subjects and collected data 
on two walking sessions two days apart. All subjects used the same standard running 
shoes with the Pedar insoles located inside the shoe, between the foot and the inside of 
the shoe. They calculated PP across the whole foot and did not use mask areas to 
investigate pressures at different anatomical structures. This approach, of not using a 
mask, may not be appropriate if the aim is to understand the repeatability of plantar 
pressure collection as peak pressures are very different across the whole foot and 
averaging them might lead to misleading conclusions. With their approach, they obtained 
an ICC for peak pressure of 0.95 which is considerably higher than our data and that of 
Murphy et al. (2005). As mentioned previously, this difference could be explained by the 
study population used, healthy young subjects versus patients with diabetes and 
neuropathy.  
The repeatability of in-shoe plantar pressure data was also characterised by de 
Castro et al. (2014) using the ICC test. However, in their study, they assessed the 
reliability of both the WalkingSense system and the Pedar system at the same time. They 
recruited 40 young healthy participants, placing both insole systems, one on top of each 
other, inside standard ballet running shoes. This approach may not be appropriate as 
systems can interfere and influence each other’s measurement when in direct contact. 
Moreover, they compared the first right and left steps of two different walks. It has been 
suggested that the first steps of a data collection set should be removed and that a 
minimum of 20 steps is required to obtain enough data to be comparable (Melvin et al., 
2014). Despite these limitations, they demonstrated higher ICC values (> 0.8 in most of 
the areas studied) than in the current study. They also found similar levels of repeatability 
between the PP and PTI, which is in agreement with our results. 
Several papers have studied the reliability of in-shoe plantar pressure collection 
with different approaches. However, there is no previous research regarding the 
reproducibility of plantar pressure measurements in patients with diabetes and 
neuropathy, which is the population most affected by complications resulting from 
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elevated peak pressures. Moreover, there are no previous studies exploring the 
reproducibility of plantar pressure collection on customised contoured insoles, which are 
commonly prescribed to offload pressures in medium or high-risk patients. Interesting, 
all previous research published found higher levels of agreement and reliability than those 
observed in the current study. It is possible that this is due to the variability in the gait of 
people with diabetes and neuropathy (Allet et al., 2008) and must be taken into 
consideration when interpreting the results of studies analysing plantar pressures in this 
cohort. 
6.7.3 Limitations of this study 
The main limitation of this study is the small sample size (n = 8), potential 
participants were reluctant to attend this type of testing on two separate days (which 
would have meant them attending on three different days in total). Nevertheless, it was 
felt that 8 subjects would be sufficient to characterise the level of variability between 
repeated sessions. Furthermore, this number was only slight below the sample size of 10 
used in some other repeatability studies (Gurney et al., 2008, Sawacha, 2013). Another 
limitation of this study was the relatively long period between repeated tests, typically 2-
4 weeks. Although previous repeatability studies typically report repeatability between 
sessions separated by approximately one week (Ramanathan et al., 2010), a longer period 
was chosen in this study to inform the interpretation of data from subsequent studies in 
this thesis. Specifically, to establish a clear threshold above which a change in pressure 
was the result of a change in insole design, rather than due to variability in the 
measurement. However, it is possible that the lower level of reproducibility observed in 
this study may have been, in part, the result of the longer time period. 
Self-selected walking speed for each subject was used in this study by calculating 
an average from five separate preliminary walking trials. All subsequent trials were then 
accepted if the walking speed was within a ±10% tolerance. Although for many 
participants, it was possible to work to ±5% tolerance, the participants with diabetes were 
often not able to repeatedly walk within this tightly controlled speed. Therefore, speed 
tolerance was increased to ±10% to ensure participants could complete the testing before 
becoming fatigued. However, research has shown that walking speed can influence 
plantar pressures (Segal et al., 2004), so, it is possible that some of the variability in the 
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measurements could be attributed to differences in walking speed between the two days. 
Nonetheless, a tolerance of 10% was adopted to ensure data could be collected from every 
participant. 
6.7.4 Conclusions and implications for subsequent plantar pressure 
analysis 
Peak pressure (PP) is the most common outcome used to quantify plantar foot 
loading in diabetic foot research. This is because diabetic foot ulceration has been 
associated with the presence of elevated PP (Frykberg et al., 1998, Kastenbauer et al., 
2001). Pressure time integral (PTI) is often reported and has also been associated with 
foot ulceration, but this association has only been demonstrated through retrospective 
analysis (Stess et al., 1997). Interestingly, Waaijman et al. (2012) used the Pearson 
correlation coefficient to study the correlation between PP and PTI, concluding that they 
are highly interdependent. These findings suggest that these parameters may be 
interchangeable and the value of reporting both parameters in the same study may be 
limited (Keijsers et al., 2010, Waaijman&Bus, 2012). The results of our study suggest 
that the reproducibility of PTI and PP is very similar and therefore support the practice of 
only reporting PP, rather than both and PP, given that only PP has been definitively 
associated with ulceration. 
This is the first study investigating the reproducibility of plantar pressure 
measurements in medium-risk patients while wearing customised insoles. All previous 
research in this area has been performed on healthy subjects, despite elevated peak 
pressures being a risk factor for foot ulceration. Although the effectiveness of insoles for 
reducing pressure has been studied extensively, the interpretation of these data has been 
based on repeatability studies from healthy subjects. However, the results of this study 
show that measurements from people with diabetes and neuropathy have a high level of 
variability. These results need to be taken into consideration when interpreting the results 
of future studies testing the efficacy of different insole designs. 
The data from this study was used as a basis for interpreting change in plantar 
pressure measures associated with different insole designs in the final experimental 
chapter which focused on predicting individual pressure responses. Specifically, the aim 
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was to set a threshold for PP above which we could be confident that changes were real 
and not the result of variability in the measurement. To this end, the highest values for 
the SEM results for PP under each anatomical region was selected and set as a threshold 
to filter noise on the measurement and false results (Table 6.9.). Accordingly, given the 
similarity of the SEM values for PP across the metatarsal heads, the same threshold was 
set for all these regions. However, large differences were found between the SEM results 
on PP values for the hallux and the rest of the anatomical regions, so it was decided to set 
a different threshold for this region (Table 6.9.), a 55 KPa threshold was set for PP under 
metatarsal heads and 85 KPa for the hallux.  
These thresholds were especially relevant for the second quantitative study 
(Chapter 8), in which the aim was to explore individual pressure responses and to 
understand if they were associated with individual biomechanical/clinical variables. 
Accordingly, when a participant showed a reduction of pressure equal or higher than the 
threshold selected (55 KPa for metatarsal heads and 85 KPa for the hallux), was 
considered as a positive response. On the other hand, if the pressure reduction was lower 
than the threshold, or a PP increase was found, they were considered as a non-responder. 
However, the thresholds were less important for the study described in the next chapter 
which was aimed at understanding the mean pressure responses to different insole 
designs. For this type of analysis, individual variability will typically average out 
provided the cohort is sufficiently large. 
  
 
1st metatarsal 
head 
Central metatarsal 
heads 
5th metatarsal head Hallux 
SEM result 53.91 KPa 43.94 KPa 30.26 KPa 85.08 KPa 
Threshold 
set 
55 KPa 55 KPa 55 KPa 85 KPa 
Table 6.9: PP SEM results and thresholds set per anatomical region. 
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7 Understanding the effect of 
systematically varying insole design 
characteristics on in-shoe plantar 
pressure 
7.1 Background 
Insoles have shown to be effective for offloading peak pressures (PP) in patients 
with diabetes and neuropathy. There are numerous possible design approaches which can 
be used to achieve offloading, but custom-made insoles have been shown to be the most 
effective (Guldemond et al., 2007, Zequera et al., 2007, Healy et al., 2012). However, a 
total contact insole on its own may not be sufficient to reduce PP in the diabetic foot 
(Hastings et al., 2007) and so, it is often necessary to incorporate additional changes to 
the contours of the insole. The most common addition used to reduce PP under the 
forefoot is a metatarsal bar, which has been shown to be effective under the metatarsal 
heads (Hsi et al., 2005). Some authors combined custom-made orthoses and metatarsal 
bars resulting in the most efficient offloading design (Hodge et al., 1999, Bus et al., 2004, 
Mueller et al., 2006, Guldemond et al., 2007, Cheung&Zhang, 2008). However, only one 
study by Owings (2008) customised the metatarsal bar based on participant’s PP and in a 
fully customised insole. Their results showed that full insole customization is the best 
approach to reducing PP under the forefoot of the diabetic foot.  
Soft and cushioning materials are also commonly used by practitioners in insole 
design to offload PP. However, a broad range of materials with different physical 
properties is available for manufacturing insoles. These physical properties, such as shock 
absorption and hardness, should be considered thoroughly to achieve the maximal 
therapeutic effect (Kang et al., 2006). Materials normally used in podiatry can be 
classified into three main types depending on their function in the insole, adaptation or 
accommodation, cushioning and filling materials (Fauli et al., 2008). The material on the 
top, which is in contact with the foot, is the adaptation or accommodation material and 
helps to homogenise plantar pressures. Under this layer is the cushioning material, 
normally located under the areas of PP in order to absorb and reduce them. Finally, the 
filling material conforms to the rest of the insole and provides motion control and stability 
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to the insole. The physical properties of the most commonly used materials in podiatric 
clinical practice have been studied and shown to be an effective in reducing PP (Paton et 
al., 2007, Fauli et al., 2008). Some authors have tested the effect of insoles manufactured 
with cushioning materials in PP concluding that they are an appropriate approach to 
reduce PP (Burns et al., 2008, Healy et al., 2012). However, these studies used the 
cushioning materials to manufacture the whole insole, rather than using them only under 
the regions of peak pressure. To date, only Actis et al. (2008) have tested the effect of 
using used cylinders of cushioning material under the metatarsal heads and found them 
to be a suitable approach for reducing PP. 
Different approaches have been used to reduce PP using a range of different insole 
designs and materials. The combination of a cushioning material with a metatarsal bar is 
an effective approach for plantar pressure reduction. However, there are no studies 
investigating the effect of material combined with customised insoles and a metatarsal 
bar in PP. Therefore, further research is needed to identify the optimum insole design 
combination which could be used to achieve maximal PP reduction. To this end, fully 
customised insoles were designed for each participant based on both foot shape and 
plantar pressures, combining the additions previously shown to be most effective in the 
literature, metatarsal bar and cushioning material. To design these insoles, a 3D foot scan 
was used to customise the insole top surface and plantar pressure data to tailor the 
metatarsal bar shape and the area for cushioning material under the metatarsal heads (see 
Chapter 5). As a result, a customised contoured insole was obtained with a customised 
metatarsal bar and cushioning forefoot material. To understand the optimum metatarsal 
bar position, it was moved 2% of the length of the foot distally and proximally. The two 
cushioning materials used under the forefoot were the most commonly prescribed by 
podiatrists, soft EVA and Poron. This approach was used to address the following 
research questions: 
1. What is the effect of systematically varying the metatarsal bar position in 
combination with cushioning material on in-shoe plantar pressures? 
2. Which is the mean optimum design? 
3. What is the effect of each insole configuration when compared to the control 
condition? 
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4. How much additional value is there is in individually choosing specific design 
features? 
7.2 Study design 
A total of 60 subjects with diabetes and neuropathy were recruited and asked to 
visit the Gait Laboratory at Salford University on two different occasions. On the first 
visit, barefoot plantar pressures with the Novel Emed pressure platform and a 3D scan of 
each foot were collected. These data were used to fully customise the insole designs to 
both foot shape (top surface of the insole) and plantar pressures (metatarsal bar distal line 
shape, see Chapter 5). A total of 9 customised insoles were designed for each participant 
by systematically varying the position of the metatarsal bar and the cushioning material 
under the metatarsal heads (see Chapter 5). Subjects were asked to return for a second 
testing once their insoles had been manufactured. They were then instructed to walk, 
wearing each one of the insoles, while pressure data was collected using the Novel Pedar 
system. For a detailed description of the data collection process, see Chapter 5. 
7.3 Data analysis 
7.3.1 In-shoe pressure data analysis: 
A custom Matlab programme was written to process the pressure data. Each insole 
condition data file consisted of a minimum of 4 trials (minimum depending on additional 
trials) which were separated out into 4 “blocks” of steps (17-22 steps per block 
approximately) representing the trials (Figure 7.1). Each trial was then subdivided into 
steps using a manually set threshold and the first and last two steps were removed from 
each trial as these represented gait initiation and termination. Following trial and step 
division, the information was saved in a mat file format. Once the steps were defined, 
mean peak pressure could be calculated. 
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Figure 7.1: Step selection on 
PP pressure during the stance phase of walking was used to characterise the effect 
of varying the design features. PP has been shown to be a key risk factor for ulceration in 
patients with peripheral neuropathy (Abouaesha et al., 2001, Patry et al., 2013) and was, 
therefore, the most appropriate outcome for this study. PP and pressure-time integral 
(PTI) have been shown to be highly correlated (Keijsers et al., 2010, Waaijman&Bus, 
2012). However, there is only weak evidence to support the link between elevated PTI 
and increased ulceration, with only one paper using retrospective methods finding a 
correlation between PTI and ulceration risk (Stess et al., 1997). Given the high correlation 
between PTI and PP as well as their similar reproducibility, only PP was used as an 
outcome in all of the analyses.  
The PP was calculated for the 1st metatarsophalangeal joint, 2-4th metatarsal head, 
the hallux, and 5th metatarsal head. The first three plantar regions were reported to be the 
locations at most risk from ulceration (Weijers et al., 2003). The regions were defined 
using the measurements of Cavanagh&Ulbrecht (1994) and the pressure measurements 
from the respective sensors were used to calculate the peak pressures for each separate 
step. It was then averaged across all steps to give a single PP value for each region (Figure 
7.2). Using this approach, PP was obtained for each of the five regions, for each condition 
for each participant.  
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Figure 7.2: Different areas defined on the Pedar mask used in the study 
7.4 Statistical analysis 
Different statistical methods were used in order to answer each of the four research 
questions: 
1. The effect of systematically varying metatarsal bar position in combination with 
cushioning material on in-shoe plantar pressures 
A two-way repeated measures ANOVA was conducted to understand the effect 
of material properties, metatarsal bar position and the combination of both in PP for each 
anatomical region. Bonferroni post hoc testing was then used to further understand the 
differences found by the ANOVA. Bonferroni corrects the p-value, dividing it by the 
number of variable pairs to produce a new p-value for each specific pairwise comparison 
test. Despite being a conservative test, a Bonferroni post hoc test was used. This was 
deemed appropriate due to the relatively large sample size (n=60) used in this study which 
will lead to low p-values for relatively small effect sizes. However, rather than perform 
pairwise comparisons between each different pair of insoles, pairwise comparisons were 
made between the three material properties (averaged across metatarsal bar position) and 
between the three metatarsal bar positions averaged (across material property). 
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2. Identification of the mean optimum design  
The inter-subject variability in response to the different insole conditions was 
examined to identify the mean optimum insole design. Specifically, the insole condition 
that led to a minimal PP was selected for each one of the participants. This data was then 
used to obtain the distribution of optimal insole conditions across subjects and therefore, 
to identify the mean optimum design across participants. The choice of mean optimal 
design was then validated against the ANOVA analysis. 
3. Comparison of the different insole designs with the control condition 
A repeated measures ANOVA was performed to understand the differences in PP 
between the 9 different insole conditions and the control shoe for each anatomical region. 
The Bonferroni post hoc test was again used to identify pairwise differences between 
conditions. With this approach, there was a large number of pairwise comparisons which, 
with the Bonferroni correction will mean that the critical p-value was adjusted down by 
a considerable margin. However, the differences between the control and most of the 
insole conditions were relatively large. This combined with the large number of subjects 
(n=60) made it possible to use a Bonferroni correction to identified differences with a 
high level of confidence. 
4. Comparison of the individual optimal design with group optimal design and 
control shoe (How much additional value is there is in individually choosing 
specific design features?) 
To understand the potential effect of full individual customisation, an individual 
optimal design was identified for each participant in each anatomical region. This was 
achieved by identifying the insole design which was associated with the lowest PP value 
across all conditions. Then, this PP value was averaged across all participants to obtain 
the mean individual optimal design PP value. This value was then compared to the group 
mean PP value for the best group design (identified in research question 2) and also to the 
mean PP for the control shoe.   
Results were calculated for all the different anatomical regions on both the left 
and right sides. The results obtained for both limbs were very similar and the number of 
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cases was 50% per limb. Given the large amount of data obtained, reporting the results 
for both limbs would have been redundant and not provided any relevant information. 
Accordingly, it was decided to only report the results obtained for the right side because 
for the majority of the general population, it is the dominant limb and the results from the 
left side were almost identical. 
7.5 Results 
7.5.1 Sample demographics 
This study comprised a total of 40 males and 20 females, with a mean age of 65.93 
± 12.62 years, ranging from 25 to 87 years old. The subjects were overweight to obese, 
with a mean BMI of 29.41 ± 5.19 kg/m2 ranging from 21.45 to 45.18 kg/m2.  
7.5.2 The effect of systematically varying metatarsal bar position in 
combination with cushioning material on in-shoe plantar 
pressures 
In order to understand the effect of each one of the additions investigated in this 
study, a two-way repeated measures ANOVA was used with the Bonferroni post-hoc test.    
7.5.2.1 1st metatarsal head 
There was no significant change in PP as metatarsal bar position was moved 
distally (p = 0.655). However, when the material properties were varied, there was a 
significant change in PP (p < 0.001). The ANOVA analysis showed no interaction 
between material properties and metatarsal bar position (p = 0.818), indicating that the 
effect of the metatarsal bar position was consistent across the different materials.  
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Mean 
Difference 
Std. 
Error 
95% CI 
p 
Lower 
Bound 
Upper 
Bound 
Material 
Eva 222.689 9.627 203.426 241.952 <0.001 
Poron 219.865 9.402 201.052 238.678 
Void 238.955 9.619 219.707 258.203 
Metatarsal bar 
position 
Proximal 228.365 9.578 209.199 247.530 0.655 
Base 224.871 10.383 204.095 245.646 
Distal  228.273 9.270 209.725 246.822 
Interaction - - - - 0.818 
Table 7.1: Two-way repeated measures ANOVA results for material, metatarsal 
bar position and interaction of both. 
The Bonferroni post hoc test revealed that both material conditions (Poron and 
EVA) lead to significantly lower PP in comparison to the Void condition (p < 0.001) 
(Table 7.2). However, no differences were observed between EVA and Poron. 
Material Mean Difference Std. Error 
95% CI 
p 
Lower Bound Upper Bound 
EVA Poron 2.824 1.997 -2.097 7.745 0.488 
EVA Void -16.266 2.820 -23.215 -9.316 <0.001 
Poron Void -19.090 2.899 -26.234 -11.946 <0.001 
Table 7.2: Pairwise comparisons with Bonferroni correction for the different 
materials tested under the 1st metatarsal head.  
7.5.2.2 Central metatarsal heads 
Significant differences in PP were found when the metatarsal bar position was 
moved distally (p = 0.003; Table 7.3). When material properties were varied, there was a 
significant change in PP (p < 0.001; Table 7.3). The ANOVA analysis showed that the 
interaction between the different metatarsal bar positions and the different material 
conditions had no significant effect on PP (p = 0.754; Table 7.3).  
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Mean 
Difference 
Std. Error 
95% CI 
p Lower 
Bound 
Upper 
Bound 
Material 
Eva 215.269 8.271 198.718 231.820 
<0.001 Poron 215.163 8.250 198.656 231.670 
Void 234.292 8.856 216.571 252.012 
Metatarsal bar 
position 
Proximal 217.805 8.338 201.121 234.489 
0.003 Base 216.408 9.502 197.394 235.422 
Distal 230.510 8.335 213.832 247.188 
Interaction - - - - 0.754 
Table 7.3: Two-way repeated measures ANOVA results for material, metatarsal 
bar position and interaction of both. 
The Bonferroni post hoc test showed that both base (0) and distal (+2) metatarsal 
bar positions led to a significantly lower PP than the proximal position (-2) (Table 7.4). 
However, no differences were found between the base and distal metatarsal bar positions. 
Regarding material conditions, the test results showed that both cushioning materials 
Poron and EVA) led to significantly lower PP in comparison to the Void condition (Table 
7.4). However, no differences were observed between EVA and Poron. 
Metatarsal bar position Mean Difference Std. Error 
95% CI 
p 
Lower Bound Upper Bound 
Proximal Base 1.397 3.857 -8.107 10.901 1 
Proximal Distal -12.705 4.192 -23.034 -2.375 0.011 
Base Distal -14.102 5.316 -27.202 -1.001 0.031 
Table 7.4: Pairwise comparisons with Bonferroni correction for the different 
metatarsal bar positions tested under central metatarsal heads.  
7.5.2.3 5th Metatarsal head 
The metatarsal bar position did not have a significant effect on PP (p = 0.426; 
Table 7.5). However, when material properties were varied, there was a significant 
change in PP (p < 0.001; Table 7.5). The ANOVA analysis showed that the interaction 
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between the metatarsal bar position and material had no significant effect on PP (p = 
0.220)  
 
Mean 
Difference 
Std. Error 
95% CI 
p Lower 
Bound 
Upper 
Bound 
Material 
Eva 109.444 5.086 99.267 119.622 
<0.001 Poron 109.507 5.089 99.324 119.689 
Void 115.531 5.006 105.514 125.549 
Metatarsal bar 
position 
Proximal 111.156 5.164 100.823 121.489 
0.426 Base 112.914 5.017 102.875 122.953 
Distal 110.412 5.133 100.141 120.683 
Interaction - - - - 0.220 
Table 7.5: Two-way repeated measures ANOVA results for material, metatarsal 
bar position and interaction of both. 
The Bonferroni post hoc test revealed that both material conditions (Poron and 
EVA) led to a significantly lower PP when compared to the Void condition (Table 7.6). 
However, no differences were observed between EVA and Poron. 
Material Mean Difference Std. Error 
95% CI 
p 
Lower Bound Upper Bound 
EVA Poron -0.062 1.320 -3.315 3.190 1 
EVA Void -6.087 1.552 -9.912 -2.262 0.001 
Poron Void -6.025 1.815 -10.497 -1.552 0.005 
Table 7.6: Pairwise comparisons with Bonferroni correction for the different 
materials tested under the 5th metatarsal head.  
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7.5.2.4 Hallux 
Significant differences in PP were found (p = 0.043; Table 7.7) as the metatarsal 
bar position was moved distally. However, when the material properties were varied, 
there was no significant change in PP (p = 0.970; Table 7.7). The ANOVA analysis 
showed no interaction between material properties and metatarsal bar position (p = 
0.696), indicating that the effect of metatarsal bar position was consistent across the 
different materials (Table 7.7).  
Table 7.7: Two-way repeated measures ANOVA results for material, metatarsal 
bar position and interaction of both. 
The Bonferroni post hoc test showed that the base metatarsal bar position led to a 
significantly lower PP than the proximal metatarsal bar position (p = 0.042; Table 7.8). 
Metatarsal bar position Mean Difference Std. Error 
95% CI 
p 
Lower Bound Upper Bound 
Proximal Base 4.127 2.944 -3.129 11.382 0.499 
Proximal Distal -4.430 3.730 -13.622 4.761 0.719 
Base Distal -8.557 3.375 -16.874 -0.240 0.042 
Table 7.8: Pairwise comparisons with Bonferroni correction for the different 
materials tested under the hallux.  
 
 
Mean 
Difference 
Std. Error 
95% CI 
p Lower 
Bound 
Upper 
Bound 
Material 
Eva 233.589 13.323 206.929 260.250 
0.970 Poron 233.825 13.178 207.456 260.194 
Void 233.255 13.109 207.024 259.485 
Metatarsal bar 
position 
Proximal 233.455 13.399 206.645 260.266 
0.043 Base 229.328 13.099 203.118 255.539 
Distal 237.886 13.336 211.200 264.571 
Interaction - - - - 0.696 
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7.5.3 Identification of the mean optimum design  
To identify the mean optimum design, descriptive statistics were used to establish 
which combination of additions achieved the lowest PP. The control shoe was not 
included in the comparisons as it never resulted in a lower PP under the metatarsal heads. 
Moreover, the focus of this study was to better understand the effect of each of the 
additions rather than comparing them to the control shoe. 
  
 130 
 
7.5.3.1 1st metatarsal head 
The combination of Poron with each of the three metatarsal bar positions was the 
design which most frequently led to the lowest PP (Figure 7.3). This is, to some degree, 
consistent with the results of the ANOVA analysis, section 7.5.1. However, although the 
ANOVA results did not show any significant differences between EVA and Poron, Poron 
led to minimal pressures more frequently with each metatarsal bar position (Figure 7.3). 
For the EVA material condition, minimal pressures were more often achieved when 
combined with the base metatarsal bar position. The void material condition with each of 
the three metatarsal bar positions rarely achieved the lowest PP, consistent with the 
ANOVA analysis, section 7.5.1. These findings indicate that the optimum design was 
Poron as the material condition combined with either a proximal or distal metatarsal bar 
position. 
 
 
Figure 7.3: Frequency of best insole design for PP per condition for the 1st 
metatarsal head 
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7.5.3.2 Central metatarsal heads 
The combination of Poron with the base metatarsal bar position most frequently 
lead to the lowest PP (Figure 7.4), in agreement with the results of the ANOVA analysis, 
section 7.5.1. Moreover, the ANOVA results showed that both EVA and Poron had a 
significant effect on PP, and the distribution results revealed that both material conditions 
led to lower pressures more often than the void condition, although Poron most frequently 
achieved the lowest PP (Figure 7.4). The void condition with each of the three metatarsal 
bar positions was rarely associated with lowest PP, consistent with the ANOVA analysis, 
section 7.5.1. 
 
Figure 7.4: Frequency of best insole design for PP per condition for central 
metatarsal heads 
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7.5.3.3 5th metatarsal head 
The combination of Poron with the base metatarsal bar position most frequently 
lead to the lowest PP (Figure 7.5). This is consistent with the results of the ANOVA 
analysis, section 7.5.1. However, although the ANOVA results showed that both EVA 
and Poron had a significant effect on PP, the distribution results showed that Poron led to 
lower pressures more frequently than EVA (Figure 7.5). The void material condition with 
each of the three metatarsal bar positions rarely achieved the lowest PP, in agreement 
with the ANOVA analysis, section 7.5.1.  
 
 
Figure 7.5: Frequency of best insole design for PP per condition for the 5th 
metatarsal head 
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7.5.3.4 Hallux 
Interestingly, the combination of void with the base metatarsal bar position was 
the design which most frequently led to the lowest PP (Figure 7.6). This is, to some 
degree, consistent with the results of the ANOVA analysis, section 7.5.1. For all material 
conditions, the distal metatarsal bar position more often led to higher pressures.  
 
Figure 7.6: Frequency of best insole design for PP per condition for hallux 
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7.5.4 Comparison of the different insole designs with the control 
condition 
One-way ANOVA with Bonferroni post-hoc correction was chosen to investigate 
the effect of the different insole designs compared to the control shoe.  
7.5.4.1 1st metatarsal head 
There was a significant difference in PP when the insole conditions were 
compared to the control shoe (p < 0.001). The Bonferroni post hoc test showed that Poron 
combined with all metatarsal bar positions significantly reduced PP when compared to 
the control shoe (Figure 7.7). Also, EVA combined with the base position was 
significantly different to the control shoe.  
 
Figure 7.7: Mean PP for the three insole materials with each of the metatarsal bar 
positions (-2%, 0 and +2% bars from left to right) for the 1st metatarsal head. The 
red horizontal dotted line represents the pressure from the control shoe. The red horizontal 
line represents the threshold set as non-risk of ulceration (200 KPa). The black horizontal 
lines indicate significant differences between insole conditions (p < 0.05 with Bonferroni 
correction). 
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7.5.4.2 Central metatarsal head 
There was a significant difference in PP when the insole conditions were 
compared to the control shoe (p < 0.001). The results of the Bonferroni post hoc test 
showed that both proximal and base metatarsal bar positions combined with any 
cushioning material (EVA and Poron) significantly reduced PP when compared to the 
control shoe (Figure 7.8).  
 
Figure 7.8: Mean PP for the three insole materials with each of the metatarsal bar 
positions (-2%, 0 and +2% bars from left to right) for the central metatarsal heads. 
The red horizontal dotted line represents the pressure from the control shoe. The red 
horizontal line represents the threshold set as non-risk of ulceration. The black horizontal 
lines indicate significant differences between insole conditions (p <0.05 with Bonferroni 
correction). 
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7.5.4.3 5th metatarsal head 
There was no significant difference in PP when the insole conditions were 
compared to the control shoe (p = 0.066). Interestingly, the cushioning materials did not 
seem to have any effect on PP. Nevertheless, all PP values for this anatomical region were 
observed to be under 200 KPa, which has been set as a safe threshold for ulceration.  
 
Figure 7.9: Mean PP for the three insole materials with each one of the metatarsal 
bar positions (-2%, 0 and +2% bars from left to right) for the right 5th metatarsal 
head. The red horizontal dotted line represents the pressure from the control shoe.  
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7.5.4.4 Hallux 
There was a significant difference in PP for all the insole conditions when 
compared to the control shoe (p < 0.001). The Bonferroni post hoc test revealed that all 
insole conditions significantly increased PP when compared to the control shoe (Figure 
7.10). This increase in PP showed a trend, being higher for the proximal metatarsal head 
position, followed by distal when combined with any material condition. The base 
metatarsal bar position seemed to increase PP the least when combined with any material 
condition. Interestingly, in this anatomical region, the control shoe PP was 200 KPa, but 
all the insole conditions increased PP to approximately 230-240 KPa.  
 
Figure 7.10: Mean PP for the three insole materials with each of the metatarsal bar 
positions (-2%, 0 and +2% bars from left to right) for the hallux. The red horizontal 
dotted line represents the pressure from the control shoe. The red horizontal line 
represents the threshold set as non-risk of ulceration. The black horizontal lines indicate 
significant differences between insole conditions (p < 0.05 with Bonferroni correction). 
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7.5.5 Comparison of best subject design with the best group design and 
control shoe 
Descriptive statistics were used to better understand the effect of insole 
customisation on PP reduction. To this end, the best condition for each patient was 
selected and averaged across all participants. This PP was compared to the average PP 
for the condition that resulted in the lowest PP across the whole sample and the control 
shoe. This approach was selected in an attempt to gain a better understanding of the 
difference in PP reduction achieved with the customisations. To the best of our 
knowledge, this is the first time that a comparison between the effect of fully customised 
insoles with semi-customised and flat insoles has been made. 
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7.5.5.1 1st metatarsal head 
The mean PP for the best insole configuration was approximately 190 KPa (Figure 
7.11); lower than the 200 KPa safe threshold for ulceration (ref). For the 1st metatarsal 
head, the best group design was Poron combined with the proximal metatarsal bar 
position (Section 5.7.2.), achieving a mean PP value of 220 KPa. This result represented 
an increase of 30 KPa when compared to the best subject design PP. The control shoe 
mean PP was approximately 240 KPa, which is a mean increase of 20 KPa when 
compared to the best group design and 50 KPa when compared to the best subject design. 
An increasing trend of average PP of 20-30 KPa can be observed in Figure 7.11 when 
moving from fully customised insoles (best subject design) to semi-customised insoles 
(best group design) to standard insoles/shoes (control shoe). 
 
Figure 7.11: PP distributions for best subject design, best group design and control 
shoe 
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7.5.5.2 Central metatarsal heads 
 The best subject design PP was approximately 190 KPa under the central 
metatarsal heads, below the safe threshold of 200 KPa (Guldemond et al., 2007). The best 
group design for the central metatarsal heads was the base metatarsal bar position 
combined with Poron, giving a mean PP value of 210 KPa, which represented an increase 
of 20 KPa when compared to the best subject design PP. The control shoe mean PP was 
approximately 240 KPa, which represented an increase of 30 KPa when compared to the 
best group design and 50 KPa when compared to the best subject design. Again, there 
was an increasing trend of 20-30 KPa in PP when moving from full customised insoles 
(best subject design) to semi-customised insoles (best group design) to standard 
insoles/shoes (control shoe). 
 
Figure 7.12: PP distributions for best subject design, best group design and control 
shoe 
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7.5.5.3 5th metatarsal head 
The best subject design resulted in a PP of approximately 90 KPa under the 5th 
metatarsal head. For this anatomical region, the best group design was again Poron 
combined with the base metatarsal bar position. The mean PP value for this design 
combination was 110 KPa, which represented an increase of 20 KPa from the best subject 
design. Interestingly, the control shoe showed the same PP value as the best group design 
of 110 KPa. For this region, a small increase of 20 KPa in PP was observed when moving 
from fully customised insoles  (best subject design) towards more standard approaches 
(both best group design and standard shoe). 
 
Figure 7.13: PP distributions for best subject design, best group design and control 
shoe 
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7.5.5.4 Hallux 
The best subject design for the hallux resulted in a PP of approximately 220 KPa. 
Interestingly, this PP value was almost the same as the one obtained from the standard 
shoe. Moreover, the PP achieved with the best group design was approximately 230 KPa, 
almost 30 KPa higher than best subject design and standard shoe PP.  
 
Figure 7.14: PP distributions for best subject design, best group design and control 
shoe 
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7.6 Discussion  
7.6.1 Summary of the key findings 
The main aim of this study was to investigate the effect of systematically varying 
the metatarsal bar position and the cushioning material on PP. First, the individual effect 
of the two separate design features (metatarsal bar position and material) was investigated 
and then possible interactions were analysed using a repeated measures two-way 
ANOVA approach. To understand the variability in the response to the insole, descriptive 
statistics were used to identify which insole design led to the lowest PP. The effect of 
each insole condition, when compared to the control shoe, was investigated using a 
repeated measures ANOVA. Finally, to understand the importance of customization, the 
main effect of the best subject design (fully customised) was compared to the best group 
design (semi customised) to the standard shoe using descriptive statistics. The main 
findings of this study were that cushioning materials are an effective approach to reducing 
PP under the metatarsal heads, with the exception of the hallux. The metatarsal bar 
position significantly influenced PP under the central metatarsal heads and the hallux, 
with the base position performing better than the proximal position. Interestingly, there 
were minimal interactions between the metatarsal bar position and cushioning material 
with respect to PP. 
When compared to the flat insole condition (control), the results demonstrated that 
a combination of a cushioning material and metatarsal bar is an effective approach for 
reducing PP in the high-risk region of the foot. All metatarsal bar positions combined 
with Poron were effective in reducing PP under the first metatarsal head. A similar result 
was found for EVA combined with a base metatarsal bar. For the central metatarsal heads, 
proximal and base metatarsal bar positions combined with any cushioning material (EVA 
or Poron) resulted in a significant reduction in PP. Interestingly, for the 5th metatarsal 
heads, none of the insole conditions tested was found to have a significant effect on PP. 
Surprisingly, for the hallux, all the insole conditions led to an increase in PP when 
compared to the flat insole. Overall, the insole conditions that most frequently achieved 
a reduction in pressure were the combination of poron with a distal metatarsal bar for the 
first metatarsal head, poron with the base position for both the central and 5th metatarsal 
heads, and void with the base metatarsal bar for the hallux. 
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These results indicate that the combination of cushioning materials and metatarsal 
bars are an effective approach for reducing PP. The comparison of the different conditions 
to the control shoe suggests that any cushioning material combined with a base or distal 
metatarsal bar position would be the best choice to offload high-risk areas. However, 
while the PP was reduced in the metatarsal heads, the hallux experienced increased 
pressure, a finding which should be considered by clinicians who prescribe insoles for 
medium-risk patients. Moreover, although full insole customization was shown to achieve 
a lower PP than the shoe, the differences in pressure are large and may be the result of 
variability in the measurements (Chapter 6). 
To date, there have been no published reports investigating the effect of the 
combination of cushioning material and metatarsal bar position on PP. Therefore, in order 
to be able to compare our results to the results published in the literature, the percentage 
PP reduction for the material and metatarsal bar positions when compared to the flat 
insole condition (sshoe) were calculated and presented in the following table: 
 
1st metatarsal 
head 
2nd-4th 
metatarsal head 
5th metatarsal 
head 
Hallux 
PP 
(KPa) 
% 
PP 
(KPa) 
% 
PP 
(KPa) 
% 
PP 
(KPa) 
% 
Material 
EVA 222.69 7.56% 215.27 9.14% 109.4 0.36% 233.59 -15.37% 
Poron 219.86 8.73% 215.16 9.18% 109.5 0.27% 233.82 -15.49% 
Void 238.95 0.81% 234.29 1.11% 115.5 -5.19% 233.25 -15.21% 
Metatarsal 
bar position 
Proximal 228.27 5.24% 230.51 2.71% - - 237.88 -17.49% 
Base 224.87 6.65% 216.41 8.66% - - 229.32 -13.27% 
Distal 228.36 5.20% 217.81 8.01% - - 233.45 -15.31% 
Control shoe 240.9 - 236.92 - 109.8 - 202.46 - 
Table 7.9: PP for each condition and percentage PP reduction when compared to 
the control shoe 
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7.6.2 Using cushioning materials to offload plantar pressures 
The use of cushioning materials in foot orthoses to help to reduce PP is a common 
approach adopted by practitioners. However, there is a broad range of materials available 
for manufacturing insoles, so the physical properties of these materials, such as the 
abilities of force distribution, shock absorption and durability, should be carefully 
considered in order to achieve the maximal therapeutic effect (Kang et al., 2006). 
Practitioners combine materials of different densities in order to achieve the treatment 
goal. There are some studies that have tested the physical properties of the most 
commonly used materials in insole design in clinical practice. Fauli et al. (2008) tested 
different EVAs, polyurethanes, latex and polyethylenes to establish their ability to 
perform different applications in the insole (accommodation, energy absorption and 
filling application) in order to identify which was the most suitable material for each of 
the three applications. Low-density EVA and polyethylene were found to be the most 
appropriate for adaptation or accommodation due to their ability to homogenise plantar 
pressures. Poron was found to be the best material for a cushioning application, as it has 
high energy absorption. For the filling applications, high-density EVA and polyethylene 
were the most suitable materials to provide stability to the insole. These results agree with 
those obtained by Paton et al. (2007), who concluded that high-density EVA was the most 
suitable material for the filling application and Poron as a cushioning material. 
The effect of insoles made of different materials on PP has also been previously 
investigated. Healy et al. (2012) tested the cushioning effect of both flat and contoured 
insoles made of Polyurethane (PU) and EVA of low and medium density. Subjects were 
tested under five conditions on two separate occasions: canvas shoe with rubber sole only, 
a shoe with a 3 mm flat low-density PU insole, a shoe with a 3 mm flat medium density 
PU insole, a shoe with a 3 mm flat low-density EVA insole and shoe with a 3 mm flat 
medium density EVA insole. For the second visit, they used the same protocol changing 
the flat insoles for contoured ones of the same material. Their results show that both low-
density materials achieve a lower PP than the control shoe, which agrees with our results. 
Interestingly, they also found an increase in PP under the hallux for customised insoles. 
However, despite the similar conclusions, the results are only comparable to a certain 
extent, given that they used the cushioning material throughout the whole insole rather 
than combining different density materials as in our study. 
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The effect of combining two materials in an insole was investigated by Actis et 
al. (2008). In this study, they first produced patient-specific finite element models to study 
the influence of the insole design on PP under the metatarsal heads. Based on the results 
obtained from this model, they modified a customised insole for each one of the two 
participants, one with a history of forefoot pain and one with diabetes and neuropathy. A 
4 mm cylinder of Poron was located under the PP point and three to four cylinders both 
proximally and distally to it. Four different insoles were manufactured for each 
participant: customised 10 mm thick plastazote, customised plastazote with poron 
cylinder inserts under the areas of PP customised plastazote with Poron plugs were placed 
throughout the entire forefoot region and a customised plastazote with a single 7 mm thick 
sheet of Poron in the forefoot region. They found that all the insoles with cushioning 
material produced a decrease in PP under the central forefoot of 13% when compared to 
the insole with no material, which aligns with the 10% achieved in this region with 
cushioning materials in the present study. Interestingly, they also found a small increase 
in PP under the hallux, similar to the results obtained previously (Healy et al., 2012) and 
in line with our results. In addition, they found that insoles with cushioning material 
achieved less PP reduction in the subject with diabetes compared to the subject without 
this condition. This difference in the insole effect between subjects highlights the 
importance of considering the study subjects when interpreting papers and applying 
interventions for patients with diabetes. 
It has been shown that cushioning materials are effective in improving the 
offloading effect of insoles. Moreover, the combination of different density materials 
appears to be the best approach to achieve the highest PP reduction. However, given the 
wide range of materials available for podiatric practice, the choice of materials requires 
careful consideration. Nevertheless, there are other insole design approaches to reduce PP 
apart from cushioning materials. The most popular insole addition to offloading forefoot 
PP is the metatarsal bar (Hayda et al., 1994, Lee et al., 2014). However, there is some 
controversy in exactly where the metatarsal bar should be positioned to achieve maximal 
PP reduction. 
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7.6.3 Optimal positioning of the metatarsal bar for reducing plantar 
pressures 
Metatarsal bars and pads are one of the most commonly used additions by 
podiatrists to reduce PP. There are a number of publications investigating their effect on 
PP with very different approaches. Holmes&Timmerman (1990) used barefoot plantar 
pressure data to locate the areas of higher pressure in the metatarsal heads. Metatarsal 
pads were then fixed to the participant’s plantar aspect of the foot just proximally to the 
metatarsal heads. Barefoot plantar pressures were collected with the metatarsal pads fixed 
to the foot sole. They found a reduction in PP on all of the areas studied while wearing 
the metatarsal pad, with the exception of the hallux. These results are in line with the 
present study, achieving lower PP under the metatarsal heads, but with a small increase 
under the hallux. However, their choice of collecting barefoot plantar pressure may not 
be the best approach as it may not give an accurate indication of the in-shoe plantar 
pressure. Moreover, they used standard metatarsal pads, which are not the best choice 
given the wide range of materials, shapes and sizes available. This makes them unsuitable 
for all subjects and not comparable to other studies given their different physical 
properties. 
Hsi et al. (2005) investigated the optimum position of the metatarsal pad to reduce 
PP. They recruited ten male participants with a history of metatarsalgia but with no other 
foot disorders. They taped Novel Pliance to the sole of the foot of each participant to 
ensure that the same anatomic region of the foot was in contact with the same sensors. 
Barefoot plantar pressure was measured and the metatarsal heads were located on the 
sensors based on PP. A metatarsal pad was then taped two sensors proximal to the 
metatarsal heads on the Novel Pliance. The metatarsal pad was moved 4.4 mm (one 
sensor) distally twice from the first placement to just proximal to the metatarsal heads 
and distal to the metatarsal heads. They found that the optimum metatarsal pad position 
to be just proximal to the metatarsal heads. This is in agreement with our work that found 
that the base position was the most efficient along with a distal position. However, this 
study uses barefoot plantar pressures which are not comparable to in-shoe plantar 
pressures. Also, taping the metatarsal pad to the foot may not be the most appropriate 
approach. Moreover, they used standard metatarsal pads which are not the most 
appropriate choice and are not comparable to other studies given the most likely different 
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physical properties. Koenraadt et al. (2012) followed the approach of Hsi et al. (2005), 
locating metatarsal pads just proximal to the metatarsal heads. This was performed by an 
experienced physical therapist using double sided tape, rather than using PP data. They 
also found a significant reduction under the metatarsal heads with a metatarsal pad. Our 
results agree with theirs, but the limitations of their study are very similar to those of Hsi 
et al. (2005), which is a more inaccurate approach to metatarsal pad positioning. 
 Kang et al. (2006) aimed to understand the effect of metatarsal pads on PP; they 
investigated the effect that the metatarsal pad had on PP when fixed to the shoe insole. 
To this end, they recruited a total of 13 patients with a history of forefoot pain. An 
experienced physiatrist located the metatarsal pad just proximally to the second 
metatarsal head. They did not standardise the shoe and collected pressures with and 
without the metatarsal pad. A significant PP reduction of approximately 10% was 
achieved with the metatarsal pad when compared to the shoe on its own. However, 
although these results agree with ours, the approach chosen to locate the metatarsal bar 
may have been inconsistent. Moreover, they fixed the metatarsal pad to the shoe rather 
than using a contoured insole and did not standardise the shoe. Additionally, they allowed 
a 15% speed deviation which may have influenced plantar pressure behaviour. 
Furthermore, they used standard metatarsal pads, which are not suitable for all subjects 
and not comparable to other studies given the most likely different physical properties. 
Finally, they did not standardise the shoe, which makes the comparison between subjects 
more difficult given the different characteristics of the shoes used. 
Lee et al. (2014) also investigated the effect of metatarsal pads and bars in PP. To 
this end, they recruited a total of 37 participants older than 65years of age to measure 
plantar pressures with a Novel Pedar in-shoe system. Five different conditions were 
tested: extra-deep shoe, metatarsal pad 10 mm proximal to metatarsal heads, metatarsal 
pad 5 mm distal to metatarsal heads, metatarsal bar 10 mm proximal to metatarsal heads 
and plantar cover. The metatarsal heads were located by palpation and the centre of the 
most distal aspect of each metatarsal head was marked on the plantar surface of the foot 
using a pen. This ink mark was then transferred onto a cardboard template where the 
additions were fixed with double sided tape. Their results showed that all the different 
additions used significantly reduced PP when compared to the control shoe. The most 
efficient condition was the metatarsal pad located distally from the metatarsal heads with 
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a reduction of 17% in PP. They obtained the highest offloading with the distal position 
similar to our findings but achieved a higher PP reduction than in this study (10%). 
However, they studied the whole forefoot as an anatomical region rather than dividing it 
into different regions of interest. This masking approach varies significantly to ours; 
hence, the results are not comparable. Moreover, the location of the metatarsal additions 
may not be very accurate and should have been based on pressure rather than marking 
anatomical prominences and transferring them to a cardboard. Additionally, a cardboard 
template may not be the most appropriate material to help to reduce PP. Furthermore, 
they used standard metatarsal pads which are not suitable for all subjects and not 
comparable to other studies given the most likely different physical properties. 
Brodtkorb et al. (2008) investigated the effect of the metatarsal bar position in 22 
healthy young subjects with asymptomatic feet by measuring static barefoot plantar 
pressures. The metatarsal pad was fixed on the Pedar insole just proximal to metatarsal 
heads with the same approach used by Lee et al. (2014). The subject was then asked to 
stand on one leg while maintaining their balance on top of the Novel Pedar insole and the 
barefoot plantar pressure was measured. They moved the metatarsal pad 5 mm distally 
on six different occasions and barefoot plantar pressure was collected following the same 
protocol. They found that the metatarsal pad significantly reduced PP, but there were no 
significant differences between the positions of the metatarsal pad while moving it 
distally. This is in agreement with our results, which did not find differences between the 
base and the distal metatarsal bar positions, but both were significantly more effective 
than the proximal position. However, the protocol followed by this study is not the most 
appropriate for several reasons. Barefoot plantar pressures are not comparable to in-shoe 
plantar pressures. Moreover, they collected static plantar pressures which are significantly 
different to dynamic plantar pressures. Finally, they measured the pressure while the 
subjects maintained their balance standing on one foot, which is not comparable to normal 
gait or even bipedal stance.  
The effect of the combination of a metatarsal pad with an insole was studied by 
Mueller et al. (2006) in 20 subjects with diabetes and neuropathy. The participants were 
provided with extra-deep shoes and customised insoles with standard metatarsal pads 
made of cork attached. The metatarsal pad was located 10 mm proximal from the 
metatarsal heads by a certified orthotist. In-shoe plantar pressure was then measured in 
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three different conditions: shoe only, customised insole and customised insole with a 
metatarsal pad. They concluded that the addition of the metatarsal pad to a customised 
insole had a substantial and additive effect on reducing PP by 19% to 24% under the 
metatarsal heads when compared to the control shoe. They achieved higher PP reductions 
than other studies previously discussed in this section by using customised insoles instead 
of flat insoles or metatarsal pads on their own. These results are in line with ours, but they 
achieved a higher PP reduction. However, an orthotist placed the metatarsal pad by 
locating the metatarsal heads on the positive mould of the foot. This is not an accurate 
approach to locating the addition. Moreover, they taped the pressure sensor to the foot 
and secured it with a sock, which might influence the data collection. Additionally, they 
used a standard metatarsal pad which might not have the same effect on subjects with 
different foot sizes. 
Hodge et al. (1999) compared the effect of metatarsal pads on contoured insoles 
and customised insoles on PP. They recruited 12 participants with rheumatoid arthritis 
and a history of forefoot pain. Plantar pressures were collected with a Novel Pedar in-
shoe device on a standard contoured insole and a custom made insole, both made of EVA. 
A standard metatarsal dome and a standard metatarsal bar were located proximal to the 
metatarsal heads by palpation and fixed to the insoles with double sided tape. Five 
different conditions were tested: shoe only, contoured insole with metatarsal pad, 
contoured insole with metatarsal bar, customised insole with metatarsal pad and 
customised insole with metatarsal bar. Their results showed that customised insoles with 
both a metatarsal pad and metatarsal bar were the most efficient to reduce PP. These 
results agree with our results, showing that customised insoles with metatarsal additions 
are effective. However, they used standard metatarsal pads and domes which may not be 
suitable for all participants for size and material properties. Additionally, the positioning 
of the metatarsal additions was made by a practitioner, which is not as accurate as using 
pressure data. 
Hastings et al. (2007) studied the effect of different metatarsal bar positions on 
customised insoles in PP. To this end, 20 subjects with diabetes and neuropathy were 
recruited and customised insoles were manufactured from a foam box. Subjects were 
tested in three conditions: shoe only, customised insole with proximal metatarsal pad and 
customised insole with distal metatarsal pad. The metatarsal pad was made of cork and 
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located by an orthotist, who drew a line identifying the metatarsal heads. The distal 
metatarsal pad location was just distal to the line for the metatarsal heads and the 
proximal, 10 mm proximal to this line. Interestingly, they found consistent PP reduction 
when the metatarsal pad was located 6 to 11 mm proximal to the metatarsal heads. This 
finding is contrary to most of the literature discussed in this chapter, as well as our results, 
which show that base and distal positions of the metatarsal bar achieve higher PP 
reductions than proximal.  
The effect on PP of different insole configurations changing the arch and the 
metatarsal pad characteristics were studied by Guldemond et al. (2007). They collected 
pressure data from 20 male patients with diabetes and neuropathy who had elevated 
barefoot plantar pressures. Basic customised insoles were manufactured for each 
participant and additions for the arch and the metatarsal pad were added in different 
combinations to investigate their offloading effect. Arch height could be modified and 
the dome was positioned 5 mm proximal from the metatarsal heads based on a pressure 
sheet footprint. They found that the main PP reductions of approximately 15% were 
achieved by the metatarsal dome and the extra arch support, slightly higher than achieved 
in our study. This finding highlights the importance of the arch support to reduce pressure, 
which a customised insole provides. Their results agree with ours, achieving offloading 
with a customised insole with a metatarsal pad just behind PP. However, the extra arch 
support was reported as being uncomfortable by most participants and a special extra-
deep shoe would be required to accommodate this type of insole. On the contrary, our 
insole design focused on being suitable for most normal footwear. 
The effect of flat insoles and customised insoles with a metatarsal bar in PP was 
performed byBus et al. (2004). They collected data from 20 subjects with diabetes and 
neuropathy. The used a standard flat insole and a fully customised insole manufactured 
with a CAD-CAM system, based on plantar pressures and footprints sent to a trained 
orthopaedic shoemaker. Their results showed a decrease in PP of 16% under all metatarsal 
heads when comparing the customised insole to the flat insole, which is in agreement with 
our results. The use of a CAD-CAM system to manufacture these insoles increased the 
accuracy and repeatability of the process. However, the customised insoles were very 
thick, which might explain the slightly higher PP reductions they achieved and would 
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require special extra-deep therapeutic shoes. Our insole design, on the other hand, 
achieved slightly lower offloading but would fit in most normal footwear. 
All the studies discussed above show that the combination of a cushioning 
material with a metatarsal bar is an effective approach for PP reduction. Moreover, this 
plantar pressure reduction increases when these additions are combined with a customised 
insole rather than flat insoles or the shoe. Customised insoles have been shown to be 
effective in reducing PP, with those designed and manufactured with a CAD-CAM 
system being the most efficient. However, all the studies presented have used standard 
metatarsal bars and pads rather than customising them based on plantar pressures. Only 
one study by Patry et al., 2013Owings et al. (2008) used fully customised insoles with 
fully customised metatarsal bars based on both foot shape and plantar pressures.  
In their study, Owings et al. (2008) recruited a total of 22 subjects with diabetes 
and neuropathy with a barefoot PP higher than 750 KPa under the forefoot. This barefoot 
plantar pressure was measured from the first step taken over the Novel Emed pressure 
platform. Foam boxes were sent to three different orthotic supply companies, but only 
one was also supplied with plantar pressure data as well. Therefore, they obtained two 
different customised insoles without pressure data: the first was made of polypropylene 
with a plastazote top cover, and the second was made of EVA with a plastazote top cover. 
The third pair of insoles were designed and manufactured with a CAD-CAM system. The 
software adapted a template insole to the subject’s foot shape and an automated design 
algorithm identified a pressure contour along with a metatarsal bar. Furthermore, a 3 mm 
deep void was created under regions of excessive PP (> 1,000 KPa). Subjects were tested 
with each one of the insoles inside an extra-deep shoe with a normal sole and inside the 
same shoe with a rocker sole. There was a total of 7 conditions using the shoe with a 
normal sole as the control condition with its stock insole inside. In-shoe plantar pressures 
were collected while walking at their self-speed and a ±10% deviation was allowed. 
Owings et al. (2008) found that the fully customised insole with a customised 
metatarsal bar was the optimum design to offload PP. Furthermore, they found that the 
combination of this insole design with a rocker shoe increased PP reduction, 37% 
compared to the other insole designs with the rocker shoe. Our results are similar to theirs, 
although they achieved a higher offloading with the flexible shoe. This is most likely 
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because they used very thick insoles that required special extra-deep therapeutic shoes, 
whereas we aimed to design insoles that would fit in most normal footwear. This choice 
was motivated by previous studies which have shown that participants are often unwilling 
to change their normal shoes (Williams et al., 2010). In addition, they only recruited 
subjects with very high PP, while we did not use pressure as inclusion criteria. Moreover, 
they only analysed plantar pressure for the first step taken, which is not representative of 
the normal gait pressures. Finally, although they used fully customised insoles, they did 
not add any cushioning material in order to increase the PP reduction.   
7.7 Limitations of the study 
This study has a number of limitations. The first is the difficulty in interpreting 
small changes in the plantar pressure data because of the relatively high level of 
variability observed (observed in Chapter 6). It is likely that this variability results from 
the participants, rather than the measurement system, as all participants were elderly with 
diabetes and neuropathy. Nevertheless, this level of variability may impact on the data 
and the potential to draw a conclusion on an individual basis. However, the primary 
objective of this Chapter was to understand the average group effect of the two different 
insole design features. As there is no reason that the variability would lead to a systematic 
offset, the average pressure responses across the 60 participants should have removed the 
random variability which results from gait variability. Thus, the study findings are likely 
to give an accurate insight into the mean effect of changing both the metatarsal bar 
position and material. However, the large standard deviations which may, to some degree, 
be the result of within-subject variability in gait. 
Self-selected walking speed for each subject was used in this study by calculating 
an average from five separate preliminary walking trials. All subsequent trials were then 
accepted if the walking speed was within a ±10% tolerance. Although for many 
participants it was possible to work to ±5% tolerance, the participants with diabetes were 
often not able to repeatedly walk within this tightly controlled speed range. Therefore, 
speed tolerance was increased to ±10% to ensure participants could complete the testing 
before becoming fatigued. However, research has shown that walking speed can influence 
plantar pressures (Segal et al., 2004). Therefore, it is possible that some of the variability 
in the measurements could be attributed to differences in walking speed between the two 
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days. Nonetheless, a tolerance of 10% was adopted to ensure data could be collected from 
every participant. 
Another possible limitation of this study is that the subjects were without a history 
of ulceration, such patients are likely to have lower PP than subjects who have had an 
ulcer previously. Nevertheless, the population in this study would still be considered at 
risk of suffering an ulcer at some stage. Therefore, this study is still one of the first to 
provide insight into customised insole design for patients at risk of developing foot 
ulceration. 
7.7.1 Clinical implications & conclusions 
The results obtained in this study show that the combination of a cushioning 
material with a metatarsal bar is an effective approach for reducing PP under the 
metatarsal heads. Specifically, cushioning materials led to significantly lower PP under 
all metatarsal heads when compared to the void condition. Interestingly, there were no 
significant differences in the effect on PP between both cushioning materials. Regarding 
the metatarsal bar position, both base and distal metatarsal bar resulted in lower PP under 
the hallux and central metatarsal heads. For the rest of the anatomical regions, the 
metatarsal bar position had no significant effect on PP. Accordingly, a base or distal 
metatarsal bar with a cushioning material should be prescribed to offload metatarsal bars 
and be combined with a void for the hallux. 
For all anatomical regions, the base and distal metatarsal bar positions most 
frequently resulted in a lower PP. Regarding the cushioning materials, Poron achieved 
the highest PP reductions under metatarsal heads. Interestingly, under the hallux, the void 
was the best approach to significantly reduce PP. Accordingly, the conditions that most 
frequently led to a minimal PP under the metatarsal heads were the base and distal 
metatarsal bars combined with Poron and combined with a void for the hallux.  
Compared to the control shoe, any cushioning material combined with a 
metatarsal base or distal metatarsal bar achieved PP reduction under the 1st and central 
metatarsal heads. Interestingly, no insole design significantly reduced PP for the 5th 
metatarsal head, PP increased for all insole conditions tested. Accordingly, we can 
conclude that the combination of a customised metatarsal bar and cushioning material is 
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an effective approach for reducing PP under the metatarsal heads, but an increase of under 
the hallux should be expected.  
The PP distribution with the best subject design was compared to that achieved 
by the best group design and the control shoe to help understand the importance of 
customization (Section 7.5.4). The lowest PP distribution under all anatomical regions, 
except the hallux, was achieved by the best subject design. Also, PP distribution with the 
best subject design remained below 200 KPa for all regions, which might dramatically 
reduce the risk of ulceration. The results from this study indicate that new technologies 
provide the opportunity for a quantitative customised prescription, which itself has also 
been shown to be effective in reducing PP.  
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8 Identifying variables which may affect 
an individual’s response to insole 
design 
 
8.1 Background 
Plantar pressure during walking is influenced by multiple factors, for example, 
foot structure can affect peak pressure (Ledoux et al., 2005, Guiotto et al., 2013). Foot 
deformity has also been found to be a strong predictor of PP. Indeed, Mueller et al. (2003) 
found the presence of hammer-toe on the hallux predicts peak pressure under the 
metatarsal heads and hallux. In addition, Barn et al. (2015) found evidence that the 
presence of a local deformity is a major contributing factor to barefoot dynamic pressures 
in high-risk diabetic patients. Furthermore, a strong inverse relationship between plantar 
tissue thickness and dynamic foot pressure has been reported (Abouaesha et al., 2001). 
Moreover, limited joint mobility, produced by peripheral neuropathy, contributes to 
increasing plantar pressure by limiting foot flexibility and restraining the forward 
progression of body weight during the stance phase of gait (Fernando et al., 1991, 
Fernando et al., 2013). Taken together, these studies show that a range of different 
structural factors can have a strong influence on plantar pressure during walking. 
In addition to structural factors, biomechanical factors also have the potential to 
influence plantar pressure during walking. For example, Morag&Cavanagh (1999) found 
that PP under the 1st metatarsophalangeal joint (MPJ) and hallux pressures were highly 
influenced by the 1st MPJ range of movement (ROM). Payne et al. (2001) also showed 
that the 1st MPJ ROM is important in determining pressures under the hallux. In another 
study, Fernando et al. (2013) found that patients with neuropathy walked slower and had 
a reduced stride length when compared to non-neuropathic patients with diabetes and 
healthy subjects. They also found that patients with neuropathy spent a longer period of 
time in the stance phase compared to the non-neuropathic subjects with diabetes. Taken 
together, these findings illustrate that plantar pressure during walking can be influenced 
by biomechanical factors. 
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To date, there have been a number of studies which have sought to understand 
whether structural or biomechanical factors may predict plantar pressure patterns during 
walking. However, it is possible that such factors may also dictate the way an individual 
responds to a particular insole design. For example, a patient with limited 1st MPJ range 
of movement may experience decreases in pressure under the forefoot when wearing an 
insole design incorporating a distally positioned metatarsal bar but minimal changes in 
pressure with another insole design. Clearly, such information is of enormous value to 
clinicians who regularly prescribe insoles designed to decrease pressure in patients with 
risk of ulceration. However, to date, there have been no studies which have attempted to 
identify the factors which could be used to predict individual responses to a range of 
different insole designs. Such an understanding would lead to effective clinical decision 
tools which could be used to target orthotic interventions more appropriately. Therefore, 
the aim of this chapter was to develop an understanding of the characteristics that may 
influence individual response to different insole designs. 
8.2 Research questions 
 Which characteristics influence in-shoe PP reduction? 
 Which characteristics influence in-shoe PP increase? 
 Which characteristics could be used to inform the choice of insole design? 
8.3 Study design 
Different biomechanical, clinical and demographic characteristics were recorded 
for each subject along with in-shoe pressure data in each of the insole conditions (Section 
8.4). Hypotheses relating to each characteristic were tested by analysing whether the 
characteristic influenced the individual response to each customised insole design. To this 
end, different subject’s characteristics that may have an impact on PP behaviour were 
identified and recorded during the data collection. These characteristics were selected on 
the basis of their association with PP in previous studies, such as different joint ROM, 
tissue stiffness or foot and ankle biomechanics. Further justification for each of these 
characteristics is given in section 8.4. 
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8.4 Experimental procedure 
For this study, the same sample as for the previous study (n = 60) was used so see 
Chapter 5 for details of the inclusion/exclusion criteria and screening. Each participant 
was required to visit the Human Performance Laboratory in the Brian Blatchford building 
at the University of Salford on two separate occasions. 
8.4.1 First visit 
Initially, all participants underwent a neuropathy screening in a lying position to 
confirm their suitability to participate in the study (described in Chapter 5). Once the 
diagnosis of neuropathy was confirmed and the participant deemed eligible for the study, 
all the subject’s characteristics that may influence their response to insole design were 
collected, including BMI, tissue stiffness on five different regions of the plantar aspect of 
the foot, arch height, ankle, 1st MPJ and subtalar joints ROM, and foot and ankle joints 
velocities. The protocol for this data collection is detailed below. 
8.4.1.1 Foot characterisation 
A range of simple clinical measurements was used to characterise foot 
morphology, joint movement/mobility, skin tissue stiffness and foot and ankle motion as 
described below with a rationale for inclusion in the study. 
Arch height: Foot structure has been shown to be a predictor of plantar pressure 
(Barn et al., 2015). One of the most common foot deformities is increased arch height 
(cavus foot), which is also common among patients with diabetes (Ledoux et al., 2005). 
A greater arch height results in a smaller contact area of the foot with the ground while 
walking, which causes a redistribution of peak pressures across the foot. Chuckpaiwong 
et al. (2008) found that PP was significantly decreased in the low arch foot when 
compared to the normal foot. For this study, arch height was recorded as the distance 
from the navicular to the floor with the participant standing barefoot; this distance was 
measured using a tape measure for both feet (Menz&Morris, 2006).  
Joint mobility was tested as subjects with diabetes often have ROM limitations 
in their foot joints (Guiotto et al., 2013). The limited dorsiflexion and subtalar ROM 
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restrict the foot’s ability to absorb shock and transverse rotation, increasing plantar 
pressures (Rao et al., 2010), therefore increasing the risk of plantar ulceration in the foot 
with a lack of sensitivity (Fernando et al., 1991). In addition to ankle and subtalar joints, 
limitation on the 1st MPJ ROM has been shown to increase pressures, and consequently, 
the risk of ulceration (Viswanathan et al., 2003, Viswanathan et al., 2008). Accordingly, 
the mobility of these three joints was measured using a goniometer. For these 
measurements, the participant was asked to lie down on a bed, to relax and to not 
contribute to the movement. A further rationale for each of the joints recorded and the 
protocol followed are as follows: 
 Subtalar joint mobility: the subtalar joint has been documented to have reduced 
passive mobility in subjects with diabetes (Fernando et al., 1991), which may 
result in a reduced calcaneal eversion and inversion ROM during walking. This 
loss of mobility may be associated with a decrease in forefoot mobility because 
the subtalar joint is believed to ‘‘unlock’’ the midfoot to allow greater mobility 
(Blackwood et al., 2005). Rao et al. (2007) found decreased eversion ROM in 
subjects with diabetes and subsequently, associations between decreased subtalar 
ROM and PP increase on the medial forefoot (Rao et al., 2010). 
In this study, the subtalar ROM was recorded by a goniometer placed on the 
central axis of the leg and calcaneus, positioning the fulcrum on the Achilles' 
tendon. The leg-heel angle in the relaxed position was recorded and then, from 
this neutral position, a complete inversion movement was performed on the joint 
and the reading on the goniometer was recorded. The joint was brought back to 
neutral position and a complete eversion movement was performed, with the 
goniometer measurement recorded as inversion and eversion.  
 1st MPJ mobility: the 1st MPJ is one of the most common joints of the foot 
affected by neuropathy (Guiotto et al., 2013). Birke et al. (1995) reported that 
when this joint becomes restricted, PP under the 1st metatarsal head rises in 
patients with diabetes. However, Bryant et al. (1999) reported that peak pressure 
under the 1st MPJ was significantly reduced in subjects with hallux limitus 
compared to controls. There is controversy about the relationship between the 1st 
MPJ ROM and PP behaviour, but several authors have concluded that it acts as a 
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PP predictor (Payne et al., 2001, Menz&Morris, 2006, Turner et al., 2007, Rao et 
al., 2010). 
In this study, the ROM of this joint was recorded by placing the goniometer 
fulcrum on the joint, positioning one arm along the hallux, and the other arm along 
the 1st metatarsal up to the navicular. A complete dorsal flexion of the joint was 
performed and recorded as 1st MPJ ROM. 
 Ankle joint mobility: the ankle is the joint most commonly affected by 
neuropathy (Guiotto et al., 2013). The lack of mobility has been associated with 
high PP and PTI under the forefoot (Zimny et al., 2004). Moreover, a lack of 
mobility on the ankle can lead to an elevated time-dependent load on the forefoot 
(Fernando et al., 1991), a variable which has previously been found to be one of 
the predictors of plantar pressure (Payne et al., 2001).  
In this study, the ROM of this joint was recorded by positioning the goniometer 
fulcrum on the external malleoli, with one arm following the fibula and the other 
arm going down to the 5th metatarsal head, then a complete dorsal flexion of the 
foot was performed  
Plantar tissue stiffness properties were collected as they are believed to play a 
fundamental role in PP cushioning during gait. Plantar soft tissues, in particular on the 
forefoot and heel regions, are specially structured to provide cushioning and shock 
absorption during walking. Stiffening of these tissues is associated with diabetic 
neuropathy and has been found to significantly increase the plantar pressure and internal 
stress. Therefore, it has been proposed to be an additional predictive factor of ulcer 
development (Pai&Ledoux, 2010, Sun et al., 2011, Periyasamy et al., 2012, Patry et al., 
2013). Durometers are used for characterising material stiffness but have also been shown 
to be reliable to characterise tissue stiffness (Piaggesi et al., 1999).  
In this study, a durometer was used to measure tissue stiffness at five different 
locations on the plantar foot to characterise the tissue stiffness properties. These areas 
were the 1st, 3rd and 5th metatarsal heads, arch and heel. To test the skin stiffness, the 
durometer was located in the test area and pressed against it perpendicularly (Figure 8.1). 
On the metatarsal heads, a plantarflexion of the joint was performed to avoid its 
dorsiflexion while being pressed and to reproduce the movement on the push-off phase 
of the gait where the highest PP occurred. 
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Figure 8.1: Different regions tested with the durometer. 
8.4.1.2 Lower limb 3D motion capture 
Previous studies have shown that biomechanical variables, such as ankle and 1st 
MPJ ROM or velocity, influence PP (Fernando et al., 2013). Moreover, foot orthoses are 
prescribed to reduce PP by modifying foot position and motion during gait. Therefore, it 
is conceivable that gait pattern and foot motion might have some influence on an 
individual’s response to the insole design. Accordingly, 3D motion data was collected in 
order to investigate their effect: 
Ankle joint maximum angular velocity: the decrease on ankle joint ROM 
present in patients with diabetes and neuropathy leads to an abnormal joint motion 
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(Fernando et al., 2013). This lack of mobility on the ankle can also result in an elevated 
time-dependent load of the forefoot (Fernando et al., 1991), a variable which has 
previously been found to be one of the predictors of plantar pressure (Payne et al., 2001). 
Moreover, Rao et al. (2010) found decreased ankle moment and power which was 
associated with increased plantar loading in patients with diabetes.  
1st MTJ joint maximum angular velocity time: research has shown that there is 
a reduction in mobility at the 1st MPJ joint in patients with diabetes and neuropathy 
(Fernando et al., 2013). The ROM in this joint and its motion during gait has been 
previously associated with PP (Turner et al., 2007, Barn et al., 2015). Given the 
consequences that prolonged PP may have in neuropathic tissues, it is important to further 
understand the influence of this variable in PP. 
In order to collect foot motion data, Vicon TM (Oxford, UK) infra-red cameras and 
passive reflective markers were used. The software package used for the data collection 
was Vicon Nexus, Vicon’s exclusive software. Once the data was collected, it was pre-
processed with a custom Matlab program detailed below.  
Camera setup and calibration  
Motion data collection was performed in the Human Performance Laboratory at 
Brian Blatchford building where 10 Vicon MTX40-s cameras are fixed on the ceiling 
(Figure 8.2). Before data collection, both static and dynamic calibrations were performed 
to extrapolate 3D coordinates from each 2D camera (Richards, 2008). For the static 
calibration and origin definition, a “T” shaped wand was placed onto the edges of the 
force plate (Figure 8.3). Also, a dynamic calibration was performed by moving the wand 
through the volume in which the cameras will record.  
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Figure 8.2: Vicon cameras and force plates layout 
 
Figure 8.3: Calibration wand on the coordinate origin. 
Kinetic data 
The ground reaction force was also collected with two fixed Kistler 9281B force 
platforms. These force platforms were aligned (Figure 8.3) and embedded in the gait lab 
ground to ensure a consisted height surface allowing the subject to walk normally. 
Participants were asked to walk over the force plates but were not instructed to hit them 
while walking. This was achieved by establishing a fixed walking starting point that 
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allowed them to take a few steps before making contact with the force plates, as well as 
assuring a consistent speed. The same self-selected speed used for the plantar pressure 
collection was used for this test. A total of 10 good trials were collected per subject. A 
trial was considered as good when the subject hit the platform with the leg where the 
markers were placed (see next section) within the correct speed range. 
Kinematic marker set and placement 
A multi-segment model for the foot developed in Salford University (Nester et 
al., 2014) was chosen in order to track the foot movement accurately. To this end, plates 
with sets of three non-collinear markers were located on each one of the foot segments 
(Figure 8.4). Also, static markers on the malleoli and internal and external epicondyles 
were used for the anatomical calibration. Marker sets with a diameter of 9 mm were 
attached to subject’s skin with double-sided tape. Motion data was collected on the leg 
most affected by neuropathy or the one with the highest PP in cases of bilateral 
neuropathy (Figure 8.4).  
Calcaneus segment was tracked by three markers. Two of them were vertically 
aligned on the posterior side of the calcaneus, one on the most proximal part of the bone, 
and the other one just above the plantar fat pad. The third marker was located on the 
lateral side of the calcaneus just above the plantar fat pad (Figure 8.4).  
The midfoot segment was tracked by an elongated plate with three markers 
attached to it. It was placed on the anterior side of the ankle, with the medial marker on 
the navicular tuberosity and the lateral marker towards the lateral malleoli (Figure 8.4). 
Medial forefoot segment was tracked with a triangular plate with three markers 
attached to it. It was placed with its straight side along the proximal part of the first 
metatarsal shaft towards the navicular (Figure 8.4). 
Lateral forefoot segment was tracked with a three marker plate located on top of 
the cuboid and running distally along the proximal part of the fifth metatarsal shaft 
(Figure 8.4). 
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Hallux segment was tracked by a plate attached to the top of the hallux with three 
markers attached to the plate with pins (Figure 8.4). This plate was fixed with tape to the 
distal phalange of the hallux and was used to define and track this segment.  
In addition to the multi-segment foot model, a segment for the shank was defined 
in order to help calculate ankle mobility. It was defined by static anatomical markers, and 
its movement was tracked with a plate of four markers. 
Shank segment was defined by four static markers, two on the malleoli and two 
on the internal and external epicondyles. The movement of this segment was tracked 
using a plate with four markers attached to it; that was placed on the distal third of the leg 
(Figure 8.4). 
 
Figure 8.4: Location of the different reflective markers used to define and track 
foot and ankle movement 
Motion data collection protocol 
Prior to the data collection, participants were instructed to wear shorts and to take 
their shoes and socks off. Reflective markers (see the previous section) were attached to 
their skin using double sided tape on the anatomical regions defined previously, which 
were located by palpation. Before motion collection, a static calibration was performed, 
after which the subject was asked to walk over the force platforms at the same self-
selected speed used for the plantar pressure (Chapter 5). A total of 10 good trials were 
collected per participant. For all trials, kinematic data was collected with the Vicon 
system at a rate of 100 Hz and force data at a rate of 1000 Hz. 
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8.4.2 Second visit  
Only in-shoe pressure data was collected on the second visit. Subjects were asked 
to walk with each one of the insole conditions that were designed for them. The data 
collection protocol is detailed in Chapter 5. The pressure data used in this study is the 
same used in the previous study (Chapter 7).  
8.5 Data analysis 
Each of the demographic and clinical variables outlined in Section 1.4 were 
summarised in an Excel sheet. BMI was calculated from height and weight, age from date 
of birth and tissue stiffness was averaged from the four different recordings taken. All 
variables collected are presented below (Table 8.1) with the associated ranges of 
measurement across all participants. 
Input feature Approximate Range of values 
Subject demographics  
BMI 21 – 45g/m2 
Foot Morphology Mm 
Arch height 25-40 
Joint mobility Degrees 
Inversion 15-25 
Eversion 5-15 
Ankle dorsiflexion 80-110 
1st MPJ 5-25 
Skin stiffness Hardness º shore A 
1st metatarsal head stiffness 450-600 
3rd metatarsal head stiffness 450-600 
5th metatarsal head stiffness 450-600 
Arch stiffness 250-400 
Heel stiffness 350-450 
Table 8.1: Variables collected during the 1st visit 
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8.5.1 Motion data analysis  
Once all data was collected, individual markers for each trial were labelled using 
Nexus Vicon® software, after which the raw marker data was exported to C3D format. 
This C3D data for each trial was then imported into the Visual 3D software which was 
used to perform the kinematic calculations. Firstly, a gap-filling algorithm was used to 
complete marker trajectories in which there was missing data for a maximum of ten 
frames. A 4th order Butterworth low-pass filter with a cut-off frequency of 12 Hz was then 
applied to remove noise. Low-pass filters eliminate the high-frequency component of the 
signal, removing the small random digitising and soft tissue errors. However, it should be 
noted that the filtering does not change the movement data itself (Richards, 2008). A low 
pass Butterworth filter was also used to filter the ground reaction force and free moment 
signals at 25 Hz. A footstep was defined from heel contact to toe-off and was determined 
using a threshold of 20 N.  
8.5.1.1 Kinematic model  
The static trial was used to define local coordinate systems for each segment. 
However, rather than define anatomically based coordinate systems for each of the 
individual foot segments, the coordinate system, used to define the shank (see segment 
descriptions above) was also used to define each foot segment coordinate system. Within 
these local coordinate systems, x was defined to be in the mediolateral direction, y in the 
anterior-posterior direction and z in the vertical direction. Segmental angular positions 
(joint angles) and joint velocities were then calculated relative to the laboratory system 
and also relative to adjacent segments using the Visual 3D software. For these joint 
angles, x defined the flexion-extension axis, y the abduction-adduction axis, and z the 
longitudinal axis. Although this kinematic analysis leads to a relatively large number of 
kinematic trajectories, only a small number were chosen to be included in the subsequent 
analysis. These variables were selected based on the hypotheses (outlined in section 
1.4.1.2; Table 8.2) about kinematic variables and the way in which they may affect the 
plantar pressure response to insole design. 
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Table 8.2: Kinematic parameters used as algorithm inputs 
8.6 Statistical analysis 
What factors influence an individual’s response to insole design? 
Stepwise logistic regression was used to understand the influence of the different 
clinical/biomechanical variables on the individual subject responses to different insole 
designs. Logistic regression is a statistical method that investigates the association 
between a dependent variable (i.e., PP change) and one or more independent variables 
(i.e., subject’s characteristics). With this approach, it is possible to understand the 
predictive ability of each of the independent variables on the dependent variable. With 
this technique, the independent variable that has the strongest association with the 
dependent variable is first included in the model. Then, the independent variable with the 
next strongest association is included and this process continues until no enhancement of 
the prediction is achieved. 
To perform a logistic regression, the dependent variable has to be categorical 
whereas the independent variables can be either categorical or scalar. For this analysis, 
the dependent variable was defined as “PP change” and was quantified, for each insole 
design separately, by deducting the PP for that insole from the PP recorded from the 
control shoe. This PP change was then converted to a categorical variable based on the 
level of variability observed in the repeatability study (Chapter 6) and is detailed in the 
following section. The subject’s characteristics were set as the independent variables. For 
each one of the subject’s characteristics, extreme groups were identified. The idea behind 
this approach was that the subjects with the extreme values (highest and lowest) for each 
variable would have the largest changes in PP. A detailed explanation of how these 
calculations were made is presented below.  
Variable Definition Unit 
1st MTP joint maximum 
angular velocity (x, y, z) 
The maximum angular velocity during 
stance for the 1st MTP joint. 
Radians 
Ankle joint maximum angular 
velocity (x, y, z) 
The maximum angular velocity during 
stance for the ankle joint. 
Radians 
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8.6.1 Dependent variable calculation: PP change 
The effect of the insole was calculated by deducting the PP obtained with each 
one of the insole conditions from the PP recorded with the control insole. The results 
obtained from this approach were positive when the insole condition had successfully 
decreased PP and negative in the cases that PP increased, such as hallux. These changed 
PP measures were then recoded based on thresholds of 55 KPa (for the metatarsal heads) 
and 80 KPa for the hallux, thresholds chosen based on the results obtained on the 
variability of plantar pressure collection in Chapter 5.  
Two separate logistic regression models were performed, one investigating the 
characteristics that influence a reduction in PP and a second investigating the 
characteristics that influenced an increase in PP. For the first analysis (investigating PP 
reduction), an insole was classified as effective at decreasing PP if the change in PP was 
larger than 55 KPa (or 80 KPa for the hallux region), otherwise, it was classified as non-
effective (Figure 8.5). For the second analysis (investigating PP increase), an insole was 
classified as effective at increasing PP if the change in PP was lower than -55 KPa (or - 
80 KPa for the hallux region), otherwise, it was classified as non-effective (Figure 8.5). 
 
Figure 8.5: Variable recode process for the effect on PP used in each of the logistic 
regression models 
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8.6.2 Independent variable calculation: extreme groups of subject’s 
characteristics  
The main aim of this study was to find associations between clear differences in 
the subject’s clinical/biomechanical variables (Section 1.4) with unequivocal differences 
in PP. Extreme groups were defined in order to define clear differences in each of the 
different clinical/biomechanical variables. Specifically, each variable was recoded into 
three categories, low, normal and high, based on the distribution of that variable (Figure 
8.6). To select the subjects that would go into each one of the categories, quartiles were 
calculated for each variable. With this approach, the group labelled as “low” included the 
subjects with values from the first quartile and the group labelled as “high” included the 
subjects from the upper quartile, with the remaining 50% of subjects in the “normal” 
group.  
 
Figure 8.6: Extreme groups for tissue stiffness under the 1st metatarsal head 
8.6.3 Logistic regression calculation 
Logistic regression analysis is used to explore the relationship and influence that 
one or several independent variables (subject’s characteristics) have on a dependent 
 171 
 
variable (change in PP). If two or more independent variables are studied, as was the case 
in this study, logistic regression can identify the combination of variables to predict the 
dependent variable. Furthermore, this analysis can be used to identify the independent 
variable which has the strongest influence on the dependent variable. There are different 
ways to find this combination, but for this study, the stepwise approach was used, where 
the independent variable with the strongest association is first introduced into the 
prediction equation. The next best predictor variable is then entered, and so on until a 
point is reached when no further enhancement of the model is achieved. 
In order to perform the logistic regression and associate specific variables with 
either a decrease or an increase in PP, it was necessary to hypothesise the potential effect 
of each variable on the PP change (see Table 8.3).  
Variable Hypotheses for PP reduction 
BMI Low 
Arch height Low 
Tissue stiffness Low 
Ankle joint mobility High 
1st MPJ mobility High 
Eversion High 
Inversion High 
1st MPJ joint maximum angular velocity High 
Ankle joint maximum angular velocity High 
Table 8.3: Hypothesis of which category will lead to PP reduction in the logistic 
regression model for each variable 
8.6.4 Logistic regression outcome variables 
The logistic regression results are represented by the odds ratio (OR) with its 95% 
confidence interval (95% CI), the p-value and the Nagelkerke square (r2). The OR 
represents the probability that the dependent variable (PP change) will occur given a 
particular category of the independent variable (high tissue stiffness) compared to the 
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odds of occurring in the baseline category (low tissue stiffness). In other words, it reflects 
the odds that PP will change in the presence of high tissue stiffness when compared to 
low tissue stiffness. The OR values ranged from 0 to infinite, where OR = 1 means that 
the independent variable has no influence on the dependent variable; OR < 1 implies that 
the independent variable is considered as a protective factor and for a value of OR > 1 the 
variable is considered as a risk factor. For example, an OR = 3 for skin stiffness would 
show that an individual with high skin stiffness would be three times more likely to 
exhibit high PP compared to individuals with low skin stiffness. 
 
Figure 8.7: OR interpretation. A change in PP would represent either an increase 
or decrease depending on the logistic regression model 
The 95% confidence interval (95% CI) was used to estimate the precision of the 
OR, with a large CI indicating a low level of precision of the OR, whereas a small CI 
indicates a higher precision of the OR. It was represented by the minimum and maximum 
of the OR with 95% confidence. 
The p-value represents the statistical significance associated with each regression 
coefficient within the model. It expresses the probability of OR ≠ 1 representing either a 
risk or a protection factor. 
The r2 is a measure of the proportion of variation in the dependent variable that 
can be attributed to the independent variables. It is a measure of the strength of the linear 
relationship between the dependent and the independent variables; the larger the value of 
r, the greater the linear relationship. 
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This study sought to address the following research questions: 
1. Which characteristics influence in-shoe PP reduction? 
2. Which characteristics influence in-shoe PP increase? 
3. Which characteristics could be used to inform the choice of insole design? 
To address the first two research questions, two separate logistic regression 
analyses were performed using the SPSS software for each individual condition and 
anatomical region. The first analysis was designed to explore factors which influence PP 
reduction (RQ 1) and the second, to explore factors which influence PP increase (RQ 2). 
To address the third research question, the results of the first two analyses were compared 
between the different insoles conditions to identify the characteristics that had an effect 
on PP and were common across insole conditions. Characteristics that also had an effect 
on PP but which were not common across insole conditions were also identified and, 
together, these findings were used to identify characteristics which could be used to 
inform insole prescription. For example, under the first metatarsal head, the characteristic 
high tissue stiffness featured in all significant regression analyses being associated with 
a PP reduction in four insole designs (base/distal metatarsal bars with both poron/EVA). 
However, low inversion ROM was only associated with PP reduction in one of the four 
significant regression analyses, base metatarsal bar condition and poron. Therefore, for 
patients with high tissue stiffness and low range of inversion, base metatarsal bar 
combined with poron would be appropriate for a PP reduction. However, for patients with 
a high range of inversion, poron as a cushioning material should be avoided.  
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8.7 Results 
8.7.1 Which characteristics influence in-shoe PP reduction? 
8.7.1.1 First metatarsal head 
Associations between subject’s characteristics and PP reduction were found on 
four of the nine insole conditions. No associations were found for proximal metatarsal 
bar position with poron or EVA, or for any of the metatarsal bar positions with a void. 
High tissue stiffness under the 1st metatarsal head was associated with the prevention of 
a PP reduction on four different insole conditions (Table 8.4). This shows that individuals 
with higher levels of tissue stiffness experienced a greater risk of higher PP under this 
anatomical region than those with low tissue stiffness in the four insole designs identified 
below. Moreover, a low range of inversion was three times more likely to lead to a lower 
PP with a poron base metatarsal bar. Finally, for the distal metatarsal bar combined with 
poron, a low 1st MPJ mobility was twice as likely to achieve PP reduction.  
Material 
condition 
Met bar 
position 
Subject’s 
variable 
OR 95% CI p-value r2 
EVA 
Base 1st tissue stiffness 0.290 0.099 - 0.851 0.024 0.147 
Distal 1st tissue stiffness 0.290 0.099 - 0.851 0.024 0.147 
Poron 
Base 
Inversion 3.090 1.038 - 9.202 0.043 
0.279 
1st tissue stiffness 0.212 0.067 - 0.673 0.08 
Distal 
1st MPJ ROM 2.574 1.013 - 6.542 0.047 
0.224 
1st tissue stiffness 0.266 0.085 - 0.830 0.023 
Table 8.4: Binary linear logistic regression results for predictors of reductions in 
PP under the 1st metatarsal head. 
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8.7.1.2 Central metatarsal heads 
Inversion was the best predictor of PP reduction with most insole designs (7 out 
of 9). No associations between subject’s characteristics and PP reduction were found for 
a distal metatarsal bar with both EVA and void. Contrary to our hypothesis, for most 
conditions, a low inversion ROM was associated with a PP reduction in most significant 
analyses (Table 8.5). Interestingly, for the base metatarsal bar combined with void, the 
opposite result was obtained for the inversion. However, although low ankle joint velocity 
was included in the model, it had a p > 0.05, which makes the association not reliable 
enough.  
Material 
condition 
Met bar 
position 
Subject’s 
variable 
OR 95% CI p-value r2 
EVA 
Proximal Inversion 3.761 1.342 - 10.353 0.012 0.143 
Base Inversion 3.761 1.342 - 10.353 0.012 0.171 
Poron 
Proximal Inversion 3.761 1.342 - 10.535 0.012 0.171 
Base Inversion 3.244 1.245 - 8.449 0.016 0.148 
Distal Inversion 4.025 1.390 - 11.654 0.010 0.182 
Void 
Proximal Inversion 8.191 2.212 - 30.328 0.002 0.311 
Base 
Ankle 
joint vel 
3.514 0.931 - 13.266 0.64 
0.377 
Inversion 0.931 1.981 - 42.853 0.005 
Table 8.5: Logistic regression results for predictors of PP reductions under 
central metatarsal heads  
No significant associations were found between a PP reduction and the subject’s 
characteristics for the 5th metatarsal head or the hallux. This may be explained by the 
results obtained in Chapter 7, where it was found that on average, PP on the hallux 
increased and under the 5th metatarsal heads, PP stayed approximately the same with all 
the insole conditions tested.  
  
 176 
 
8.7.2 Which characteristics influence in-shoe PP increase? 
8.7.2.1 First metatarsal head 
Associations between characteristics and PP increase were only found in two 
insole conditions. For the distal metatarsal bar position with EVA, a low range of 
inversion prevented the PP increase. This finding is consistent with the results for PP 
reduction under the central metatarsal heads (Table 8.6), which showed that PP reduction 
was 3 times more likely with a low range of inversion. Furthermore, for the proximal 
metatarsal bar position with poron, the low range of eversion, the opposite subtalar joint 
movement, prevented increases in PP. Finally, although low 1st MPJ range of movement 
was identified by the regression analysis, the p-value was greater than 0.05 and therefore 
the association may not be meaningful. 
Material 
condition 
Met bar 
position 
Subject’s 
variable 
OR 95% CI p-value r2 
EVA Distal Inversion 0.173 0.030 - 0.981 0.047 0.179 
Poron Proximal 
1st MPJ 6.478 0.771 - 54.436 0.085 
0.381 
Eversion 0.034 0.002 - 0.698 0.028 
Table 8.6: Binary linear logistic regression results for predictors of increase in PP 
under 1st metatarsal head 
 
8.7.2.2 Central metatarsal heads 
Significant associations between the characteristics and increases in PP were only 
found for the distal metatarsal bar with all three material conditions and for the proximal 
metatarsal bar with poron. For the distal metatarsal bar position with EVA, higher skin 
stiffness under both heel and the 1st metatarsal head was associated with a prevention of 
the increased PP. However, although tissue stiffness under the 1st metatarsal head was 
included in the model, the p > 0.05 and therefore, is not significant. Nonetheless, high 
tissue stiffness under the 1st metatarsal head was strongly associated with increased PP 
(OR > 16). Furthermore, increases in PP were four times more likely with high skin 
stiffness under the heel with the proximal metatarsal bar combined with a void. Finally, 
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a low range of eversion prevented a PP increase with a distal metatarsal bar combined 
with both poron and void.  
Material 
condition 
Met bar 
position 
Subject’s 
variable 
OR 95% CI 
p-
value 
r2 
EVA Distal 
1st 
durometer 
0.133 0.014 - 1.258 0.078 
0.362 
Heel 
durometer 
16.693 1.648 - 169.081 0.017 
Poron Distal Eversion 0.272 0.075 - 0.987 0.048 0.135 
Void 
Proximal 
Heel 
durometer 
4.048 1.085 - 15.105 0.037 0.150 
Distal Eversion 0.322 0.112 - 0.931 0.037 0.126 
Table 8.7: Logistic regression results for predictors of PP increase under 
central metatarsal heads  
 
8.7.2.3 Fifth metatarsal head 
An association between characteristics and PP increase was only found for the 
distal metatarsal bar with poron. For this condition, high tissue stiffness under the 1st 
metatarsal head prevented the PP increase. 
Material 
condition 
Metbar 
position 
Subject’s 
variable 
OR 95% CI p-value r2 
Poron Distal 
1st 
durometer 
0.106 0.011 - 0.982 0.048 0.240 
Table 8.8: Logistic regression results for predictors of PP increase under 
the 5th metatarsal head 
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8.7.2.4 Hallux 
Eversion was the variable that influenced PP most frequently under the hallux. 
Significant associations were found for four separate conditions (proximal/distal 
metatarsal bar combined with EVA). A low range of eversion movement prevented the 
PP increase in all cases. In addition to eversion, the PP increase was four times more 
likely when the ankle joint velocity was low in the proximal metatarsal bar and void 
condition. Moreover, the high tissue stiffness under the 1st metatarsal head of the distal 
metatarsal bar with void prevented an increase in PP.  
Material 
condition 
Met bar 
position 
Subject’s 
variable 
OR 
95% CI p-
value 
r2 
EVA  
Proximal Eversion 0.168 0.040 - 0.706 0.015 0.220 
Base Eversion 0.155 0.029 - 0.823 0.029 0.211 
Void Proximal 
Ankle 
joint vel 
4.369 
1.068 - 20.139 
0.041 
0.278 
Eversion 0.201 0.055 - 0.733 0.015 
Void Distal 
1st 
durometer 
0.198 
0.047 - 0.841 
0.028 0.185 
Table 8.9: Logistic regression results for predictors of the PP increase 
under the hallux  
 
8.7.3 Which characteristics could be used to inform the choice of insole 
design? 
At the first metatarsal head, high tissue stiffness was associated with a PP 
reduction for the base and distal metatarsal bars with both poron and EVA (Table 8.6). 
Given that high skin stiffness appeared to predict reductions in PP across all four 
conditions, the presence of high skin stiffness would support the use of a base or distal 
metatarsal bar with either EVA or poron. In addition, low inversion ROM was associated 
with PP reduction, but only with the base metatarsal head and poron (Table 8.6), 
therefore, for patients with high tissue stiffness and low inversion ROM, base metatarsal 
bar with poron may be the best choice to achieve a PP reduction. However, for patients 
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with a high range of inversion, poron as a cushioning material should be avoided. 
Furthermore, under the first metatarsal head, a low 1st MPJ ROM was found to be 
associated with a PP reduction with poron (Table 8.6), therefore, individuals with lower 
joint mobility may benefit from insoles incorporating poron, while it should be avoided 
in patients with higher 1st MPJ ROM. 
Under the central metatarsal heads, low eversion ROM was associated with a PP 
increase with the distal metatarsal bar position with both poron and void material 
conditions (Table 8.7), indicating that a distal metatarsal bar position should be avoided 
in patients with low eversion ROM.  
Under the first metatarsal, high tissue stiffness under the first metatarsal head 
prevented PP reduction but only for the distal metatarsal bar position. Interestingly, in the 
other forefoot regions, high tissue stiffness prevented a PP increase. Consequently, the 
distal metatarsal bar position may be the most appropriate design to prevent a PP increase 
in all regions apart from the first metatarsal head for patients with high tissue stiffness 
under the first metatarsal head.  
8.8 Discussion 
This study aimed to identify the factors influencing PP change (either increase or 
reduction), and from these to further understand which subject characteristics may be 
used to select an appropriate insole design. Logistic regression analyses were performed 
individually for each insole condition to understand the relationship between the subject 
characteristics and PP increase/decrease. These results were then compared between the 
different insoles conditions to identify the characteristics which may be used as a guide 
for insole prescription.  
The results revealed an association between PP change and the following 
characteristics: high 1st metatarsal head tissue stiffness, subtalar joint mobility MPJ ROM 
and ankle joint velocity (Table 8.10). Based on these findings and how they differed 
across different insole conditions, some prescription guidelines have been proposed, see 
section 8.7.3. 
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High 1st metatarsal head 
tissue stiffness 
Prevents PP reduction under the 1st metatarsal head 
Prevents a PP increase under the rest of the anatomical 
regions studied 
Subtalar joint ROM 
Low inversion contributes to a PP reduction under the 
central metatarsal heads 
Low eversion prevents a PP increase under all regions 
studied except 5th metatarsal head 
Low 1st MPJ ROM 
Contributes to PP reduction under the 1st metatarsal 
head with distal metatarsal bar 
Contributes to PP increase under 1st metatarsal head 
with proximal metatarsal bar 
Low ankle joint velocity 
Contributes to PP reduction under central metatarsal 
heads 
Contributes to PP increase under the hallux 
Table 8.10: Main results for characteristics that influence PP change 
This was the first study to investigate the relationship between the subject’s 
characteristics and PP change with an insole design. In contrast, all previous studies have 
aimed to predict PP, rather than PP changes. Despite this difference in methodology, it is 
still important to compare the findings of this study with those of previous research in this 
area. Following this comparison, the possible implications of these results in clinical 
practice are discussed. 
8.8.1 Structural subject’s characteristics that influence PP change 
1st metatarsal head tissue stiffness 
High tissue stiffness under the 1st metatarsal head was found to prevent PP 
reduction under the 1st metatarsal head (Table 8.10). The main function of plantar soft 
tissue is as a protective layer, to cushion the bony prominences and to prevent high PP. 
One of the consequences of peripheral neuropathy in patients with diabetes is tissue 
stiffening in the plantar aspect of their feet. This stiffening makes the tissues less capable 
of redistributing elevated pressures, which may explain why there is an ability of the 
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insole to reduce PP under the 1st MPJ when tissue stiffness is high. This effect, observed 
in this study, was also predicted by the finite element model developed by Gefen (2003), 
who showed an increased in PP under the first metatarsal head when the severity of 
diabetic stiffening of the plantar tissue was increased.  
In this study, high tissue stiffness under the 1st metatarsal head was shown to 
prevent a PP increase in the other forefoot regions (Table 8.10), the opposite to the effect 
under the 1st metatarsal head. This finding is consistent with the data reported by Mueller 
et al. (2003) who quantified foot structure using 3D images constructed from spiral X-
ray computed tomography. Structural measures were then related to PP data using 
regression analysis. Mueller et al. (2003) found that tissue stiffness under the 1st 
metatarsal head region explained some of the variability in plantar pressures observed in 
individuals under the central metatarsal heads. These results are in agreement with this 
study with regard to tissue stiffness under the 1st metatarsal head. However, they studied 
the variability in PP measurements, while the results in this study are based on PP change 
while wearing different insoles.  
8.8.2 Biomechanical characteristics that influence PP change 
1st MPJ ROM 
A low ROM at the 1st MPJ made the PP reduction twice as likely when compared 
with high range ROM under the 1st MPJ (Table 8.10). This association is consistent with 
the idea of the Windlass mechanism of the foot. At the final stages of the step, MPJ 
dorsiflexion produces a tightening of the plantar fascia and a supination on the foot. This 
transforms the foot into a rigid lever that contributes to the push-off (Menz&Morris, 
2006). Accordingly, a low ROM of the 1st MPJ would fail to tighten the plantar fascia 
and foot supination, causing this mechanism to fail. Thus, less force would be generated 
under this joint during the last stages of the step. Bryant et al. (1999) collected barefoot 
pressures on 30 control subjects, 30 subjects with hallux valgus and 30 subjects with 
hallux limitus. They found significantly lower pressures under the 1st metatarsal head in 
patients with hallux limitus, a finding which is consistent with our finding of a ROM at 
the 1st MPJ being linked to more pressure reduction. 
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In another study, Menz&Morris (2006) investigated plantar pressure in older 
people, collecting foot posture, ROM, muscle strength, sensation and toe deformity 
measurements. They found lower levels of PP in subjects with low ROM on the 1st MPJ. 
Again, this is consistent with the findings of our study. Turner et al. (2007) studied the 
effect of both ankle and 1st MPJ ROM on PP. They compared healthy subjects to people 
with diabetes both with and without ulceration history, collecting movements of the ankle 
joint complex and the 1st MPJ together with plantar pressures. Their results demonstrated 
a correlation between the gait 1st MPJ ROM and forefoot PP, again demonstrating 
consistency with the findings of our study. 
Interestingly, under the central metatarsal heads, a low 1st MPJ ROM was six 
times more likely to increase PP compared to high ROM (Table 8.10). It is important to 
note that this was the opposite effect to that observed under the 1st MPJ itself. It has been 
suggested that the inability of the 1st MPJ to plantarflex during the propulsive phase of 
gait leads to increased pressure under the hallux and also, a transfer of load to the other 
areas of the forefoot (Bryant et al., 1999). Our results are consistent with this concept 
proposed by Bryant et al. (1999) from data showing that subjects with hallux limitus had 
high PP under hallux, central and 5th metatarsal heads. In further support of this concept, 
Fernando et al. (2013) found that PP increased under the metatarsal heads with increasing 
1st MPJ ROM, suggesting that there was an increase in loading times at the metatarsal 
heads with lower 1st MPJ ROM. However, we did not find any association between this 
characteristic and the hallux PP. In another study, Payne et al. (2001) found that a 
decrease in the ROM of the 1st MPJ was associated with an increase in PP under the 
central metatarsal heads. Finally, Allan et al. (2015) suggested that this finding could 
potentially influence insole design or material selection to help reduce the pressure under 
the metatarsal.  
As explained above, there is evidence of an association between a low 1st MPJ 
ROM and elevated PP in central metatarsal heads (Payne et al., 2001). Furthermore, as 
these elevated pressures may lead to an increased risk of ulceration, a low 1st MPJ may 
increase the risk of ulceration. In line with this idea, Zimny et al. (2004) compared healthy 
subjects to both people with diabetes and neuropathy and history of ulceration and people 
with diabetes but without these risk factors for ulceration. They found a strong correlation 
between a PTI increase under metatarsal heads and reduced ROM in this joint. They also 
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reported that pressures were maintained for longer periods of time under at-risk areas, 
leading them to hypothesise that limited 1st MPJ ROM might be a factor in the 
pathogenesis of diabetic foot ulcers. In another study, Ledoux et al. (2005) investigated 
the feet of high-risk patients with diabetes, recording forefoot deformities as well as foot 
type. Interestingly, they found an association between hallux limitus and ulceration under 
the hallux. Finally, Viswanathan et al. (2003) tested four groups: patients with diabetes, 
patients with diabetes and neuropathy, patients with diabetes, neuropathy and history of 
ulceration and a healthy control group. Their data showed an increased PP to be associated 
with 1st MPJ ROM reduction in patients with a history of ulceration, leading them to 
conclude that both factors could be important determinants of foot ulceration in patients 
with diabetes. All these studies agree with our results showing that 1st MPJ ROM has a 
significant effect on PP under the forefoot. Despite the fact that we did not study 
ulceration risk, high PP has been shown to be one of the main risk factors for ulceration. 
Accordingly, it can be assumed that when high PP is present, the ulceration risk increases. 
Interestingly, our results show that distal metatarsal bar helps PP reduction in subjects 
with low 1st MPJ ROM, which is of key importance for ulcer prevention as shown 
previously in the studies discussed above. 
Subtalar ROM 
Inversion and eversion both had an effect on PP reduction for most of the 
anatomical regions studied. Specifically, a low range of inversion helps to reduce PP 
under the central metatarsal heads, with a low range of eversion preventing the PP 
increase under all anatomical regions except the 5th metatarsal head (Table 8.10). This 
offloading effect can be explained by a precise understanding of the anatomical function 
of this joint. The subtalar joint is also likely to play a key role in PP absorption and 
distribution throughout the different stages of the step (Rao et al., 2010). During heel 
strike, the subtalar joint moves into inversion, facilitating shock absorption and possibly 
reducing peak force and therefore reducing PP. Then, as the step progresses, it moves 
towards eversion, which is believed to unlock the forefoot, providing PP redistribution 
(Rao et al., 2010). It has been suggested that any reduction in the mobility of this joint 
may cause an increase in plantar pressure during walking (Fernando et al., 1991). 
Moreover, neuropathy produces a reduction in the ROM of this joint (Delbridge et al., 
1988, Rao et al., 2010), with the potential to increase peak pressure. 
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Based on the theory presented above, a lower range of movement on the subtalar 
joint should result in an increased PP. However, our results show that the low ROM of 
the inversion joint contributes to a PP reduction under the forefoot central metatarsal 
heads. Moreover, our results also showed that a low ROM of this joint eversion prevents 
the PP increase on all the anatomical regions studied except the 5th metatarsal head. The 
subtalar joint ROM used in this study were passive measurements rather than gait, but no 
differences have been found between passive and gait inversion/eversion ROM (Turner 
et al., 2007). Interestingly, in line with our results, Rao et al. (2010) compared dynamic 
foot function during gait in subjects with diabetes and neuropathy with control subjects. 
A multi-segment model of the foot was used in this study and barefoot plantar pressures 
were also collected. Similar to our results, they reported an association between a low 
range of eversion and PP reduction on the metatarsal heads. Therefore, the theory that 
reduced calcaneal eversion may result in a less mobile forefoot might not be completely 
correct and this “unlocking” mechanism might occur in earlier stages of the step. Our 
results show that both inversion and eversion help to reduce PP under the forefoot while 
wearing insoles. This reinforces the suggestion made by Rao et al. (2010) about the effect 
that subtalar joint movements have on the forefoot. 
Ankle joint velocity 
Our results show that the low ankle joint velocity contributed to a PP reduction 
under the central metatarsal heads and a PP increase on the hallux (Table 8.10). It has 
been previously shown that a low ankle ROM is associated with an increase in time spent 
during stance (Martinelli et al., 2013) and this may explain the link between ankle joint 
velocity and high pressure under the forefoot and hallux. Interestingly, the low ankle joint 
velocity predicted an increase in PP when present with a low range of eversion. A low 
range of eversion has been previously shown to help PP reduction under the metatarsal 
heads (Rao et al., 2010), which also agrees with our results. Accordingly, this PP increase 
under the hallux might be explained by the redistribution of PP from metatarsal heads 
(offloaded by a low range of eversion) to adjacent anatomical regions, such as hallux. In 
another study, Zimny et al. (2004) found a strong correlation between ankle ROM and an 
increase on PTI. Moreover, this PTI increase would result in an elevated time dependent 
load of the forefoot.  
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8.8.3 Characteristics that could be used to inform the choice of insole 
design  
To date, there has been very little research investigating the influences of different 
clinical or biomechanical characteristics on the individual patient response to insole 
design. Only one study, by van der Leeden et al. (2011), has attempted to predict the 
individual patient’s response to different insole prescriptions. However, they based their 
prediction on the patient’s satisfaction and pain reduction rather than quantifiable 
outcomes, such as plantar pressures. Moreover, they studied patients with rheumatoid 
arthritis, which are not comparable to the subjects studied in this work, who had diabetes 
and neuropathy. Therefore, in the discussion above, the focus was on previous studies of 
factors which have been shown to influence plantar pressure, rather than PP change with 
an insole design. The key findings of this research and associated explanations are 
outlined in the following sections. 
The main recommendations, outlined in Section 8.7.3, are summarised below: 
1. To reduce PP under the 1st metatarsal when high 1st MPJ tissue stiffness is present: 
a. Use a base metatarsal bar with poron if there is low 1st MPJ ROM.  
b. Use a distal metatarsal bar with poron if there is high 1st MPJ ROM. 
2. To reduce PP under the central metatarsal heads when both a low range of inversion 
and low ankle joint velocity are present use a base metatarsal bar with a void. 
3. To reduce PP under the hallux, central or 5th metatarsal heads when high 1st 
metatarsal head tissue stiffness is present use a distal metatarsal bar. 
In Chapter 7 (Section 7.5.1.2), the distal metatarsal bar position was shown to 
significantly reduce PP under the central metatarsal heads. In agreement with those 
findings, in this current study, a distal metatarsal bar position was shown to help to reduce 
PP under central metatarsal heads in the presence of high tissue stiffness under the 1st 
metatarsal head. Interestingly, in this study, the distal metatarsal bar position was also 
shown to be associated with higher PP under the 1st metatarsal head in the presence of 
high tissue stiffness under the 1st metatarsal head. This increase in pressure under the 1st 
metatarsal head with a distal metatarsal bar could be explained by the inability of the stiff 
tissue to cushion the metatarsal bar closer to the point of PP. Accordingly, for patients 
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with high tissue stiffness under the first metatarsal head, the distal metatarsal bar position 
may be an appropriate choice to prevent a PP increase under all the regions apart from 
the 1st metatarsal head.  
In the previous study, poron as the cushioning material was shown to effectively 
reduce PP under the 1st metatarsal head for all metatarsal bar positions (Chapter 7, Section 
7.5.1.1). It was also the material that most frequently lead to lower PP in the previous 
Chapter (Section 7.5.2). In agreement with those results, in this study poron was shown 
to contribute to lower PP under the 1st metatarsal head in the presence of high tissue 
stiffness and low ROM of the 1st MPJ.  
Another finding of this study was that the base metatarsal bar contributed to a PP 
reduction with high 1st MPJ ROM, and distal metatarsal bar in case of low 1st MPJ ROM. 
The lack of movement on the joint hinders the dorsiflexion that the metatarsal bar may 
try to produce at the 1st MPJ. Therefore, the closer the metatarsal bar is to the PP, the 
more effective it may be. These results are consistent with those presented in Chapter 7 
that showed that the combination of both base and distal metatarsal bars with poron 
significantly reduce PP under the 1st metatarsal head when compared to the control shoe 
(Section 7.5.3.1). 
In the previous study, the base metatarsal bar position was shown to lead to lower 
PP under the central metatarsal heads (Section 7.5.1.2). In line with these findings and 
based on the results presented in this study, it is possible that the base metatarsal bar 
position might help to prevent a PP increase under central metatarsal heads in subjects 
who have a low range of inversion and a low ankle joint velocity. In this case, the base 
metatarsal bar should be combined with a void as the material condition. However, in the 
previous chapter, this material condition did not have a significant effect on PP under 
central metatarsal heads, but it did under the hallux. Moreover, in this study, the results 
suggest that subjects with a high PP under the hallux should be prescribed a proximal 
metatarsal bar with void as material condition. Interestingly, this insole design was shown 
to produce a significant PP reduction under the hallux when compared to the control shoe 
in the previous study (Section 7.5.3.4). 
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8.9 Limitations 
This study has a number of limitations. The first is that the subjects chosen did 
not have a history of ulceration and such patients are likely to have a lower PP than 
subjects with a previous ulcer. Although this population is still at risk of suffering an 
ulcer, it is conceivable that they may exhibit lower changes in PP with the insole designs 
tested. Nevertheless, the aim of the study was to investigate the individual responses to 
customised insoles. To investigate this idea, a threshold-based approach was used to 
ensure that small (possibly measurement-related) changes in pressure did not influence 
the analysis. This cautious approach should ensure that only real changes in pressure were 
related to specific biomechanical and clinical characteristics. 
Another important limitation of this study is that a number of the different 
characteristics were measured using relatively simple tests. It is possible that these tests 
may not capture the true biomechanical and structural complexity which influences 
plantar pressure patterns. Nonetheless, most of the variables collected for this study can 
be easily collected in a typical clinical setting. This means that the findings are therefore 
more applicable to day-to-day clinical practice. 
Self-selected walking speed for each subject was used in this study by calculating 
an average from five separate preliminary walking trials. All subsequent trials were then 
accepted if the walking speed was with a ±10% tolerance. Although for many participants, 
it was possible to work to ±5% tolerance, the participants with diabetes were often not 
able to repeatedly walk within this tightly controlled speed range. Therefore, speed 
tolerance was increased to ±10% to ensure participants could complete the testing before 
becoming fatigued. However, research has shown that walking speed can influence 
plantar pressures (Segal et al., 2004), so, it is possible that some of the variability in the 
measurements could be attributed to differences in walking speed between the two days. 
However, the use of a defined 55 KPa (80 KPa for Hallux) threshold to identify the effect 
of any insole should have removed the effects of variation in walking speed within the 
10% threshold. 
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9 Summary of the findings 
 
The aim of this PhD was to gain an in-depth understanding of the role of 
technology in clinical practice and how it can be used improve insole design to reduce PP 
in medium-risk patients, such as those with diabetes and neuropathy. For this end, four 
different studies were designed. Firstly, a qualitative study (Study 1, Chapter 4) was 
performed to understand what practitioners base their clinical decisions on and the role 
of technology within current practice. Subsequently, three different quantitative studies 
were developed to gain a better understanding of how technology can be used for insole 
prescription and for predicting outcomes in medium-risk patients. The first quantitative 
study (Study 2, Chapter 6) tested the reproducibility of the plantar pressure collection. 
The second quantitative study (Study 3, Chapter 7) investigated the effect of 
systematically varying metatarsal bar and material properties on plantar pressure in fully 
customised CAD-CAM insoles. Finally, the third quantitative study (Study 4, Chapter 8) 
aimed to identify different subject characteristics that may influence an individual’s 
response to a customised insole design. 
9.1 Study 1: An exploration of current practice in relation to 
engagement with technology 
This study had three main aims: to identify 1) what variables practitioners base 
their prescription design on; 2) what processes are used for assessment and diagnosis of 
structural foot pathologies and 3) how technology fits within current practice. Focus 
groups were used to provide an ideal environment for a friendly, open dialogue where 
different ideas, habits and preferences on diagnosis and prescription were presented and 
discussed, but not necessarily agreed on. Two sets of focus groups were performed with 
a total of 17 podiatrists and orthotists with a broad expertise on lower limb pathologies 
and insole prescription. Different trigger questions were presented to start and throughout 
the discussion to guide and maintain the dialogue. Focus groups were digitally recorded 
and transcribed verbatim by a specialist transcription service. The transcripts were then 
analysed using an iterative approach to thematic analysis as described by (Attride-
Stirling, 2001, Darlington, 2002). The results were analysed and presented in two stages: 
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1) the preliminary themes were identified from field notes only and 2) the preliminary 
themes were compared with those obtained by all the co-researchers. They were discussed 
and an agreement was reached providing the final themes, subthemes and a final global 
theme as an overall conclusion.  
The results obtained showed that clinical orthotic practice is mainly based on 
training and experience and varies between practitioners, reflecting the integration of 
education with local factors. Decision making for a prescription involves a combination 
of the patient’s needs and expectations, as well as the treatment targets from the 
practitioner. Interestingly, the influence of research and evidence-based guidelines is 
limited and not regularly used in diagnosis and prescription. In general, technology is 
absent from clinical sites and is described as being too complex and time-consuming. 
However, practitioners agreed that technology would be helpful and appreciated that it 
has value and could be used to improve clinical practice. One of the most important 
aspects where technology was identified as being useful was in the measurement of 
outcomes from practice. Furthermore, a role for technology in developing a prescription 
and predicting insole effects was a common concern. The possibility of repeatable and 
accurate prescription and manufacturing provided by the CAD-CAM approach was also 
appreciated by the practitioners, but it is completely absent from clinical practice. They 
indicated that for them to invest in new technology, the real added value that it might 
provide to clinical practice had to be clear. This view shared by all the clinicians during 
the focus groups, motivated the development of different quantitative studies (Studies 2, 
3 and 4) to help to understand the areas where technology can enhance clinical practice. 
9.2 Insole design 
To investigate how technology can improve insole design, a set of nine different 
insoles were designed and manufactured using plantar pressure, 3D foot shape and CAD-
CAM. First, the 3D foot shape was used to customise the insole top surface using CAD 
software. The 3D foot shape was combined with the pressure data in order to locate the 
different defining points of the metatarsal bar and the void. These points were later 
transferred to the customised insole defining the metatarsal bar and the void distal shapes. 
Once the metatarsal bar and the void shapes had been designed on the base insole, two 
more insoles were designed by moving the metatarsal bar proximally and distally. This 
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process resulted in three different insole designs for each participant. Finally, the insoles 
were manufactured with a CAM system and two different materials were tailored to fit 
into the void space. This ultimately allowed the production of nine different insole designs 
using technology, which were subsequently investigated in the three different quantitative 
studies. 
9.3 Study 2: Reproducibility of plantar pressure collection 
using a wireless in-shoe pressure device 
PP are normally collected in order to assess the ulceration risk in patients with 
diabetes and neuropathy. For this assessment to be reliable, it has to be both precise and 
repeatable. However, repeated measurements of physiological/biomechanical variables, 
such as plantar pressures, are associated with some variability. This variability can arise 
both from variability in an individual’s capacity to repeat a given task, from 
errors/variability in the measurement processor and from the circumstances under which 
the measurements take place (de Vet et al., 2006). Reproducibility of in-shoe plantar 
pressure collection has been studied before by some authors who have demonstrated high 
agreement and reliability (Ramanathan et al., 2010, Sawacha, 2013, de Castro et al., 
2014). However, these studies found good results in healthy subjects while wearing 
standard shoes with a flat insole (Murphy et al., 2005, Putti et al., 2007, Ramanathan et 
al., 2010). Consequently, these findings may not extrapolate to patients with diabetes and 
neuropathy who often use complex customised insoles. This patient group are also likely 
to have impairments in balance associated with their neuropathy (Allet et al., 2008), 
which may affect cadence and foot biomechanics leading to inconsistent gait patterns 
(Allet et al., 2008). Therefore, a clear understanding of the level of reproducibility of 
plantar pressure measurement in people with diabetes and peripheral neuropathy is 
needed. 
To investigate the reproducibility of plantar pressure collection, pressure data was 
collected on two separate occasions from eight individuals with diabetes and peripheral 
neuropathy. On both visits, plantar pressures were collected using a Novel Pedar in-shoe 
pressure device while wearing standard shoes and different fully customised insoles. For 
each participant, a total of nine different insole designs were tested (Chapter 5), along 
 191 
 
with a standard contoured control insole in a controlled laboratory environment. The data 
from the two sessions was compared using SEM and ICC to quantify reproducibility.  
The results of this study showed that measurements from people with diabetes and 
neuropathy have a high level of variability. Specifically, SEMs under all metatarsal heads 
were around 25-30% of the average PP, in the corresponding region. The results for ICC 
were similar across the different anatomical regions tested, ranging from 0.4 to 0.6, 
demonstrating moderate to poor reliability. These results illustrate that there can be 
differences in repeated plantar pressure measurements in subjects with diabetes and 
neuropathy. It may, therefore, be difficult to differentiate between subjects and to prevent 
this, in Study 4, we adopted a threshold of 55 KPa (80 KPa for the hallux) above which 
we were confident of a true change in plantar pressure.  
This is the first study to investigate the reproducibility of plantar pressure 
collection in medium-risk patients while wearing customised insoles. Most previous 
research in this area has found high levels of reproducibility, however, the research was 
performed on healthy subjects despite elevated peak pressures being a risk factor for 
medium or high-risk patients. Importantly, the results of this study showed that 
measurements of people with diabetes and neuropathy have a high level of variability. 
This variability may be explained by the abnormal gait that has been reported in patients 
with diabetes and neuropathy (Fernando et al., 2014). Furthermore, an increase in 
unsteadiness has been observed in patients with diabetes, most likely due to a more rigid 
foot less adaptable to walking on different surfaces (Garcia-Alvarez et al., 2013, Allan et 
al., 2015). Other characteristics of this group include limited joint mobility, limited foot 
flexibility, a slower gait and a reduced stride (Fernando et al., 1991, Fernando et al., 
2013). It is likely that these differences may explain some of the variability observed in 
our study. However, further research is required to understand the separate influence of 
each characteristic on plantar pressure variability, and this needs to be factored into future 
plantar pressure interpretation.  
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9.4 Study 3: Understanding the effect of systematically 
varying insole design characteristics on in-shoe plantar 
pressure 
Insoles have shown to be an effective approach for offloading PP in patients with 
diabetes and neuropathy. However, a total contact insole on its own may not be sufficient 
to reduce PP in the diabetic foot (Hastings et al., 2007). The most common addition used 
to reduce PP under the forefoot is a metatarsal bar, which has been shown to be effective 
under the metatarsal heads (Hsi et al., 2005). However, the precise position of a metatarsal 
bar can have a considerable influence on pressure reduction under the metatarsal heads 
(Hayda et al., 1994, Hsi et al., 2005, Kang et al., 2006, Mueller et al., 2006, Hastings et 
al., 2007, Brodtkorb et al., 2008, Koenraadt et al., 2012). In addition, the use of soft and 
cushioning materials has also been studied and has shown to be effective for pressure 
offloading (Healy et al., 2012). In 2007, Paton et al. (2007). Of these materials, 6 mm 
poron offered the best results, and ethyl vinyl acetate was also cited as an effective 
material (Fernandez et al., 2013).  
Cushioning materials and metatarsal bars have both been shown to be effective 
for plantar pressure reduction. However, there have been no studies investigating the 
effect of material combined with a customised metatarsal bar position. To address this 
limitation in previous research and to ensure full reproducibility in designs, a CAD-CAM 
approach was chosen to design fully customised insoles for each participant based on foot 
shape and plantar pressure data, combining ay metatarsal bar and cushioning materials. 
With this approach, we expected to develop a better understanding of the effect of each 
addition, the interaction between additions, to identify the mean optimum design and to 
determine the real value of full customization. 
A total of sixty subjects with diabetes and neuropathy were tested while wearing 
the fully customised insoles. The results showed that the combination of a metatarsal bar 
with cushioning material was an effective approach for reducing PP. In general, 
cushioning materials led to a significantly lower PP under all metatarsal heads when 
compared to the void condition. Interestingly, there were no significant differences in PP 
between the different types of cushioning materials. Regarding the position of the 
metatarsal bar, both a base and distal metatarsal bar resulted in lower PP under the hallux 
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and central metatarsal heads. For the rest of the anatomical regions, the metatarsal bar 
position had no significant effect on PP.  
Base and distal metatarsal bar positions most frequently led to significantly lower 
PP under all anatomical regions. With regard to cushioning materials, poron was shown 
to achieve the lowest PP under the metatarsal heads most frequently. Taken together, the 
optimum conditions were the base and distal metatarsal bars combined with poron for 
metatarsal heads and the same combined with a void for the hallux. These designs also 
achieved PP reduction for the 1st and central metatarsal heads when compared to the 
control shoe. Interestingly, a PP increase can be appreciated with all of the insole designs 
tested on the hallux. Accordingly, we can conclude that the combination of a customised 
metatarsal bar and cushioning material is an effective approach for reducing PP under the 
metatarsal heads. These results show that the approach taken in clinical practice of 
combining metatarsal bars with a cushioning material is an effective approach to reducing 
PP under the metatarsal heads. However, it should be kept in mind that this design will 
lead to an increase in pressure under the hallux.  
To understand the importance of customization, PP values were compared for 
each anatomical region, the mean optimal design, the best individual design and the 
control shoe (Section 7.5.4). Furthermore, the results indicate that the PP distribution with 
the best subject design remained below 200 KPa for all regions. Moreover, customised 
insoles managed to reduce the high PP to below 200 KPa in 40% of the subjects. This PP 
reduction achieved aims to prevent ulceration which, in broader terms, would be highly 
beneficial not only to the patient but also the NHS, given that each diabetic foot ulcer 
prevented by a prescribed insole offers a potential cost saving of approximately £23,000 
(Paton et al., 2012).  
In this study, new technologies were used to design fully customised insoles to 
reduce PP in medium-risk patients. The customization of the insole top surface was 
performed using the 3D foot shape, which helped to redistribute PP throughout the plantar 
aspect of the foot. Moreover, the combination of plantar pressure measurements with a 
CAD system helped to accurately design and position the metatarsal bar, which has been 
previously shown to be crucial for PP reduction (Hayda et al., 1994, Weijers et al., 2003, 
Hastings et al., 2007). The results of this study show that technology can assist in the 
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design of insoles which are effective in reducing PP. Accordingly, clinical practice could 
benefit from the accuracy and reproducibility that new technologies can offer to insole 
design. 
9.5 Study 4: Identifying variables which may affect an 
individual’s response to insole design 
PP can be influenced by a range of different factors and it is possible that, as well 
as directly influencing pressure, these factors may also dictate the individual responses to 
different insole designs. Moreover, insoles are often prescribed to patients with similar 
characteristics, but insole response is not always positive and it may happen in different 
time periods for different subjects (Williams et al., 2016). Therefore, a more in-depth 
understanding is required of the effect of specific clinical, biomechanical and 
demographic characteristics on individual responses to different insole designs. Such an 
understanding would lead to effective clinical decision tools which could be used to target 
orthotic interventions more appropriately.  
This study aimed to identify which factors influence PP change (either increase 
or reduction) and to gain an understanding of which characteristics may affect an 
individual’s response to different insole designs. To address these aims, logistic 
regression analyses were used to explore the influence of a range of different 
characteristics on changes in peak plantar pressure. The results of this analysis were then 
compared across conditions to identify the different characteristics which influence 
pressure responses in a subset of the different insole conditions. This information was 
then used to make some tentative clinical recommendations. 
Several factors were identified which influenced changes in PP with the different 
insoles designs. These included high 1st MPJ tissue stiffness which was shown to prevent 
PP reduction under the 1st metatarsal head, but, in contrast, prevented an increase in PP 
across the other anatomical regions. Low inversion was shown to be associated with PP 
reduction under the central metatarsal heads, in contrast with the presence of low 
eversion, which was shown to prevent PP increase under all regions studied except the 5th 
metatarsal head. Finally, a low 1st MPJ ROM was shown to contribute to PP reduction 
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under the 1st metatarsal head, but this effect was only observed with a distal metatarsal 
bar. 
From the associations identified above, it was possible to make some tentative 
recommendations which may guide prescription of insoles incorporating metatarsal bars 
and cushioning materials. For example, for patients with high PP under the first metatarsal 
heads, we recommend a distal metatarsal bar position with poron if both high tissue 
stiffness and low 1st MPJ ROM are present. Furthermore, a base metatarsal bar with a 
void should be prescribed to reduce PP under the central metatarsal heads when there is 
a low range of inversion and low ankle joint velocity. 
This is the first study to provide insight into different factors that may influence 
an individual’s response to a specific insole design. The findings demonstrated clear links 
between both structure and biomechanical characteristics and changes in PP, which 
occurred with insoles incorporating metatarsal bars and cushioning materials. Although 
tentative, this allowed us to make some suggestions about insole prescription. These 
tentative suggestions were made based on customised insoles designed using technology. 
The results of this work show that technology can help to enhance medium-risk patient’s 
prescriptions and that the individual’s response to these prescriptions can be predicted to 
some extent. Accordingly, the integration of new technologies to help insole design could 
potentially help to predict treatment outcomes, which would add value to clinical practice. 
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10  Final conclusions and 
recommendations 
 
10.1 Recommendations and implications of plantar pressure 
reproducibility 
Our results suggest that reproducibility of PP in patients with diabetes and 
neuropathy while wearing customised insoles is not high. Interestingly, this finding 
contrasts with previous literature on healthy individuals which shows lower levels of 
variability. Clinicians should keep in mind that there is a variability of up to 55 KPa under 
the metatarsal heads and up to 85 KPa under the hallux on PP measurements in medium-
risk subjects. It is possible that smaller changes in PP are the result of variability in 
walking patterns and this should be factored into future plantar pressure analysis, both in 
research settings and in the clinic. Although technology is not used very frequently in 
day-to-day clinical practice, some practitioners who participated in our qualitative study 
reported using plantar pressure devices to test treatment efficacy in medium-risk patients 
or in cases where treatment was not successful. Clearly, this type of clinical interpretation 
of plantar pressure data needs to be performed with caution. 
Most of the papers reporting plantar pressure data recruit medium or high-risk 
subjects such as patients with diabetes or rheumatoid arthritis. However, they collect, 
analyse and interpret pressure data based on reproducibility results of healthy young 
subjects who are significantly different to the study population. Importantly, our results 
have highlighted the differences in reproducibility of plantar pressure data between 
healthy and pathological groups. Therefore, further research is required to fully 
understand the factors which affect the reproducibility of plantar pressure collection in 
medium or high-risk patients. In the meantime, the results of this study should be taken 
into consideration while interpreting plantar pressure data from research studies which 
focus on high-risk groups. 
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10.2 Recommendations regarding insole design 
The results showed that both a metatarsal bar and cushioning material are effective 
at reducing peak plantar pressures under high-risk regions of the foot. This approach has 
been used in clinical practice for medium and high-risk patients (Williams et al., 2016), 
but, until now, there was no evidence to support this practice. Our data shows that for 
patients with high PP under the metatarsal heads, a poron cushioning material combined 
with a base or distal metatarsal bar is the most effective design. The base metatarsal bar 
was located just behind the PP and this bar was moved distally 2% of the foot length (the 
process was detailed in Chapter 5). This finding is of great importance for patients with 
diabetes and neuropathy who have high PP that predisposes them to ulceration. However, 
results show that while the PP under the metatarsal heads was reduced, pressures under 
the hallux were increased. This should be kept in mind by practitioners who prescribe 
insoles to medium or high-risk patients, given that the hallux can be a common ulceration 
site. 
It was also found that fully customised insoles are beneficial for patients with high 
PP under the metatarsal heads. PP reduction was obtained under metatarsal heads with all 
customised designs when compared to the standard shoe alone. Moreover, results from 
Chapter 7 show that the PP distribution for the best subject insole design achieved values 
of 200 KPa or lower (Section 7.5.4). This finding is of key importance because 200 KPa 
was suggested in the literature as a safe threshold for ulceration prevention. Also, the best 
insole design across subjects achieved PP distributions slightly higher than 200 KPa but 
still lower that the control shoe. Accordingly, the results show that fully or semi-
customization is the best approach to reducing PP close to safe thresholds to prevent 
ulceration in medium-risk patients. 
In the final experimental study, a number of factors were identified which may 
influence changes in plantar pressure for different insole designs. Although this was an 
exploratory study, we were able to show that factors which are straightforward to measure 
in a clinical setting, such as joint mobility, may be useful in guiding future practice for 
the prescription of insoles with customised metatarsal bars and different material 
properties. Three main recommendations were suggested based on the insole design 
subject’s characteristics tested in this study: 
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1. In the case of high tissue stiffness under the 1st metatarsal head, use a distal 
metatarsal bar to offload central or 5th metatarsal heads and hallux and a base 
metatarsal bar to offload the 1st metatarsal head. 
2. To reduce PP under the 1st metatarsal head in a patient with high tissue stiffness 
under the 1st metatarsal head, a base metatarsal bar with poron should be prescribed 
if they have a low 1st MPJ ROM, and distal metatarsal bar with poron if the 1st MPJ 
ROM is high. 
3. To reduce PP under the central metatarsal heads when there is a low range of 
inversion and low ankle joint velocity, a base metatarsal bar with a void should be 
prescribed. 
 
10.3 Future research  
Study 1 (Chapter 4) was the first study to provide an insight into podiatric clinical 
practice in the UK and enabled us to understand the different influences on diagnosis and 
prescription habits. The sample recruited for this study was carefully selected to represent 
the full range of podiatry clinical practices in the UK and included professionals with a 
broad range of experience. However, further research is required to fully validate these 
findings, using larger samples drawn from a wider geographical area, to fully understand 
what influences clinical practice. Accordingly, national surveys could be performed 
targeting all practitioners that prescribe insoles to medium or high-risk patients. Another 
approach would be the creation of online platforms in which practitioners could share 
diagnosis and prescriptions, as well as review the latest publications or innovations. This 
type of work would lead to a more uniform consensus of diagnostic and prescription 
habits which would help to enhance and homogenise podiatry clinical practice across the 
UK. 
Study 2 (Chapter 6) was the first study investigating the reproducibility of plantar 
pressure collection with an in-shoe device in subjects with diabetes and neuropathy. 
Unlike all the previously published studies, the results obtained showed a high variability 
in plantar pressure collection (SEM ≈ 55 KPa). Further research is now required to better 
understand the factors which may influence the repeatability of plantar pressure data in 
medium or high-risk patients. These studies should collect PP data from medium or high-
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risk patients, such as those with diabetes or rheumatoid arthritis, along with 
biomechanical data on other factors, such as gait variability, balance and muscle function. 
Another factor which needs to be investigated is the influence of different time periods 
between testing sessions. This could be achieved in a study with three or four different 
visits with longer and shorter time lapses between them, such as the second visit two days 
after the first test, third visit one week after, and the fourth visit after one month.  
Study 3 (Chapter 7) showed that the combined effect of metatarsal bars and 
cushioning materials are an effective approach for reducing PP. However, the sample 
recruited for this study had no history of ulceration, and, as a result, appeared to exhibit 
lower pressures than other similar studies investigating high-risk groups. Therefore, it 
would be interesting to investigate the effect of both additions in subjects who would be 
considered a high-risk group and who would demonstrate very high PP. These studies 
could recruit subjects with foot deformities, such as claw toes or flat feet, which have 
been associated with both a higher PP and higher risk of ulceration in the literature. Also, 
subjects with a history of ulceration have a higher PP and represent a very high-risk 
population. The higher PP that these samples have may facilitate the understanding of the 
interaction effect of these two additions and the possible enhancing effect on PP 
reduction. 
Study 4 (Chapter 8) was designed to identify characteristics which could be tested 
in a clinical setting and could inform the decision-making process for insole prescription. 
As a result of the high variability in the pressure data (Study 2), we defined specific 
thresholds to identify insole conditions which had a definite effect on peak plantar 
pressures. However, it is likely that if patients with high pressures at baseline were tested, 
then larger differences in peak pressures may have been observed. This may have 
removed the need to impose thresholds and may have given a clearer indication of the 
different effects of the different insole designs and how these link to individual 
characteristics. Also, the characteristics used in this study were relatively simple and easy 
to measure in clinical practice. However, they may not be the most representative 
characteristics that influence PP. This emphasises the need for more advanced clinical 
tools to help practitioners measure more complex characteristics that may have an 
influence in PP, and therefore, in their prescription process. 
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More complex approaches such as Neural Networks might provide a more 
thorough understanding of the factors that influence PP behaviour. Another popular 
approach is FEMs, which are developing fast and becoming more accurate. This approach 
also has the advantage of offering the possibility of testing many different insole designs 
without the manufacturing costs and time-consuming testing sessions. Moreover, these 
research approaches could incorporate factors that are complex and hard to measure in 
real subjects. They could help narrow the number of variables that influence PP change 
in individuals, informing future studies on human subjects. The outcomes from these 
more complex studies might be useful for podiatrists who work in multidisciplinary 
departments and have access to more complex clinical tests. Moreover, they might 
provide a better understanding of why similar patients have different responses to the 
same prescription. 
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12 Appendix 1: Qualitative study 
university ethics approval  
 
 
Research, Innovation and Academic 
Engagement Ethical Approval Panel 
 
College of Health & Social Care 
AD 101 Allerton Building 
University of Salford 
M6 6PU 
 
T +44(0)161 295 7016 
r.shuttleworth@salford.ac.uk 
 
www.salford.ac.uk/ 
 
24 October 2012 
Dear Anita, 
RE: ETHICS APPLICATION HSCR12/62 – Current approaches to the 
prescription of foot orthoses and specialist footwear 
Following your responses to the Panel’s queries, based on the information you provided, 
I am pleased to inform you that application HSCR12/62 has now been approved. If there 
are any changes to the project and/ or its methodology, please inform the Panel as soon 
as possible. 
Yours sincerely, 
Rachel Shuttleworth 
Rachel Shuttleworth 
College Support Officer (R&I) 
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13 Appendix 2: Participant information 
sheet for the qualitative study 
 
 
PARTICIPANT INFORMATION SHEET  
What is the purpose of the study? 
Foot orthoses is one of the main interventions for foot related pathology. 
However, there is a lack of knowledge about how current approaches to the prescription 
in relation to the role of foot geometry and pressure, materials used, and how these factors 
are combined in a bespoke insole product. Further, it is unclear how practitioners 
prioritise those factors with greatest impact on the foot health of their patients and for 
their professional practice and how these factors might integrate with technology. This 
qualitative study aims to support the development of a set of technological devices and 
computer tools that will assist practitioners to achieve the best therapeutic orthotic 
prescription for their patients. 
Why have I been chosen? 
You have been chosen because you are a practitioner who has experience of 
prescribing foot orthoses.  
Do I have to take part? 
Taking part in the research is entirely voluntary.  It is up to you to decide whether 
or not to take part.  If you do decide to take part you will be given this information sheet 
to keep. If you take part you are still free to withdraw at any time and without giving a 
reason.  A decision to withdraw at any time during the study, or a decision not to take 
part, will not affect any current or future links that you may have with the University of 
Salford, Directorate of xxxx or the School of xx. 
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What will happen to me if I agree to take part? 
You will be contacted by the researcher whose details appear at the end of this 
information sheet. Any questions you may have will be answered. You will receive travel 
reimbursement and any other reasonable expenses. The study will take place between 
January 2013 and December 2013 at the University of Salford and a specific day and time 
will be provided to you. As we are using focus groups as the method to collect the data 
you will be in a group of 8 other practitioners. Each focus group will be facilitated by 
both Dr. Anita Williams and Dr. Ana Martínez Santos. Before the focus group starts, a 
presentation will be delivered on recent technological advancements in assessing patients 
for foot orthoses by Dr. Ana Martínez Santos.  
What are the possible disadvantages and risks of taking part? 
There are no physical risks associated with taking part in focus group work. It is 
acknowledged by the researchers that you, as a practitioner will be voicing your opinions 
and revealing your own thoughts on professional practice. We endeavour to create a 
respectful environment in which every participant will be supported to voice their 
opinions. Any unreasonable challenges or comments made by other members of the group 
will be dealt with sensitively by the facilitators. You are within your rights to withdraw 
from the process of data collection should you feel uncomfortable or unable to continue 
and you will be supported in this decision by Dr. Anita Williams and Dr. Ana Martínez 
Santos. If you do withdraw then you will be able to decide whether or not your 
contribution is included in transcription of the audio recording and the data analysis. 
What are the possible benefits of taking part? 
You will receive information about technology which has the potential to enhance 
the prescription of diabetic foot orthoses. You will also be able, as part of the focus group, 
to share good practice and also debate the challenges of the prescription process.  
Will my taking part in this study be kept confidential? 
Confidentiality will be maintained at all times through the study and in the use of 
data following the end point of the study.  All information which is collected during the 
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study will be locked in a secure filing cabinet and electronic data stored on a password 
protected computer and server at the University of Salford.  Any information about you 
will have your name and address removed so that you cannot be recognised from it and a 
code used for tracking you through the study. Only Dr. Anita Williams and Dr. Ana 
Martínez Santos will have access to your name and address for the purpose of initial 
contact, contact for the interviews and to post a summary of the results once the study has 
been completed. Data and personal information will not be provided to any third party. 
What will happen to the results of this research study? 
Once the research is complete the work will be published in professional journals 
and presented at conferences. A general acknowledgement for your contribution to the 
study will be included if you request this. Further, a summary of the results of this study 
will be sent to you for your own information. All paper records and recorded data will 
then be destroyed.  
Ethical Approval  
Ethical approval for this study has been obtained from The University of Salford 
Research Ethics Committee  
Contact for Further Information   
Dr. Anita Williams: a.e.williams1@salford.ac.uk 
Dr. Ana Martínez Santos: a.martinezsantos@edu.salford.ac.uk 
University of Salford 
Frederick Road, Salford, M6 6PU 
0161 295 7027 
 
Thank you for reading this Information sheet and considering your inclusion in this 
study 
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14 Appendix 3: Qualitative study 
participant consent form 
 
CONSENT FORM 
Study Title: Current approaches to the prescription of foot orthoses and specialist 
footwear 
Please initial each box if you agree 
1. I confirm that I have read and understand the information sheet dated XX/XX/XX 
version X) for the above study and have had the opportunity to ask questions. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any 
time, without giving any reason, without my current or future links with the University 
of Salford being affected. 
 
3. I agree to my verbal responses in the focus group being audio taped  
 
4. I understand that a pseudonym will replace my name in the results of this study when 
published or presented in any form. 
  
5. I request that I am acknowledged by name at the end of publications and presentations 
 
6. I agree to take part in the above study.    
 
Name of Participant ________________________________ Date___/___/___ 
Signature of Participant______________________________ 
 
Name of Person taking consent (if different from the researcher) _________________ 
Date___/___/___ Signature____________________________________________ 
 
Researchers name _____________________________________ Date___/___/___ 
Signature_____________________________________________ 
1 copy for participant; 1 copy for researcher 
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15 Appendix 4: Quantitative studies 
NHS ethics approval 
 
 
 
 
 
Dr Stephen Preece, 
School of Health Sciences, 
Centre for Health Sciences 
Research Office: P.O. 33, 
Brian Blatchford Building 
Fredierick Road Campus, 
University of Salford, 
Salford 
M6 6PU 
Research & Development Office 
F08, Pinewood House 
Stepping Hill Hospital 
Poplar Grove 
Stockport 
SK2 7JE 
Tel: 0161 419 5801 / 5814 
E-mail: 
research.development@stockport.nhs.uk 
 
 
 
04 November 2013 
Dear Dr Preece, 
Research Office Reference Number: 2013041 Project Title: SMARTPIF Diabetic 
insole design 
REC number: 13/NW/0331 
NIHR CSP No: 115521 
Thank you for your application for Research Office approval for the above study. 
I am pleased to confirm that we have now received and reviewed all necessary 
documentation, and Stockport NHS Foundation Trust has no objection to being a 
Participant Identification Centre (PIC) for this study. 
Please note, as a PIC, activity at Stockport will be limited to identifying eligible patients 
and sending out Patient Information Sheets and Patient Invitation Letters. 
I would like to take this opportunity to wish you well with your research. 
 
Yours sincerely, 
Christine Harvey 
Research & Development Manager 
 
cc: Dr Ana Martinez Santos 
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16 Appendix 5: Quantitative studies 
university ethics approval  
 
 
Research, Innovation and Academic 
Engagement Ethical Approval Panel 
 
College of Health & Social Care 
AD 101 Allerton Building 
University of Salford 
M6 6PU 
 
T +44(0)161 295 7016 
r.shuttleworth@salford.ac.uk 
www.salford.ac.uk 
 
13 December 2013 
 
Dear Ana, 
 
RE: ETHICS APPLICATION HSCR13/67 – SMARTPIF ‐ Smart tools for the 
prescription of orthopaedic insoles and footwear 
 
Based on the information you provided, I am pleased to inform you that application 
HSCR13/67 has now been approved. Please ensure that you include on the participant 
information sheet that the study has had R&D approval and University Ethics approval. 
If there are any changes to the project and/ or its methodology, please inform the Panel 
as soon as possible. 
 
 
Yours sincerely, 
 
Rachel Shuttleworth 
Rachel Shuttleworth 
College Support Officer (R&I)   
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17 Appendix 6: Quantitative studies 
participant information sheet 
School of Health, Sports and Rehabilitation Sciences 
Participant Information Sheet 
SMARTPIF – Diabetic insole design 
You are being invited to take part in a research study to help us develop a new 
way to prescribe insoles for people with DM. Before you decide, it is important for you 
to understand why the research is being done and what it will involve. This document 
gives you important information about the purpose, risks, and benefits of participating in 
the study.  Please take time to read the following information carefully. If you have any 
questions then feel free to contact the researcher whose details are given at the end of the 
document. Take time to decide whether or not you wish to take part.  
BACKGROUND TO THE STUDY 
People with DM are at risk of developing foot ulcers. To reduce this risk, special 
insoles are often prescribed to reduce pressure under the foot. These insoles are designed 
so that the pressures are not high under the foot, due a specific device and/or with a 
cushioning material. Although these insoles are used widely by diabetic patients, we do 
not know the best design for each individual. This research project will test how different 
design features change the pressure under the foot and develop a quick and simple way 
to choose the best insole design for each person. 
The study will involve 60 participants with DM. Participating in this study is 
completely voluntary and you may withdraw at any time. A decision to withdraw at any 
time, or a decision not to take part, will not affect the care you receive.  
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WHAT WILL HAPPEN TO ME IF I PARTICIPATE IN THIS STUDY? 
How long will it take? 
If you agree to take part in the study, you will be required to visit the movement 
science laboratory at Salford University on two or three occasions. The total time for each 
visit is 2-3 hours.  
The first visit will involve: 
 Taking consent (10 minutes) 
 Clinical tests on your feet (neuropathy, joints and skin tests) (10-15 min) 
 Scan of the shape of your foot (5 minutes) 
 Walk over a pressure measurement plate 10 or 20 times (15 mins) 
 Have reflective markers attached to your legs and feed and walk over a force 
plate whilst we record your way of walking (30 mins) 
 Walking up and down the assessment room in a specific pair of shoes whilst 
we measure pressure under your foot (10 minutes). 
The second visit will involve: 
 Walking up and down the assessment room 4 or 5 times in 10 different pairs 
of insoles (60 minutes)  
 You will then be offered to chance to keep and use a new pair of insoles (one 
of the set you have used during the testing) along with the shoes. It is up to 
you if you want to keep these insoles and shoes. If you do keep them then you 
will be required to visit the lab a third time (see details below). Before you 
take the new insoles/shoes we will ensure that they reduce pressure when 
compared to your current footwear choice. 
The third visit will involve: 
 Walking up and down the assessment room in the selected insoles used during 
the last two weeks (15-20 minutes) 
 In case you want to keep the insoles, you will be provided with a prescription 
which specifies the insole design so you can go to your podiatrist or 
orthopedist and ask for a new pair. 
 Measurement of the fatty pads under your foot (30 minutes) 
 232 
 
Further details on the specific tests?  
1. Consent and medical screening: We will first test your feet and legs for diabetic 
neuropathy. This will involve touching different parts of your foot with a vibrating 
tuning fork and then a thin wire and asking you if you can feel anything. The 
reflexes in your calf muscles will also be tested. Then we will perform some 
movements on your feet to measure how much do your joints move. 
2. Footscan: this will involve placing your foot in a box containing a number of 
special cameras which record data for approximately 5 seconds and then generate 
a 3D picture of your foot. 
3. Attaching reflective markers: You will be asked to wear shorts, 
and we will stick on your skin reflective markers on your hip, legs 
and foot. When all the markers are placed, you will be asked to 
walk up and down with them while specific cameras record your 
walking. These cameras only record the markers movement and 
send this data to a computer that will join them and make a schematic image of 
your legs and how they move. 
4. Walking in different pairs of insoles: We want to assess how 
different insole designs change the pressure under your foot as 
you walk. To do this we will use an in-shoe pressure 
measurement system which has a pressure sensing insole 
connected by wires to a transmitter worn on your waist, as 
shown in the picture opposite. You will be asked to walk in each 
pair of insoles for 3-5 minutes each whilst we record in-shoe pressures with this 
system.  
5. Measurement of the fatty pads under your foot: You will be asked to seat and 
your foot will be positioned using a specific boot to ensure that it remains still 
during testing and also permitting you to relax the foot. The device will push 
against the bottom of your foot, loading and then unloading the it in a similar way 
to walking. During this loading some ultrasound data will be collected to see how 
your skin behaves while changing pressure. This testing poses no risk to you as 
the loading is similar to that during normal walking. 
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Expenses 
The researcher team will arrange and pay for a taxi to pick you up and to take you 
back home at the end of each visit. If you prefer to make your own transport arrangements, 
we will refund any reasonable travel expenses.  
RISKS & POTENTIAL BENEFITS OF THE STUDY 
What risks are involved in participating in the study? 
This is a very simple, straight forward study with negligible risks. The foot 
pressure measurements will be operated by an experienced researcher, and involves well-
designed technical equipment that has been used for many years both in movement 
science laboratories and in routine patient care in hospitals around the world.  
In case you accept coming a third time and using the insoles we will offer you on 
the second visit, there is a small risk of blister formation. To avoid this from happening 
we will give you specific instructions to start using the insoles, and how to identify any 
risky area. 
If I participate in this study, can I also participate in other studies? 
As the testing for the SMARTPIF project only takes two or three visits and there 
is no on-going treatment or assessment taking part should not affect any other studies that 
you are involved in. However, if you are already taking part in other research, or would 
like to do so, please discuss this with the researcher (Dr Preece)  
What benefits are involved in participating in the study? 
You will be given a pair of insoles and footwear that assures a pressure reduction 
under your feet while walking. You will also be given a ”love2shop” £20 voucher in each 
visit that you can use in a wide range of stores. Furthermore, the results from your 
participation on this study, should improve our understanding of how to produce insoles 
for individuals with DM which reduce their chance of developing an ulcer. In the future 
this should enable us to quickly design and produce insoles which minimize pressure 
problems for people with DM; this will ultimately reduce the number of ulcers and 
complications, such as foot amputation. 
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What if something goes wrong? 
The university has insurance to cover against any harm to you which may occur 
whilst you are taking part in these tests. However, if you decide to take legal action, you 
may have to pay for this. If you wish to complain, or have any concerns about any aspect 
of the way you have been approached or treated during the course of this study, you can 
approach the University of Salford and if you are not happy you may then go through the 
standard NHS complaints procedure. 
ENDING THE STUDY 
What if I want to leave the study early? 
You can withdraw from this study at any time without loss of any non-study 
related benefits to which you would have been entitled before participating in the study. 
If you want to withdraw you may do so by notifying the study representative listed in the 
“Contact Information” section below. 
FINANCIAL INFORMATION 
Who is organizing and funding the research? 
The European Union is funding this study which is part of the SMARTPIF project. 
Will I be paid for participating? 
Although we are not permitted to pay cash we will offer each participant a 
love2shop £20 voucher, which can be used to buy goods from a wide range of different 
stores, each time you attend for testing at the University of Salford. 
CONFIDENTIALITY OF SUBJECT RECORDS 
Will my taking part in this study be kept confidential? 
All information which is collected about you during the course of the research 
will be kept strictly confidential. Any information about you which leaves the University 
of Salford will have your name and address and any other identifying features removed 
so that you cannot be recognized from it.  
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What will happen to the results of the research study? 
A summary of the research findings will be sent to everyone who participates in 
the experiments. Significant findings may be published in clinical and engineering 
journals.  
CONTACT INFORMATION 
If you require more information about the study, want to participate, or if you are 
already participating and want to withdraw, please contact 
Dr Ana Martínez 
Email:   a.martinezsantos@edu.salford.ac.uk 
Phone :  0161 295 5311 // 07756112637 
Address :  School of Health, Sport and Rehabilitation Sciences 
Room 34, Blatchford Building, University of Salford, 
Frederick Rd Campus, 
Salford  
M6 6PU 
If you have any complaints, please contact 
Anish Kurien 
R&I Manager 
Email:   A.kurien@salford.ac.uk  
Phone:   01612955276 
 
RECORD OF INFORMATION PROVIDED 
Your will receive a copy of the information sheet and a signed consent form to 
keep for your personal records. 
 
Thank you very much for taking time to read this document! 
We appreciate your interest in this study and hope to welcome you at the 
School of Health, Sport and Rehabilitation Sciences, University of Salford. 
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18 Appendix 7: Letter of invitation to 
participants for the quantitative 
studies  
(IN PRACTICE’S HEADED PAPER) 
 
-RESPECTIVE DATE- 
Dear --------Patient’s name--------, 
I am writing to you to offer you the chance to take part in a research study to 
develop new preventative insoles for patients with DM at the University of Salford. An 
information sheet with all the details of the study is enclosed.  If you would like to take 
part, or would like further information, please contact Dr Ana Martínez at the University 
by post, phone or email (details given below) who will arrange a suitable time for you to 
visit the University. If you choose to participate, the University will cover your travel 
expenses, any loss of earnings and offer you a £20 gift voucher. 
 If you do not wish to participate then please ignore this letter. 
Yours Faithfully, 
--------General Practitioner-------- 
Contact Details: 
Researcher’s Name:  Dr Ana Martínez 
Email:   a.martinezsantos@edu.salford.ac.uk 
Phone :  0161 295 5311 
Address :  School of Health Sciences 
Room 34 , Blatchford Building, 
University of Salford, 
Allerton Campus, 
Salford 
M6 6PU, 
Website:  http://www.healthcare.salford.ac.uk/ 
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19 Appendix 8: Radio script for 
quantitative studies recruitment 
 
 
Contact 
Global 
E:Sam.Young@Thisisglobal.com  T:0161 
6624753 
F:01612790354 
Client University of Salford Job / 
Audio ID 
 
Title "Insole Research" Duration 30" 
Creati
ve  
Sam Young Airtime Rachael Browne 
Produc
e By 
 TX Date  
Statio
n(s) 
Capital FM Manchester 
FVO - Bright, Professional. 
FVO: The University of Salford is currently researching how to design 
Insoles which will be used to treat a range of foot problems. We're 
looking for volunteers with DM to come to our lab and test our insoles. 
 If you're interested in getting involved in our research, and suffer with 
DM, then we'd like to hear from you. 
 All volunteers will receive payment for their time and have travel 
expenses covered. 
 For more information contact The University of Salford today simply 
text the word 'insole' to 81156 that's 'insole' to 81156. 
I have approved the contents of the above script and authorise Global Radio to proceed with production subject to the 
conditions of the Master Agreement.  All work remains copyright of Global Radio. 
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20 Appendix 9: Quantitative studies 
phone screening sheet 
Crib sheet for participants recruited through radio advert 
Basic information 
1. Name: 
2. Address: 
3. Phone: 
4. Shoe size : 
Recruitment information 
5. DM duration (at least 5 years)? 
6. Type DM?  
7. Neuropathic?   Yes   /   No 
8. Any surgery on the foot?   Yes   /   No 
9. Any foot deformity?   Yes   /  No 
10. Walking problems, e.g. are you able to walk for 2-3 minute spells several times?  
Yes   /   No 
11. Any balance problems, walk with cane?   Yes   /   No 
12. Feet problems, e.g.  current blisters, ulcers?   Yes   /   No 
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21 Appendix 10: Quantitative studies 
participant consent form 
Center Number: 
Study Number: 
Patient Identification Number for this trial: 
CONSENT FORM  
Title of Project:  
SMARTPIF – Diabetic insole design 
Name of Researcher: 
Ana Martínez, PhD, Postgraduate Research Student, School of Health Sciences, 
University of Salford, Salford, M6 6PU. 
Please initial the boxes: 
1. I confirm that I have read and understood the Patient Information Sheet 
dated ___________ (version 2) for the above study and have had the 
opportunity to ask questions. 
2. I understand that my participation is voluntary and that I am free to withdraw 
at any time, without giving any reason, without my medical care or legal 
rights being affected. 
3. I understand that sections of any of my medical notes and data collected 
during the study will be kept up to 5 years, and may be looked at by 
individuals from the University of Salford, from regulatory authorities 
or from the NHS trust, where it is relevant to my taking part in 
research. I give permission for these individuals to have access to my 
records. 
4. I agree to take part in the above study. 
Name of Patient   Date  Signature 
 Name of Researcher   Date  Signature 
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22 Appendix 11: 1st visit data collection 
sheet for the quantitative studies  
Subject nº: Date of birth: Shoe size: 
Weight: Height: Arch height: 
 
Neuropathy  
Monofilament 
 
1st 
toe 
3rd 
toe 
5th 
toe 
1ºMTF 3ºMTF 5ºMTF 
Med 
Arch 
Lat 
Arch 
Heel Dorsum 
Right           
Left           
Tuning fork 
 Med malleolus Lat malleolus 1st met head 5th met head 
Right     
Left     
Neuropathy Symptom Score (NSS)  
 
Unsteadiness in 
walking 
Burning, aching pain 
or tenderness 
Prickling 
sensation 
Numbness 
Right     
Left     
 
Joint mobility 
 1st toe ASA Inversion Eversion TPA knee flx TPA knee ext 
Right       
Left       
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Durometer 
 1ºMTF 3ºMTF 5ºMTF Med Arch Heel 
Right 
          
          
Left 
          
          
 
Motion capture 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Speed                
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23 Appendix 12: 2nd visit data collection 
sheet for the quantitative studies 
 
Subject nº 
Inshoe pressure (randomized) 
 1 2 3 4 5 6 7 8 9 10 
Shoe           
Stand           
Cond 1           
Cond 2           
Cond 3           
Cond 4           
Cond 5           
Cond 6           
Cond 7           
Cond 8           
Cond 9           
Cond 10           
 
 
